Form 10-Q
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2010
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to .
Commission file number: 1-32381
HERBALIFE LTD.
(Exact name of registrant as specified in its charter)
|
|
|
Cayman Islands
(State or other jurisdiction of
incorporation or organization)
|
|
98-0377871
(I.R.S. Employer
Identification No.) |
P.O. Box 309GT
Ugland House, South Church Street
Grand Cayman, Cayman Islands
(Address of principal executive offices) (Zip code)
(213) 745-0500
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files). Yes
o No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act. (Check one):
Large accelerated filer þ |
Accelerated filer o |
Non-accelerated filer o (Do not check if a smaller reporting company) |
Smaller reporting company o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act). Yes o No þ
Number
of shares of registrants common shares outstanding as of
April 29, 2010 was 59,951,384
PART I. FINANCIAL INFORMATION
|
|
|
Item 1. |
|
FINANCIAL STATEMENTS |
HERBALIFE LTD.
CONSOLIDATED BALANCE SHEETS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
|
(In thousands, except share amounts) |
|
ASSETS
|
|
|
|
|
|
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
165,271 |
|
|
$ |
150,801 |
|
Receivables, net of allowance for doubtful accounts of $4,493 (2010) and $3,982 (2009) |
|
|
87,484 |
|
|
|
76,958 |
|
Inventories |
|
|
146,440 |
|
|
|
145,962 |
|
Prepaid expenses and other current assets |
|
|
107,810 |
|
|
|
101,181 |
|
Deferred income taxes |
|
|
52,715 |
|
|
|
38,600 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
559,720 |
|
|
|
513,502 |
|
|
|
|
|
|
|
|
Property, at cost, net of accumulated depreciation and amortization of $160,082
(2010) and $147,392 (2009) |
|
|
172,702 |
|
|
|
178,009 |
|
Deferred compensation plan assets |
|
|
17,489 |
|
|
|
17,410 |
|
Deferred financing costs, net of accumulated amortization of $1,902 (2010) and $1,778
(2009) |
|
|
1,375 |
|
|
|
1,498 |
|
Marketing related intangibles and other intangible assets, net |
|
|
311,189 |
|
|
|
311,782 |
|
Goodwill |
|
|
102,549 |
|
|
|
102,543 |
|
Other Assets |
|
|
21,725 |
|
|
|
21,306 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
1,186,749 |
|
|
$ |
1,146,050 |
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
55,717 |
|
|
$ |
37,330 |
|
Royalty overrides |
|
|
136,902 |
|
|
|
144,689 |
|
Accrued compensation |
|
|
51,031 |
|
|
|
65,043 |
|
Accrued expenses |
|
|
106,805 |
|
|
|
107,943 |
|
Current portion of long-term debt |
|
|
3,372 |
|
|
|
12,402 |
|
Advance sales deposits |
|
|
48,429 |
|
|
|
22,261 |
|
Income taxes payable |
|
|
42,407 |
|
|
|
40,298 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
444,663 |
|
|
|
429,966 |
|
|
|
|
|
|
|
|
NON-CURRENT LIABILITIES: |
|
|
|
|
|
|
|
|
Long-term debt, net of current portion |
|
|
244,008 |
|
|
|
237,931 |
|
Deferred compensation plan liability |
|
|
17,673 |
|
|
|
16,629 |
|
Deferred income taxes |
|
|
78,376 |
|
|
|
77,613 |
|
Other non-current liabilities |
|
|
24,216 |
|
|
|
24,600 |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
808,936 |
|
|
|
786,739 |
|
|
|
|
|
|
|
|
CONTINGENCIES |
|
|
|
|
|
|
|
|
SHAREHOLDERS EQUITY: |
|
|
|
|
|
|
|
|
Common shares, $0.002 par value, 500.0 million shares authorized, 59.9 million (2010)
and 60.2 million (2009) shares outstanding |
|
|
120 |
|
|
|
120 |
|
Paid-in-capital in excess of par value |
|
|
227,604 |
|
|
|
222,882 |
|
Accumulated other comprehensive loss |
|
|
(26,508 |
) |
|
|
(23,396 |
) |
Retained earnings |
|
|
176,597 |
|
|
|
159,705 |
|
|
|
|
|
|
|
|
Total shareholders equity |
|
|
377,813 |
|
|
|
359,311 |
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity |
|
$ |
1,186,749 |
|
|
$ |
1,146,050 |
|
|
|
|
|
|
|
|
See the accompanying notes to unaudited consolidated financial statements.
3
HERBALIFE LTD.
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
|
(In thousands, except per share amounts) |
|
Product sales |
|
$ |
527,222 |
|
|
$ |
446,948 |
|
Handling & freight income |
|
|
91,411 |
|
|
|
74,735 |
|
|
|
|
|
|
|
|
Net sales |
|
|
618,633 |
|
|
|
521,683 |
|
Cost of sales |
|
|
140,472 |
|
|
|
102,400 |
|
|
|
|
|
|
|
|
Gross profit |
|
|
478,161 |
|
|
|
419,283 |
|
Royalty overrides |
|
|
207,319 |
|
|
|
175,532 |
|
Selling, general & administrative expenses |
|
|
206,883 |
|
|
|
181,458 |
|
|
|
|
|
|
|
|
Operating income |
|
|
63,959 |
|
|
|
62,293 |
|
Interest expense, net |
|
|
1,953 |
|
|
|
1,712 |
|
|
|
|
|
|
|
|
Income before income taxes |
|
|
62,006 |
|
|
|
60,581 |
|
Income taxes |
|
|
10,135 |
|
|
|
19,039 |
|
|
|
|
|
|
|
|
NET INCOME |
|
$ |
51,871 |
|
|
$ |
41,542 |
|
|
|
|
|
|
|
|
Earnings per share: |
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.86 |
|
|
$ |
0.68 |
|
Diluted |
|
$ |
0.83 |
|
|
$ |
0.67 |
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
Basic |
|
|
60,160 |
|
|
|
61,510 |
|
Diluted |
|
|
62,672 |
|
|
|
61,614 |
|
Dividends declared per share |
|
$ |
0.20 |
|
|
$ |
0.20 |
|
See the accompanying notes to unaudited consolidated financial statements.
4
HERBALIFE LTD.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
|
(In thousands) |
|
CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
|
|
|
|
|
|
Net income |
|
$ |
51,871 |
|
|
$ |
41,542 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
17,262 |
|
|
|
14,821 |
|
(Excess) Deficiency in tax benefits from share-based payment arrangements |
|
|
(2,606 |
) |
|
|
963 |
|
Share-based compensation expenses |
|
|
5,295 |
|
|
|
4,880 |
|
Amortization of discount and deferred financing costs |
|
|
124 |
|
|
|
121 |
|
Deferred income taxes |
|
|
(13,671 |
) |
|
|
586 |
|
Unrealized foreign exchange transaction (gain) loss |
|
|
(2,608 |
) |
|
|
6,537 |
|
Foreign exchange loss from adoption of highly inflationary
accounting in Venezuela |
|
|
15,131 |
|
|
|
|
|
Other |
|
|
1,078 |
|
|
|
919 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Receivables |
|
|
(12,048 |
) |
|
|
(4,047 |
) |
Inventories |
|
|
474 |
|
|
|
12,235 |
|
Prepaid expenses and other current assets |
|
|
(4,357 |
) |
|
|
979 |
|
Other assets |
|
|
(71 |
) |
|
|
750 |
|
Accounts payable |
|
|
19,311 |
|
|
|
(9,566 |
) |
Royalty overrides |
|
|
(7,081 |
) |
|
|
(1,035 |
) |
Accrued expenses and accrued compensation |
|
|
(14,022 |
) |
|
|
(6,703 |
) |
Advance sales deposits |
|
|
26,741 |
|
|
|
16,666 |
|
Income taxes payable |
|
|
5,566 |
|
|
|
6,574 |
|
Deferred compensation plan liability |
|
|
1,044 |
|
|
|
(206 |
) |
|
|
|
|
|
|
|
NET CASH PROVIDED BY OPERATING ACTIVITIES |
|
|
87,433 |
|
|
|
86,016 |
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES |
|
|
|
|
|
|
|
|
Purchases of property |
|
|
(11,623 |
) |
|
|
(14,073 |
) |
Proceeds from sale of property |
|
|
3 |
|
|
|
|
|
Deferred compensation plan assets |
|
|
(79 |
) |
|
|
612 |
|
|
|
|
|
|
|
|
NET CASH USED IN INVESTING ACTIVITIES |
|
|
(11,699 |
) |
|
|
(13,461 |
) |
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|
Dividends paid |
|
|
(12,065 |
) |
|
|
(12,300 |
) |
Borrowings from long-term debt |
|
|
102,000 |
|
|
|
19,000 |
|
Principal payments on long-term debt |
|
|
(104,951 |
) |
|
|
(25,487 |
) |
Share repurchases |
|
|
(28,010 |
) |
|
|
|
|
Excess (Deficiency in) tax benefits from share-based payment arrangements |
|
|
2,606 |
|
|
|
(963 |
) |
Proceeds from exercise of stock options and sale of stock under employee stock purchase plan |
|
|
1,888 |
|
|
|
365 |
|
|
|
|
|
|
|
|
NET CASH USED IN FINANCING ACTIVITIES |
|
|
(38,532 |
) |
|
|
(19,385 |
) |
|
|
|
|
|
|
|
EFFECT OF EXCHANGE RATE CHANGES ON CASH |
|
|
(22,732 |
) |
|
|
(9,284 |
) |
|
|
|
|
|
|
|
NET CHANGE IN CASH AND CASH EQUIVALENTS |
|
|
14,470 |
|
|
|
43,886 |
|
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD |
|
|
150,801 |
|
|
|
150,847 |
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS, END OF PERIOD |
|
$ |
165,271 |
|
|
$ |
194,733 |
|
|
|
|
|
|
|
|
CASH PAID DURING THE PERIOD |
|
|
|
|
|
|
|
|
Interest paid |
|
$ |
2,691 |
|
|
$ |
3,429 |
|
|
|
|
|
|
|
|
Income taxes paid, net |
|
$ |
13,430 |
|
|
$ |
13,374 |
|
|
|
|
|
|
|
|
NON CASH ACTIVITIES |
|
|
|
|
|
|
|
|
Assets acquired under capital leases and other long-term debt |
|
$ |
|
|
|
$ |
280 |
|
|
|
|
|
|
|
|
See the accompanying notes to unaudited consolidated financial statements.
5
HERBALIFE LTD.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Organization
Herbalife Ltd., a Cayman Islands exempted limited liability company, or Herbalife, was
incorporated on April 4, 2002. Herbalife Ltd. (and together with its subsidiaries, the Company)
is a leading global network marketing company that sells weight management, nutritional supplement,
energy, sports & fitness products and personal care products through a network of approximately 2.1
million independent distributors, except in China, where the Company currently sells its products
through retail stores, sales representatives, sales employees and licensed business providers. The
Company reports revenue in six geographic regions: North America, which consists of the U.S.,
Canada and Jamaica; Mexico; South and Central America; EMEA, which consists of Europe, the Middle
East and Africa; Asia Pacific (excluding China) which consists of Asia, New Zealand and Australia;
and China.
2. Basis of Presentation
The unaudited interim financial information of the Company has been prepared in accordance
with Article 10 of the Securities and Exchange Commissions, or the SEC, Regulation S-X.
Accordingly, it does not include all of the information required by generally accepted accounting
principles in the U.S., or GAAP, for complete financial statements. The Companys unaudited
consolidated financial statements as of March 31, 2010, and for the three months ended March 31,
2010 and 2009, include Herbalife and all of its direct and indirect subsidiaries. In the opinion of
management, the accompanying financial information contains all adjustments, consisting of normal
recurring adjustments, necessary to present fairly the Companys unaudited consolidated financial
statements as of March 31, 2010, and for the three months ended March 31, 2010 and 2009. These
unaudited consolidated financial statements should be read in conjunction with the Companys Annual
Report on Form 10-K for the year ended December 31, 2009, or the 2009 10-K. Operating results for
the three months ended March 31, 2010, are not necessarily indicative of the results that may be
expected for the year ending December 31, 2010.
Recently Adopted Accounting Pronouncements
In January 2010, the Financial Accounting Standards Board, or FASB, issued Final Accounting
Standards Update 2010-06, Improving Disclosures about Fair Value Measurements, or ASU 2010-06. ASU
2010-06 sets forth additional requirements and guidance regarding disclosures of fair value
measurements. ASU 2010-06 requires the gross presentation of activity within the Level 3 fair value
measurement roll forward and details of transfers in and out of Level 1 and 2 fair value
measurements. It also clarifies two existing disclosure requirements of Accounting Standards
Codification, or ASC, Topic 820, Fair Value Measurements and Disclosures, or ASC 820, relating to
the level of disaggregation of fair value measurements and disclosures on inputs and valuation
techniques. ASU 2010-06 is effective for fiscal years and interim periods beginning after December
15, 2009, except for the Level 3 roll forward, which is effective for fiscal years and interim
periods beginning after December 15, 2010. The adoption of this guidance did not have a material
impact to the Companys consolidated financial statements.
In June 2009, the FASB issued guidance to revise the approach to determine when a variable
interest entity, or VIE, should be consolidated. The new consolidation model for VIEs considers
whether the Company has the power to direct the activities that most significantly impact the VIEs
economic performance and shares in the significant risks and rewards of the entity. The guidance on
VIEs requires companies to continually reassess VIEs to determine if consolidation is appropriate
and provide additional disclosures. The guidance is effective for the Companys 2010 fiscal year.
The adoption of this guidance did not have a material impact to the Companys consolidated
financial statements.
3. Venezuelas Currency Restrictions and Highly Inflationary Economy
Currency restrictions enacted by the Venezuelan government in 2003 have become more
restrictive and have impacted the ability of the Companys subsidiary in Venezuela, Herbalife
Venezuela, to obtain U.S. dollars in exchange for Venezuelan Bolivars, or Bolivars, at the official
foreign exchange rate from the Venezuelan government and its Foreign Exchange Commission, CADIVI.
The application and approval processes have been intermittently delayed in recent periods. In
certain instances, the Company has made appropriate applications through CADIVI, for approval to
obtain U.S. dollars to pay for imported products and an annual dividend at the official exchange
rate. In other instances, in order to timely provide products to its distributors, the Company did
not submit
applications but instead has used a legal parallel market mechanism for payment. In this legal
parallel market Bolivars can be exchanged for U.S. dollars, but at a less favorable exchange rate
than the official rate.
6
Venezuelas
inflation rate as measured using the blended National Consumer Price Index and Consumer Price
Index rate exceeded the three-year cumulative inflation rate of 100% as of December 31, 2009.
Accordingly, effective January 1, 2010, Venezuela is considered a highly inflationary economy.
Pursuant to the highly inflationary basis of accounting, Herbalife Venezuela changed its
functional currency from the Bolivar to the U.S. dollar. Subsequent movements in the Bolivar
to U.S. dollar exchange rate will impact the Companys consolidated earnings. Beginning
January 1, 2010, based on the Companys current facts and
circumstances, the Company uses the
parallel market exchange rate for remeasurement purposes and the Company is no longer required
to translate Herbalife Venezuelas financial statements since their functional currency is now
the U.S. dollar. The Companys ability to access the official exchange rate and the parallel
market exchange rate could impact what exchange rates the Company will use for remeasurement
purposes in future periods.
On January 1, 2010, upon Venezuela being designated as a highly inflationary economy, the
Company recorded foreign exchange losses in its consolidated statement of income relating to the
remeasurement of Herbalife Venezuelas monetary assets and liabilities. The Company used the
parallel market exchange rate for remeasurement of Herbalife Venezuelas monetary assets and
liabilities on its opening balance sheet and recorded non-tax
deductible foreign exchange losses of $15.1 million primarily relating to Herbalife Venezuelas cash and cash equivalents. This charge included
a $9.9 million foreign exchange loss relating to Herbalife Venezuelas U.S. dollar cash and cash
equivalents that were remeasured at the less favorable parallel market rate and then translated at
the official rate at December 31, 2009, as discussed in the 2009 10-K. Also, Herbalife Venezuelas
$34.2 million cash and cash equivalents reported on the Companys consolidated balance sheet at
December 31, 2009, which included U.S. dollar denominated cash, was reduced to approximately $12.5
million on January 1, 2010. However, nonmonetary assets, such as inventory, reported on the
Companys consolidated balance sheet at December 31, 2009, remained at historical cost subsequent
to Venezuela becoming a highly inflationary economy. Therefore, the incremental costs related to
the Companys 2009 imported products recorded at the unfavorable parallel market exchange rate
negatively impacted the Companys first quarter 2010 consolidated statement of income by
approximately $12.7 million, non-tax
deductible, as these products were sold during the first quarter of
2010. See Note 9, Income Taxes, for additional discussion on
income tax impact related to Venezuela becoming highly inflationary.
In early January 2010, Venezuela announced an official exchange rate devaluation of the
Bolivar to an official rate of 4.30 Bolivars per U.S. dollar for non-essential items and 2.60
Bolivars per U.S. dollar for essential items. The Companys imports fall into both
classifications. Since the Company is using the unfavorable parallel market exchange rate for
remeasurement purposes, U.S. dollars obtained from CADIVI at the official rate could have a
positive impact to the Companys consolidated net earnings. During the three months ended March
31, 2010, $3.7 million foreign exchange gains were recorded in the Companys consolidated statement
of income as result of receiving U.S. dollars approved by CADIVI at the official exchange rate in
the first quarter of 2010 primarily relating to certain product importations in 2009 which were
previously registered with CADIVI. The Company continues to assess and monitor the current
economic and political environment in Venezuela. As of March 31, 2010, the parallel market rate
was approximately 38% and 62% less favorable than the official exchange rates for non-essential and
essential items, respectively.
4. Long-Term Debt
Long-term debt consists of the following:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2010 |
|
|
2009 |
|
|
|
(In millions) |
|
Borrowings under senior secured credit facility |
|
$ |
243.0 |
|
|
$ |
236.4 |
|
Capital leases |
|
|
4.4 |
|
|
|
4.8 |
|
Other debt |
|
|
|
|
|
|
9.1 |
|
|
|
|
|
|
|
|
Total |
|
|
247.4 |
|
|
|
250.3 |
|
Less: current portion |
|
|
3.4 |
|
|
|
12.4 |
|
|
|
|
|
|
|
|
Long-term portion |
|
$ |
244.0 |
|
|
$ |
237.9 |
|
|
|
|
|
|
|
|
Interest expense was $2.4 million and $3.3 million for the three months ended March 31, 2010
and 2009, respectively.
On July 21, 2006, the Company entered into a $300.0 million senior secured credit facility,
comprised of a $200.0 million term loan and a $100.0 million revolving credit facility, with a
syndicate of financial institutions as lenders. In September 2007, the Company and its lenders
amended the credit agreement, increasing the amount of the revolving credit facility by an
aggregate principal amount of $150.0 million to $250.0 million primarily to finance the increase in
its share repurchase program. See Note 11, Shareholders Equity, for further discussion of the
share repurchase program. The term loan bears interest at LIBOR plus a margin of 1.5%, or the
base rate plus a margin of 0.50%, and matures on July 21, 2013. The revolving credit facility
bears interest at LIBOR plus a margin of 1.25%, or the base rate plus a margin of 0.25%, and is
available until July 21, 2012. On March 31, 2010, and December 31, 2009, the weighted average
interest rate for the senior secured credit facility was 1.64% and 1.66%, respectively. The Company
incurred approximately $2.3 million of debt issuance costs in connection with entering into the
senior secured credit facility in July 2006, which are being amortized over the term of the senior
secured credit facility. The fair value of the Companys senior secured credit facility
approximates its carrying value.
7
The senior secured credit facility requires the Company to comply with a leverage ratio and an
interest coverage ratio. In addition, the senior secured credit facility contains customary
covenants, including covenants that limit or restrict the Companys ability to incur liens, incur
indebtedness, make investments, dispose of assets, make certain restricted payments, merge or
consolidate and enter into certain transactions with affiliates. As of March 31, 2010, the Company
was compliant with its debt covenants.
As of March 31, 2010, the Company is obligated to pay approximately $0.4 million of the term
loan every quarter until June 30, 2013, and the remaining principal on July 21, 2013. As of March
31, 2010 and December 31, 2009, the amounts outstanding under the term loan were $145.0 million and
$145.4 million, respectively.
During the first quarter of 2010, the Company borrowed an additional $102.0 million under the
revolving credit facility and paid $95.0 million of the revolving credit facility. As of March 31,
2010 and December 31, 2009, the amounts outstanding under the revolving credit facility were $98.0
million and $91.0 million, respectively.
Through the course of conducting regular business operations, certain vendors and government
agencies may require letters of credit to be issued. As of March 31, 2010 and December 31, 2009,
the Company had an aggregate of $2.6 million and $2.8 million, respectively, of issued but undrawn
letters of credit.
5. Contingencies
The Company is from time to time engaged in routine litigation. The Company regularly reviews
all pending litigation matters in which it is involved and establishes reserves deemed appropriate
by management for these litigation matters when a probable loss estimate can be made.
As a marketer of dietary and nutritional supplements and other products that are ingested by
consumers or applied to their bodies, the Company has been and is currently subjected to various
product liability claims. The effects of these claims to date have not been material to the
Company, and the reasonably possible range of exposure on currently existing claims is not material
to the Company. The Company believes that it has meritorious defenses to the allegations contained
in the lawsuits. The Company currently maintains product liability insurance with an annual
deductible of $10 million.
On April 16, 2007, Herbalife International of America, Inc. filed a Complaint in the United
States District Court for the Central District of California against certain former Herbalife
distributors who had left the Company to join a competitor. The Complaint alleged breach of
contract, misappropriation of trade secrets, intentional interference with prospective economic
advantage, intentional interference with contract, unfair competition, constructive trust and fraud
and seeks monetary damages, attorneys fees and injunctive relief. (Herbalife International of
America, Inc. v. Robert E. Ford, et al) The court entered a Preliminary Injunction against the
defendants enjoining them from further use and/or misappropriation of the Companys trade secrets
on December 11, 2007. Defendants appealed the courts entry of the Preliminary Injunction to the
U.S. Court of Appeals for the Ninth Circuit. That court affirmed, in relevant part, the Preliminary
Injunction. On December 3, 2007, the defendants filed a counterclaim alleging that the Company had
engaged in unfair and deceptive business practices, intentional and negligent interference with
prospective economic advantage, false advertising and that the Company was an endless chain scheme
in violation of California law and seeking restitution, contract rescission and an injunction. Both
sides engaged in discovery and filed cross motions for Summary Judgment. On August 25, 2009, the
court granted partial summary judgment for Herbalife on all of defendants claims except the claim
that the Company is an endless chain scheme which under applicable law is a question of fact that
can only be determined at trial. The court denied defendants motion for Summary Judgment on
Herbalifes claims for misappropriation of trade secrets and breach of contract. On March 9, 2010
the Court heard oral argument by the parties on Herbalifes motion for summary judgment to dismiss
the defendants sole remaining counterclaim, and a decision is pending. No date has been set for
trial. The Company believes that there is merit to its remaining claims for relief and that it has
meritorious defenses to the remaining counterclaim if the counterclaim is not dismissed by summary
judgment.
Certain of the Companys subsidiaries have been subject to tax audits by governmental
authorities in their respective countries. In certain of these tax audits, governmental authorities
are proposing that significant amounts of additional taxes and related interest and penalties are
due. The Company and its tax advisors believe that there are substantial defenses to their
allegations that additional taxes are owed, and the Company is vigorously contesting the additional
proposed taxes and related charges.
8
These matters may take several years to resolve. While the Company believes it has meritorious
defenses, it cannot be sure of their ultimate resolution. Although the Company has reserved an
amount that the Company believes represents the most likely outcome of the resolution of these
disputes, if the Company is incorrect in the assessment the Company may have to record additional
expenses.
6. Comprehensive Income
Total comprehensive income consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
|
(In millions) |
|
Net income |
|
$ |
51.9 |
|
|
$ |
41.5 |
|
Unrealized gain on derivative instruments, net of tax |
|
|
2.1 |
|
|
|
2.0 |
|
Foreign currency translation adjustment |
|
|
(5.2 |
) |
|
|
(10.7 |
) |
|
|
|
|
|
|
|
Comprehensive income |
|
$ |
48.8 |
|
|
$ |
32.8 |
|
|
|
|
|
|
|
|
7. Segment Information
The Company is a network marketing company that sells a wide range of weight management
products, nutritional supplements and personal care products within one industry segment as defined
under the FASB ASC Topic 280, Segment Reporting. The Companys products are manufactured by third
party providers, in the Companys Suzhou China facility, and in its recently acquired manufacturing
facility located in Lake Forest, California, and then are sold to independent distributors who sell
Herbalife products to retail consumers or other distributors. Revenues reflect sales of products to
distributors based on the distributors geographic location.
The Company sells products in 73 countries throughout the world and is organized and managed
by geographic regions. The Company aggregates its operating segments, excluding China, into one
reporting segment, or the Primary Reporting Segment, as management believes that the Companys
operating segments have similar operating characteristics and similar long term operating
performance. In making this determination, management believes that the operating segments are
similar in the nature of the products sold, the product acquisition process, the types of customers
to whom products are sold, the methods used to distribute the products, and the nature of the
regulatory environment. China has been identified as a separate reporting segment as it does not
meet the criteria for aggregation. The operating information for the Primary Reporting Segment
and China, and sales by product line are as follows:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
|
(In millions) |
|
|
|
|
|
|
|
|
|
|
Net Sales: |
|
|
|
|
|
|
|
|
Primary Reporting Segment |
|
|
|
|
|
|
|
|
United States |
|
$ |
146.7 |
|
|
$ |
119.1 |
|
Mexico |
|
|
71.8 |
|
|
|
59.2 |
|
Others |
|
|
367.7 |
|
|
|
316.6 |
|
|
|
|
|
|
|
|
Total Primary Reporting Segment |
|
|
586.2 |
|
|
|
494.9 |
|
China |
|
|
32.4 |
|
|
|
26.8 |
|
|
|
|
|
|
|
|
Total Net Sales |
|
$ |
618.6 |
|
|
$ |
521.7 |
|
|
|
|
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
|
(In millions) |
|
Operating Margin(1): |
|
|
|
|
|
|
|
|
Primary Reporting Segment |
|
|
|
|
|
|
|
|
United States |
|
$ |
67.2 |
|
|
$ |
57.0 |
|
Mexico |
|
|
24.2 |
|
|
|
26.3 |
|
Others |
|
|
150.1 |
|
|
|
137.8 |
|
|
|
|
|
|
|
|
Total Primary Reporting Segment |
|
|
241.5 |
|
|
|
221.1 |
|
China(2) |
|
|
29.3 |
|
|
|
22.6 |
|
|
|
|
|
|
|
|
Total
Operating Margin |
|
$ |
270.8 |
|
|
$ |
243.7 |
|
|
|
|
|
|
|
|
Selling,
general and administrative expenses(2) |
|
|
206.9 |
|
|
|
181.5 |
|
Interest expense, net |
|
|
1.9 |
|
|
|
1.7 |
|
|
|
|
|
|
|
|
Income before income taxes |
|
|
62.0 |
|
|
|
60.5 |
|
Income taxes |
|
|
10.1 |
|
|
|
19.0 |
|
|
|
|
|
|
|
|
Net Income |
|
$ |
51.9 |
|
|
$ |
41.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
|
(In millions) |
|
|
|
|
|
|
|
|
|
|
Net sales by product line: |
|
|
|
|
|
|
|
|
Weight Management |
|
$ |
387.2 |
|
|
$ |
329.2 |
|
Targeted Nutrition |
|
|
138.6 |
|
|
|
110.0 |
|
Energy, Sports and Fitness |
|
|
25.8 |
|
|
|
21.6 |
|
Outer Nutrition |
|
|
31.0 |
|
|
|
31.5 |
|
Literature, promotional and other(3) |
|
|
36.0 |
|
|
|
29.4 |
|
|
|
|
|
|
|
|
Total Net Sales |
|
$ |
618.6 |
|
|
$ |
521.7 |
|
|
|
|
|
|
|
|
Net sales by geographic region: |
|
|
|
|
|
|
|
|
North America(4) |
|
$ |
151.3 |
|
|
$ |
123.1 |
|
Mexico |
|
|
71.8 |
|
|
|
59.2 |
|
South and Central America |
|
|
91.3 |
|
|
|
75.3 |
|
EMEA(5) |
|
|
130.8 |
|
|
|
123.3 |
|
Asia Pacific(6) |
|
|
141.0 |
|
|
|
114.0 |
|
China |
|
|
32.4 |
|
|
|
26.8 |
|
|
|
|
|
|
|
|
Total Net Sales |
|
$ |
618.6 |
|
|
$ |
521.7 |
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Operating margin consists of
net sales less cost of sales and royalty overrides. |
|
(2) |
|
Compensation to China sales employees and service fees to
China licensed business providers totaling $16.2 million and $14.0 million, for the three
months ended March 31, 2010 and 2009, respectively, is included
in selling, general and administrative expenses while distributor
compensation for all other countries is included in royalty overrides. |
|
(3) |
|
Product buybacks and returns in all product categories are included in the literature,
promotional and other category. |
|
(4) |
|
Consists of the U.S., Canada and Jamaica. |
|
(5) |
|
Consists of Europe, Middle East and Africa. |
|
(6) |
|
Consists of Asia (excluding China), New Zealand and Australia. |
As of March 31, 2010 and December 31, 2009, total assets for the Companys Primary Reporting
Segment were $1,136.7 million and $1,097.1 million, respectively. Total assets for the China
segment were $50.0 million and $49.0 million as of March 31, 2010 and December 31, 2009,
respectively.
8. Share-Based Compensation
The Company has share-based compensation plans, which are more fully described in Note 9 to
the Consolidated Financial Statements in the 2009 10-K. During the three months ended March 31,
2010, the Company granted stock awards subject to continued service, consisting of stock units and
stock appreciation rights, with vesting terms fully described in the 2009 10-K. Also, during the
three months ended March 31, 2010, the Company granted other stock units to certain key employees
subject to continued service, one half of which vest on the first anniversary of the date of the
grant, and the remaining half of which vest on the second anniversary of the date of the grant.
10
For the three months ended March 31, 2010 and 2009, share-based compensation expense amounted
to $5.3 million and $4.9 million, respectively. As of March 31, 2010, the total unrecognized
compensation cost related to all non-vested stock awards was $28.9 million and the related
weighted-average period over which it is expected to be recognized is approximately 1.7 years.
The following tables summarize the activity under all stock-based compensation plans for the
three months ended March 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
Average |
|
|
|
|
|
|
|
|
|
|
Average |
|
|
Remaining |
|
|
Aggregate |
|
|
|
|
|
|
|
Exercise |
|
|
Contractual |
|
|
Intrinsic |
|
Stock Options & Stock Appreciation Rights |
|
Awards |
|
|
Price |
|
|
Term |
|
|
Value |
|
|
|
(In thousands) |
|
|
|
|
|
|
|
|
(In millions) |
|
Outstanding at December 31, 2009 |
|
|
7,372 |
|
|
$ |
24.84 |
|
|
5.9 years |
|
$ |
123.6 |
|
Granted |
|
|
174 |
|
|
$ |
41.15 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(204 |
) |
|
$ |
12.42 |
|
|
|
|
|
|
|
|
|
Forfeited |
|
|
(17 |
) |
|
$ |
31.29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2010 |
|
|
7,325 |
|
|
$ |
25.56 |
|
|
5.8 years |
|
$ |
152.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at March 31, 2010 |
|
|
4,402 |
|
|
$ |
20.85 |
|
|
4.7 years |
|
$ |
111.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
Average |
|
|
|
|
|
|
|
|
|
|
Grant Date |
|
|
Aggregate |
|
Incentive Plan and Independent Directors Stock Units |
|
Shares |
|
|
Fair Value |
|
|
Fair Value |
|
|
|
(In thousands) |
|
|
|
|
|
(In millions) |
|
Outstanding and nonvested at December 31, 2009 |
|
|
689.5 |
|
|
$ |
26.35 |
|
|
$ |
18.2 |
|
Granted |
|
|
18.3 |
|
|
$ |
39.82 |
|
|
|
0.7 |
|
Vested |
|
|
(167.5 |
) |
|
$ |
32.40 |
|
|
|
(5.4 |
) |
Cancelled |
|
|
(4.8 |
) |
|
$ |
22.86 |
|
|
|
(0.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
Outstanding and nonvested at March 31, 2010 |
|
|
535.5 |
|
|
$ |
24.95 |
|
|
$ |
13.4 |
|
|
|
|
|
|
|
|
|
|
|
|
The weighted-average grant date fair value of stock awards granted during the three months
ended March 31, 2010 and 2009 was $20.23 and $5.85, respectively. The total intrinsic value of
stock awards exercised during the three months ended March 31, 2010 and 2009, was $6.0 million and
$1.2 million, respectively.
9. Income Taxes
As of March 31, 2010, the total amount of unrecognized tax benefits, related interest, and
penalties was $38.8 million, $8.7 million and $2.5 million, respectively. During the three months
ended March 31, 2010, the Company recorded tax, interest, and penalties related to uncertain tax
positions of $0.6 million, $1.6 million and $0.1 million, respectively. During the three months
ended March 31, 2010, the unrecognized tax benefits were reduced by the expiration of the statutes
of limitations for tax of $1.1 million and interest of $0.3 million, which resulted in a year to
date net decrease for tax of $0.5 million and a net increase for interest of $1.3 million. The
unrecognized tax benefits relate primarily to uncertainties from international transfer pricing
issues and the deductibility of certain operating expenses in various jurisdictions. If the total
amount of unrecognized tax benefits were recognized, $38.8 million of unrecognized tax benefits,
$8.7 million of interest and $2.5 million of penalties, would impact the effective tax rate.
During the three months ended March 31, 2010, the Company benefited from the terms of a tax
holiday in the Peoples Republic of China. The tax holiday commenced on January 1, 2008 and will
conclude on December 31, 2012. Under the terms of the holiday, the Company was subject to a zero
tax rate in China during 2008 and 2009 and is subject to a graduated rate of 11% in 2010. The tax
rate will gradually increase during the years 2010-2012 to a maximum of 25%.
Venezuelas
cumulative inflation rate exceeded 100% during the three-year period ended
December 31, 2009. Therefore, beginning January 1, 2010, Venezuela is considered a highly
inflationary economy for U.S. federal income tax purposes. As a
result, for U.S. federal income tax purposes, Herbalife Venezuela is
required to account for its operations using the Dollar Approximate Separate Transactions Method of
accounting, or DASTM, and use the U.S. dollar as its functional
currency. The transitional impact of DASTM resulted
in a one-time deferred income tax benefit of approximately $14.5 million recorded during the three months ended
March 31, 2010.
11
10. Derivative Instruments and Hedging Activities
Interest Rate Risk Management
The Company engages in an interest rate hedging strategy for which the hedged transactions are
forecasted interest payments on the Companys variable rate term loan. The hedged risk is the
variability of forecasted interest rate cash flows, where the hedging strategy involves the
purchase of interest rate swaps. For the outstanding cash flow hedges on interest rate exposures at
March 31, 2010, the maximum length of time over which the Company is hedging certain of these
exposures is less than four years.
During August 2009, the Company entered into four interest rate swap agreements with an
effective date of December 31, 2009. The agreements, collectively, provide for the Company to pay
interest for less than a four-year period at a weighted average fixed rate of 2.78% on notional
amounts aggregating to $140 million while receiving interest for the same period at the one month
LIBOR rate on the same notional amounts. These agreements will expire in July 2013. These swaps
have been designated as cash flow hedges against the variability in the LIBOR interest rate on the
term loan at LIBOR plus 1.50%, thereby fixing the Companys weighted average effective rate on the
notional amounts at 4.28%. The Company formally assesses both at inception and at least quarterly
thereafter, whether the derivatives used in hedging transactions are effective in offsetting
changes in cash flows of the hedged item. As of March 31, 2010, the hedge relationships qualified
as effective hedges under FASB ASC Topic 815, Derivatives and Hedging, or ASC 815. Consequently,
all changes in the fair value of the derivatives are deferred and recorded in other comprehensive
income (loss) until the related forecasted transactions are recognized in the consolidated
statements of income. The fair value of the interest rate swap agreements are based on third-party
bank quotes. As of March 31, 2010 and December 31, 2009, the Company recorded the interest rate
swaps as liabilities at their fair value of $4.3 million and $2.6 million, respectively.
Foreign Currency Instruments
The Company also designates certain derivatives, such as certain foreign currency forward and
option contracts, as freestanding derivatives for which hedge accounting does not apply. The
changes in the fair market value of the derivatives are included in selling, general and
administrative expenses in the Companys consolidated statements of income. The Company uses
foreign currency forward contracts to hedge foreign-currency-denominated intercompany transactions
and to partially mitigate the impact of foreign currency fluctuations. The Company also uses
foreign currency option contracts to partially mitigate the impact of foreign currency
fluctuations. The fair value of the forward and option contracts are based on third-party bank
quotes.
The Company also purchases foreign currency forward contracts in order to hedge forecasted
inventory purchases and intercompany management fees that are designated as cash-flow hedges and
are subject to foreign currency exposures. The Company applied the hedge accounting rules as
required by ASC 815 for these hedges. These contracts allow the Company to sell Euros in exchange
for U.S. dollars at specified contract rates. As of March 31, 2010, the aggregate notional amounts
of these contracts outstanding were approximately $91.1 million and were expected to mature over
the next fifteen months. The Companys derivative financial instruments are recorded on the
consolidated balance sheet at fair value based on quoted market rates. Forward contracts are used
to hedge forecasted inventory purchases over specific months. Changes in the fair value of these
forward contracts, excluding forward points, designated as cash-flow hedges are recorded as a
component of accumulated other comprehensive income (loss) within shareholders equity, and are
recognized in cost of sales in the consolidated statement of income during the period which
approximates the time the hedged inventory is sold. The Company also hedges forecasted intercompany
management fees over specific months. Changes in the fair value of these U.S. dollar forward
contracts designated as cash flow hedges are recorded as a component of accumulated other
comprehensive income (loss) within shareholders equity, and are recognized in selling, general and
administrative expenses in the consolidated statement of income during the period when the hedged
item and underlying transaction affect earnings. As of March 31, 2010, and December 31, 2009, the
Company recorded assets at fair values of $5.3 million and $2.3 million, respectively, relating to
all outstanding foreign currency contracts designated as cash-flow hedges. The Company assesses
hedge effectiveness and measures hedge ineffectiveness at least quarterly. During the quarter ended
March 31, 2010, the ineffective portion relating to these hedges was immaterial and the hedges
remained effective as of March 31, 2010.
As of March 31, 2010, substantially all of the Companys outstanding foreign currency forward
contracts have maturity dates of less than fifteen months with the majority of freestanding
derivatives expiring within six months. There were no foreign currency option contracts outstanding
as of March 31, 2010. See Part I, Item 3 Quantitative and Qualitative Disclosures About Market
Risk in this Quarterly Report on Form 10-Q for foreign currency instruments outstanding as of March
31, 2010.
12
Gains and Losses on Derivative Instruments
The following table summarizes gains (losses) relating to derivative instruments recorded in
other comprehensive loss during the three months ended March 31, 2010 and 2009:
|
|
|
|
|
|
|
|
|
|
|
Amount of Gain (Loss) Recognized |
|
|
|
in Other Comprehensive Loss |
|
|
|
For the Three Months Ended |
|
|
|
March 31, 2010 |
|
|
March 31, 2009 |
|
|
|
(In millions) |
|
Derivatives designated as hedging instruments: |
|
|
|
|
|
|
|
|
Foreign exchange currency contracts relating to
inventory and intercompany management fee hedges |
|
$ |
5.1 |
|
|
$ |
2.4 |
|
Interest rate swaps |
|
$ |
(2.5 |
) |
|
$ |
|
|
The following table summarizes gains (losses) relating to derivative instruments recorded to
income during the three months ended March 31, 2010 and 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of Gain (Loss) |
|
|
|
|
|
Recognized in Income |
|
|
|
|
|
For the Three Months Ended |
|
|
Location of Gain (Loss) |
|
|
March 31, 2010 |
|
|
March 31, 2009 |
|
|
Recognized in Income |
|
|
(In millions) |
|
|
|
Derivatives designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
Foreign exchange currency contracts relating to
inventory hedges and intercompany management fee hedges (1) |
|
$ |
(0.1 |
) |
|
$ |
(0.2 |
) |
|
Selling, general and administrative expenses |
Derivatives not designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
Foreign exchange currency contracts |
|
$ |
(7.5 |
) |
|
$ |
(0.3 |
) |
|
Selling, general and administrative expenses |
|
|
|
(1) |
|
For foreign exchange
contracts designated as hedging instruments, the $0.1 million
and $0.2 million loss
recognized in income represents the amounts excluded from the assessment of hedge
effectiveness. There were no ineffective amounts reported for derivatives designated as
hedging instruments. |
The following table summarizes gains (losses) relating to derivative instruments reclassified
from accumulated other comprehensive loss into income during the three months ended March 31, 2010
and 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Location of Gain (Loss) |
|
|
Amount of Gain (Loss) Reclassified |
|
|
Reclassified |
|
|
from Accumulated Other Comprehensive |
|
|
from Accumulated Other |
|
|
Loss into Income |
|
|
Comprehensive |
|
|
For the Three Months Ended |
|
|
Loss into Income |
|
|
March 31, 2010 |
|
|
March 31, 2009 |
|
|
(Effective Portion) |
|
|
(In millions) |
|
|
|
Derivatives designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
Foreign exchange currency contracts relating to
inventory hedges |
|
$ |
(0.6 |
) |
|
$ |
|
|
|
Cost of sales |
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange currency contracts relating to
intercompany management fee hedges |
|
$ |
1.6 |
|
|
$ |
|
|
|
Selling, general and administrative expenses |
Interest rate contracts |
|
$ |
(0.9 |
) |
|
$ |
(0.4 |
) |
|
Interest expense, net |
The Company reports its derivatives at fair value as either assets or liabilities within its
consolidated balance sheet. See Note 13, Fair Value Measurements, for information on derivative
fair values and their consolidated balance sheet location as of March 31, 2010, and December 31,
2009.
13
11. Shareholders Equity
Dividends
On February 19, 2010, the Companys board of directors approved a quarterly cash dividend of
$0.20 per common share in an aggregate amount of $12.1 million, for the fourth quarter of 2009 that
was paid to shareholders on March 16, 2010. The aggregate amount of dividends declared and paid
during the three months ended March 31, 2010 and 2009 were $12.1 million and $12.3 million,
respectively.
Share Repurchases
On April 17, 2009, the Companys share repurchase program adopted on April 18, 2007 expired
pursuant to its terms. On April 30, 2009, the Company announced that its board of directors
authorized a new program for the Company to repurchase up to $300 million of Herbalife common
shares during the next two years, at such times and prices as determined by the Companys
management. During the three months ended March 31, 2010, the Company repurchased approximately 0.6
million of its common shares through open market purchases at an aggregate cost of approximately
$25.0 million or an average cost of $41.42 per share. As of March 31, 2010, the remaining
authorized capacity under the Companys share repurchase program was approximately $201.8 million.
The aggregate purchase price of the common shares repurchased was reflected as a reduction to
shareholders equity. The Company allocated the purchase price of the repurchased shares as a
reduction to retained earnings, common shares and additional paid-in-capital.
The number of shares issued upon vesting or exercise for certain restricted stock units and
stock appreciation rights granted, pursuant to the Companys share-based compensation plans, is net
of the minimum statutory withholding requirements that the Company pays on behalf of its employees.
Although shares withheld are not issued, they are treated as common share repurchases for
accounting purposes, as they reduce the number of shares that would have been issued upon vesting.
12. Earnings Per Share
Basic earnings per share represents net income for the period common shares were outstanding,
divided by the weighted average number of common shares outstanding for the period. Diluted
earnings per share represents net income divided by the weighted average number of common shares
outstanding, inclusive of the effect of dilutive securities such as outstanding stock options,
stock appreciation rights, stock units and warrants.
The following are the common share amounts used to compute the basic and diluted earnings per
share for each period:
|
|
|
|
|
|
|
|
|
|
|
For the Three Months |
|
|
|
Ended March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
|
(In thousands) |
|
Weighted average shares used in basic computations |
|
|
60,160 |
|
|
|
61,510 |
|
Dilutive effect of exercise of equity grants outstanding |
|
|
2,319 |
|
|
|
61 |
|
Dilutive effect of warrants |
|
|
193 |
|
|
|
43 |
|
|
|
|
|
|
|
|
Weighted average shares used in diluted computations |
|
|
62,672 |
|
|
|
61,614 |
|
|
|
|
|
|
|
|
Equity
grants, consisting of stock options, stock appreciation rights, and
stock units, of an aggregate of 1.8
million and 3.7 million were outstanding during the three months ended March 31, 2010 and 2009,
respectively, but were not included in the computation of diluted earnings per share because their
effect would be anti-dilutive.
13. Fair Value Measurements
The Company applies the provisions of ASC 820 for its financial and non-financial assets and
liabilities. ASC 820 defines fair value as the price that would be received to sell an asset or
paid to transfer a liability in an orderly transaction between market participants at the
measurement date. ASC 820 establishes a fair value hierarchy, which prioritizes the inputs used in
measuring fair value into three broad levels as follows:
Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or
liabilities that the reporting entity has the ability to access at the measurement date.
14
Level 2 inputs include quoted prices for similar assets or liabilities in active markets,
quoted prices for identical or similar assets or liabilities in markets that are not active,
inputs other than quoted prices that are observable for the asset or liability and inputs that
are derived principally from or corroborated by observable market data by correlation or other
means.
Level 3 inputs are unobservable inputs for the asset or liability.
The Company measures certain assets and liabilities at fair value as discussed throughout the
notes to its consolidated financial statements. Foreign exchange
currency contracts are based on observable forward and spot rates.
Interest rate swaps are estimated based on LIBOR/swap yield curves at the
reporting date. Assets or liabilities that have recurring
measurements and are measured at fair value consisted of Level 2 derivatives and are shown below at
their gross values at March 31, 2010, and December 31, 2009:
Fair Value Measurements at Reporting Date Using
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Significant |
|
|
Significant |
|
|
|
|
|
Other |
|
|
Other |
|
|
|
|
|
Observable |
|
|
Observable |
|
|
|
|
|
Inputs |
|
|
Inputs |
|
|
|
|
|
(Level 2) |
|
|
(Level 2) |
|
|
|
|
|
Fair Value at |
|
|
Fair Value at |
|
|
|
Derivative Balance Sheet |
|
March 31, |
|
|
December 31, |
|
|
|
Location |
|
2010 |
|
|
2009 |
|
ASSETS: |
|
|
|
|
|
|
|
|
|
|
Derivatives designated as cash flow hedging instruments: |
|
|
|
|
|
|
|
|
|
|
Foreign exchange currency contracts relating to inventory
and intercompany management fee hedges |
|
Prepaid expenses and other current assets |
|
$ |
5.3 |
|
|
$ |
2.3 |
|
Derivatives not designated as cash flow hedging instruments: |
|
|
|
|
|
|
|
|
|
|
Foreign exchange currency contracts |
|
Prepaid expenses and other current assets |
|
$ |
0.1 |
|
|
$ |
0.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
5.4 |
|
|
$ |
3.2 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES: |
|
|
|
|
|
|
|
|
|
|
Derivatives designated as cash flow hedging instruments: |
|
|
|
|
|
|
|
|
|
|
Interest rate swaps |
|
Accrued expenses |
|
$ |
4.3 |
|
|
$ |
2.6 |
|
Derivatives not designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
Foreign exchange currency contracts |
|
Accrued expenses |
|
$ |
5.2 |
|
|
$ |
2.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
9.5 |
|
|
$ |
5.2 |
|
|
|
|
|
|
|
|
|
|
14. Subsequent Event
On April 29,
2010, the Company announced that its board of directors has authorized a $0.20
per common share cash dividend for the first quarter of 2010, payable on May 24, 2010 to
shareholders of record as of May 10, 2010.
On
May 3, 2010, the Companys board of directors approved an increase to the current
share repurchase authorization from $300 million to $1 billion, of which approximately
$100 million
has already been utilized. In addition, the Companys board of directors approved the extension of the
expiration date of the share repurchase program from April 2011 to December 2014.
15
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
Overview
We are a global network marketing company that sells weight management products, nutritional
supplements, energy, sports & fitness products and personal care products. We pursue our mission of
changing peoples lives by providing a financially rewarding business opportunity to distributors
and quality products to distributors and their customers who seek a healthy lifestyle. We are one
of the largest network marketing companies in the world with net sales of approximately $2.3
billion for the year ended December 31, 2009. As of March 31, 2010, we sold our products in 73
countries through a network of approximately 2.1 million independent distributors. In China, we
sell our products through retail stores, sales representatives, sales employees and licensed
business providers. We believe the quality of our products and the effectiveness of our
distribution network, coupled with geographic expansion, have been the primary reasons for our
success throughout our 30-year operating history.
Our products are grouped in four principal categories: weight management, targeted nutrition,
energy, sports & fitness and Outer Nutrition, along with literature and promotional items. Our
products are often sold in programs that are comprised of a series of related products and
literature designed to simplify weight management and nutrition for consumers and maximize our
distributors cross-selling opportunities.
Industry-wide factors that affect us and our competitors include the increasing prevalence of
obesity and the aging of the worldwide population, which are driving demand for nutrition and
wellness-related products along with the global increase in under and unemployment which can affect
the recruitment and retention of distributors.
While we are closely monitoring the current global economic crisis, the Company remains
focused on the opportunities and challenges in retailing of our products, recruiting and retaining
distributors, improving distributor productivity, opening new markets, further penetrating existing
markets including China, the U.S., Brazil, Mexico and Russia, globalizing successful distributor
methods of operation such as Nutrition Clubs and Weight Loss Challenges, introducing new products
and globalizing existing products, developing niche market segments and further investing in our
infrastructure. Management remains intently focused on the Venezuela market and especially the
limited ability to repatriate cash at the official exchange rate.
We report revenue from our six regions:
|
|
|
North America, which
consists of the U.S., Canada and Jamaica; |
|
|
|
|
Mexico; |
|
|
|
|
South and Central America; |
|
|
|
|
EMEA, which consists of Europe, the Middle East and Africa; |
|
|
|
|
Asia Pacific (excluding China), which consists of Asia, New Zealand and Australia; and |
|
|
|
|
China. |
Volume Points by Geographic Region
A key non-financial measure we focus on is Volume Points on a Royalty Basis, or Volume Points,
which is essentially our weighted unit measure of product sales volume. It is a useful measure that
we rely on as it excludes the impact of foreign currency fluctuations and ignores the differences
generated by varying retail pricing across geographic markets. The Volume Point measure, in the
aggregate and in each region, can be a measure of our sales volume as well as of sales volume
trends. In general, an increase in Volume Points in a particular geographic region or country
indicates an increase in our sales volume which results in an increase in our local currency net
sales; a decrease in Volume Points in a particular geographic region or country indicates a
decrease in our sales volume, which results in decreasing local currency net sales.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
% Change |
|
|
|
(Volume points in millions) |
|
North America |
|
|
220.1 |
|
|
|
186.5 |
|
|
|
18.0 |
% |
Mexico |
|
|
124.2 |
|
|
|
120.4 |
|
|
|
3.2 |
% |
South & Central America |
|
|
101.1 |
|
|
|
102.6 |
|
|
|
(1.5 |
)% |
EMEA |
|
|
119.5 |
|
|
|
124.1 |
|
|
|
(3.7 |
)% |
Asia Pacific (excluding China) |
|
|
152.2 |
|
|
|
145.0 |
|
|
|
5.0 |
% |
China |
|
|
25.6 |
|
|
|
20.8 |
|
|
|
23.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
Worldwide |
|
|
742.7 |
|
|
|
699.4 |
|
|
|
6.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
16
Average Active Sales Leaders by Geographic Region
With the continued expansion of daily consumption business models in our different markets, we
believe the Average Active Sales Leader metric which represents the monthly average number of sales
leaders that place an order from the company in a given quarter is a useful metric. We rely on
this metric as an indication of the engagement level of sales leaders in a given region. Changes
in the Average Active Sales Leader metric may be indicative of the current momentum in a region as
well as the potential for higher annual retention levels and future sales growth through
utilization of consumption based DMOs.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
% Change |
|
|
|
(Average Active Sales Leaders) |
|
North America |
|
|
45,831 |
|
|
|
40,285 |
|
|
|
13.8 |
% |
Mexico |
|
|
34,481 |
|
|
|
33,173 |
|
|
|
3.9 |
% |
South & Central America |
|
|
27,217 |
|
|
|
26,685 |
|
|
|
2.0 |
% |
EMEA |
|
|
32,044 |
|
|
|
32,118 |
|
|
|
(0.2 |
)% |
Asia Pacific (excluding China) |
|
|
31,903 |
|
|
|
26,832 |
|
|
|
18.9 |
% |
China |
|
|
5,318 |
|
|
|
5,031 |
|
|
|
5.7 |
% |
Worldwide Average Active Sales Leaders (1) |
|
|
169,715 |
|
|
|
157,999 |
|
|
|
7.4 |
% |
|
|
|
(1) |
|
Worldwide Average Active
Sales Leaders may not equal the sum of the Average active sales
leaders in each region due to the calculation being an average of Sales
Leaders active in a period, not a summation. |
Number of New Sales Leaders by Geographic Region during the Reporting Period
We also focus on the number of distributors qualified as new sales leaders under our
compensation system. Excluding China, distributors qualify for sales leader status based on their
Volume Points. The changes in the total number of sales leaders or changes in the productivity of
sales leaders may cause Volume Points to increase or decrease. The fluctuation in the number of new
sales leaders is a general indicator of the level of distributor recruitment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
% Change |
|
|
|
(New Sales Leaders) |
|
North America |
|
|
8,127 |
|
|
|
7,893 |
|
|
|
3.0 |
% |
Mexico |
|
|
4,140 |
|
|
|
4,351 |
|
|
|
(4.8 |
)% |
South & Central America |
|
|
5,827 |
|
|
|
7,715 |
|
|
|
(24.5 |
)% |
EMEA |
|
|
3,877 |
|
|
|
5,236 |
|
|
|
(26.0 |
)% |
Asia Pacific (excluding China) |
|
|
11,562 |
|
|
|
10,737 |
|
|
|
7.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
Total New Sales Leaders |
|
|
33,533 |
|
|
|
35,932 |
|
|
|
(6.7 |
)% |
New China Sales Employees and Licensed Business Providers |
|
|
4,245 |
|
|
|
4,327 |
|
|
|
(1.9 |
)% |
|
|
|
|
|
|
|
|
|
|
|
Worldwide Total New Sales Leaders |
|
|
37,778 |
|
|
|
40,259 |
|
|
|
(6.2 |
)% |
|
|
|
|
|
|
|
|
|
|
|
Number of Sales Leaders and Retention Rates by Geographic Region as of Re-qualification Period
Our compensation system requires each sales leader to re-qualify for such status each year,
prior to February, in order to maintain their 50% discount on product and be eligible to receive
royalty payments. In February of each year, we demote from the rank of sales leader those
distributors who did not satisfy the re-qualification requirements during the preceding twelve
months. The re-qualification requirement does not apply to new sales leaders (i.e. those who became
sales leaders subsequent to the January re-qualification of the prior year).
|
|
|
|
|
|
|
|
|
Sales Leaders Statistics (Excluding China) |
|
2010 |
|
|
2009 |
|
|
|
(In thousands) |
January 1 total sales leaders |
|
|
431.3 |
|
|
|
456.9 |
|
January & February new sales leaders |
|
|
21.2 |
|
|
|
20.6 |
|
Demoted sales leaders (did not re-qualify) |
|
|
(165.9 |
) |
|
|
(181.4 |
) |
Other sales leaders (resigned, etc) |
|
|
(1.1 |
) |
|
|
(1.4 |
) |
|
|
|
|
|
|
|
End of February total sales leaders |
|
|
285.5 |
|
|
|
294.7 |
|
|
|
|
|
|
|
|
17
The distributor statistics below further highlight the calculation for retention.
|
|
|
|
|
|
|
|
|
Sales Leaders Retention (Excluding China) |
|
2010 |
|
|
2009 |
|
|
|
(In thousands) |
|
Sales leaders needing to re-qualify |
|
|
290.9 |
|
|
|
304.0 |
|
Demoted sales leaders (did not re-qualify) |
|
|
(165.9 |
) |
|
|
(181.4 |
) |
|
|
|
|
|
|
|
Total re-qualified |
|
|
125.0 |
|
|
|
122.6 |
|
|
|
|
|
|
|
|
Retention rate |
|
|
43.0 |
% |
|
|
40.3 |
% |
|
|
|
|
|
|
|
The table below reflects the number of sales leaders as of February (subsequent to the annual
re-qualification date) and sales leader retention rate by year and by region.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Sales Leaders |
|
|
Sales leaders Retention Rate |
|
|
|
2010 |
|
|
2009 |
|
|
2010 |
|
|
2009 |
|
North America |
|
|
64,668 |
|
|
|
63,726 |
|
|
|
43.3 |
% |
|
|
42.2 |
% |
Mexico |
|
|
47,068 |
|
|
|
50,099 |
|
|
|
50.4 |
% |
|
|
45.2 |
% |
South and Central America |
|
|
51,060 |
|
|
|
67,876 |
|
|
|
34.1 |
% |
|
|
32.2 |
% |
EMEA |
|
|
47,080 |
|
|
|
53,371 |
|
|
|
51.9 |
% |
|
|
48.7 |
% |
Asia Pacific (excluding China) |
|
|
75,635 |
|
|
|
59,631 |
|
|
|
38.6 |
% |
|
|
35.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Sales leaders |
|
|
285,511 |
|
|
|
294,703 |
|
|
|
43.0 |
% |
|
|
40.3 |
% |
China Sales Employees and Licensed Business Providers |
|
|
27,415 |
|
|
|
29,684 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Worldwide Total Sales Leaders |
|
|
312,926 |
|
|
|
324,387 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The number of sales leaders by geographic region as of the quarterly reporting dates will
normally be higher than the number of sales leaders by geographic region as of the re-qualification
period because sales leaders who do not re-qualify during the relevant twelve-month period will be
deleted from the rank of sales leader the following February. Since sales leaders purchase most of
our products for resale to other distributors and consumers, comparisons of sales leader totals on
a year-to-year basis are indicators of our recruitment and retention efforts in different
geographic regions.
The value of the average monthly purchase of Herbalife products by our sales leaders has
remained relatively constant over time. Consequently, increases in our sales are driven by our
retention of sales leaders, our recruitment and retention of distributors and by our distributors
increased adoption of daily consumption business methods.
We provide distributors with products, support materials, training, special events and a
competitive compensation program. If a distributor wants to pursue the Herbalife business
opportunity, the distributor is responsible for growing his or her business and personally pays for
the sales activities related to attracting new customers and recruiting distributors by hosting
events such as Herbalife Opportunity Meetings or Success Training Seminars; by advertising
Herbalifes products; by purchasing and using promotional materials such as t-shirts, buttons and
caps; by utilizing and paying for direct mail and print material such as brochures, flyers,
catalogs, business cards, posters and banners and telephone book listings; by purchasing inventory
for sale or use as samples; and by training, mentoring and following up (in person or via the phone
or internet) with customers and recruits on how to use Herbalife products and/or pursue the
Herbalife business opportunity.
Presentation
Retail sales represent the gross sales amounts on our invoices to distributors before
distributor allowances, as defined below, and net sales, which reflect distributor allowances and
handling and freight income, represent what we collect and recognize as net sales in our financial
statements. We discuss retail sales because of its fundamental role in our compensation systems,
internal controls and operations, including its role as the basis upon which distributor discounts,
royalties and bonuses are awarded. In addition, it is used as the basis for certain information
included in daily and monthly reports reviewed by our management. However, such a measure is not in
accordance with U.S. generally accepted accounting principles, or U.S. GAAP. You should not
consider retail sales in isolation from, nor as a substitute for, net sales and other consolidated
income or cash flow statement data prepared in accordance with U.S. GAAP, or as a measure of
profitability or liquidity. A reconciliation of net sales to retail sales is presented below under
Results of Operations. Product sales represent the actual product purchase price paid to us by
our distributors, after giving effect to distributor discounts referred to as distributor
allowances, which approximate 50% of retail sales prices. Distributor allowances as a percentage
of retail sales may vary by country depending upon regulatory restrictions that limit or otherwise
restrict distributor allowances.
18
Our international operations have provided and will continue to provide a significant portion
of our total net sales. As a result, total net sales will continue to be affected by changes in the
U.S. dollar against foreign currencies. In order to provide a framework for assessing how our
underlying businesses performed excluding the effect of foreign currency fluctuations, in addition
to comparing the percent change in net sales from one period to another in U.S. dollars, we also
compare the percent change in the net sales from one period to another period using net sales in
local currency disclosure. Such net sales in local currency is not a U.S. GAAP financial measure.
Net sales in local currency removes from net sales in U.S. dollars the impact of changes in
exchange rates between the U.S. dollar and the functional currencies of our foreign subsidiaries,
by translating the current period net sales into U.S. dollars using the same foreign currency
exchange rates that were used to translate the net sales for the previous period. We believe
presenting net sales in local currency basis is useful to investors because it allows a more
meaningful comparison of the net sales of our foreign operations from period to period. However,
net sales in local currency measures should not be considered in isolation or as an alternative to
net sales in U.S. dollars measures that reflect current period exchange rates, or to other
financial measures calculated and presented in accordance with GAAP.
Our gross profit consists of net sales less cost of sales, which represents the prices we
pay to our raw material suppliers and manufacturers of our products as well as costs related to
product shipments, duties and tariffs, freight expenses relating to shipment of products to
distributors and importers and similar expenses.
Royalty overrides are our most significant expense and consist of:
|
|
|
royalty overrides and production bonuses which total approximately 15% and 7%,
respectively, of the retail sales of weight management, targeted nutrition, energy, sports &
fitness, Outer Nutrition and promotional products; |
|
|
|
|
the Mark Hughes bonus payable to some of our most senior distributors in the aggregate
amount of up to 1% of retail sales of weight management, targeted nutrition, energy, sports
& fitness and Outer Nutrition products; and |
|
|
|
|
other discretionary incentive cash bonuses to qualifying distributors. |
Royalty overrides are generally earned based on retail sales and provide potential earnings to
distributors of up to 23% of retail sales or approximately 33% of our net sales. Royalty overrides
together with distributor allowances of up to 50% represent the potential earnings to distributors
of up to approximately 73% of retail sales. The compensation to distributors is generally for the
development, retention and improved productivity of their distributor sales organizations and is
paid to several levels of distributors on each sale. Due to restrictions on direct selling in
China, our full-time employed sales representatives in China are compensated with wages, bonuses
and benefits and our licensed business providers in China are compensated with service fees instead
of the distributor allowances and royalty overrides utilized in our traditional marketing program
used in our other five regions. Because of local country regulatory constraints, we may be required
to modify our typical distributor incentive plans as described above. Consequently, the total
distributor discount percentage may vary over time. We also offer reduced distributor allowances
and pay reduced royalty overrides with respect to certain products worldwide.
Our operating margins consist of net sales less cost of sales and royalty overrides.
Selling, general and administrative expenses represent our operating expenses, components of
which include labor and benefits, sales events, professional fees, travel and entertainment,
distributor marketing, occupancy costs, communication costs, bank fees, depreciation and
amortization, foreign exchange gains and losses and other miscellaneous operating expenses.
Most of our sales to distributors outside the United States are made in the respective local
currencies. In preparing our financial statements, we translate revenues into U.S. dollars using
average exchange rates. Additionally, the majority of our purchases from our suppliers generally
are made in U.S. dollars. Consequently, a strengthening of the U.S. dollar versus a foreign
currency can have a negative impact on our reported sales and operating margins and can generate
transaction losses on intercompany transactions. Throughout the last five years, foreign currency
exchange rates have fluctuated significantly. From time to time, we enter into foreign exchange
forward and option contracts to partially mitigate our foreign currency exchange risk as discussed
in further detail in Part I, Item 3 Quantitative and Qualitative Disclosures about Market Risk.
19
Summary Financial Results
Net sales for the three months ended March 31, 2010 increased 18.6% to $618.6 million as
compared to $521.7 million in 2009. In local currency, net sales for the three months ended March
31, 2010 increased 13.3%, as compared to the same period in 2009. For the three months ended March
31, 2010, net sales in U.S. dollars in our top ten countries for the period, namely the U.S.,
Mexico, Brazil, South Korea, China, Italy, Malaysia and India increased 23.2%, 21.3%, 42.1%,
109.5%, 20.5%, 5.0%, 16.7% and 102.0%, respectively, as compared to the same period in 2009, while
Taiwan and Japan, decreased 12.0% and 6.6%, respectively, as compared to the same period in 2009.
The increase in net sales in most of our top markets was primarily
due to the continued successful
adoption and operation of daily consumption business models, an
increase in average active sales leaders,
branding activities and increased distributor recruiting. The decline in Taiwan was mainly due to a
government coupon promotion in the first quarter of 2009 that increased net sales in that period
and was not available in 2010. In Japan, lower net sales were mainly due to decline in
distributor recruiting and average active sales leaders.
Net income for the three months ended March 31, 2010 increased 24.9% to $51.9 million, or
$0.83 per diluted share, compared to $41.5 million, or $0.67 per diluted share, for the same period
in 2009. The increase was primarily driven by higher net sales and
lower effective tax rate, and was partially offset by certain charges related to Venezuela discussed below, higher cost of goods
sold including the Venezuela related charges, and higher royalties, depreciation expense, salaries and benefits, and
advertising and promotion expense.
Net income for the three months ended March 31, 2010 included a $15.1 million unfavorable
impact related to remeasurement of monetary assets and liabilities resulting from Venezuela being
designated as a highly inflationary economy beginning January 1, 2010; a $12.7 million unfavorable
impact related to incremental U.S. dollar costs of 2009 imports into Venezuela which were recorded
at the unfavorable parallel market exchange rate and were not devalued based on 2010 exchange rates
but rather recorded to cost of sales at their historical dollar costs as products were sold in the
first quarter of 2010; a $3.7 million favorable impact resulting from receipt of U.S. dollars
approved by the Venezuelan governments Foreign Exchange Commission, or CADIVI, at the official
exchange rate relating to 2009 product importations which were
previously registered with CADIVI and a $14.5 million one-time
favorable impact to income taxes related to Venezuela becoming a highly inflationary economy. Net
income for the three months ended March 31, 2009 included a $0.4 million unfavorable after tax
impact in connection with our restructuring activities.
Results of Operations
Our results of operations for the periods below are not necessarily indicative of results of
operations for future periods, which depend upon numerous factors, including our ability to recruit
new distributors and retain existing distributors, open new markets, further penetrate existing
markets, introduce new products and programs that will help our distributors increase their retail
efforts and develop niche market segments.
The following table sets forth selected results of our operations expressed as a percentage of
net sales for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
|
|
2010 |
|
|
2009 |
|
Operations: |
|
|
|
|
|
|
|
|
Net sales |
|
|
100.0 |
% |
|
|
100.0 |
% |
Cost of sales |
|
|
22.7 |
|
|
|
19.6 |
|
|
|
|
|
|
|
|
Gross profit |
|
|
77.3 |
|
|
|
80.4 |
|
Royalty overrides(1) |
|
|
33.5 |
|
|
|
33.7 |
|
Selling, general and administrative expenses(1) |
|
|
33.4 |
|
|
|
34.8 |
|
|
|
|
|
|
|
|
Operating income |
|
|
10.4 |
|
|
|
11.9 |
|
Interest expense, net |
|
|
0.3 |
|
|
|
0.3 |
|
|
|
|
|
|
|
|
Income before income taxes |
|
|
10.1 |
|
|
|
11.6 |
|
Income taxes |
|
|
1.6 |
|
|
|
3.6 |
|
|
|
|
|
|
|
|
Net income |
|
|
8.5 |
% |
|
|
8.0 |
% |
|
|
|
|
|
|
|
|
|
|
(1) |
|
Compensation to our China sales employees and service fees to our licensed business providers
are included in selling, general and administrative expenses while distributor compensation
for all other countries is included in royalty overrides. |
20
Net Sales
The following chart reconciles retail sales to net sales:
Sales by Geographic Region
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handling |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handling |
|
|
|
|
|
|
|
|
|
Retail |
|
|
Distributor |
|
|
Product |
|
|
& Freight |
|
|
Net |
|
|
Retail |
|
|
Distributor |
|
|
Product |
|
|
& Freight |
|
|
Net |
|
|
Change in |
|
|
|
Sales |
|
|
Allowance |
|
|
Sales |
|
|
Income |
|
|
Sales |
|
|
Sales |
|
|
Allowance |
|
|
Sales |
|
|
Income |
|
|
Sales |
|
|
Net Sales |
|
|
|
(Dollars in millions) |
|
North America |
|
$ |
240.6 |
|
|
$ |
(114.7 |
) |
|
$ |
125.9 |
|
|
$ |
25.4 |
|
|
$ |
151.3 |
|
|
$ |
196.6 |
|
|
$ |
(93.7 |
) |
|
$ |
102.9 |
|
|
$ |
20.2 |
|
|
$ |
123.1 |
|
|
|
22.9 |
% |
Mexico |
|
|
116.1 |
|
|
|
(56.7 |
) |
|
|
59.4 |
|
|
|
12.4 |
|
|
|
71.8 |
|
|
|
97.8 |
|
|
|
(47.7 |
) |
|
|
50.1 |
|
|
|
9.1 |
|
|
|
59.2 |
|
|
|
21.3 |
% |
South & Central America |
|
|
151.9 |
|
|
|
(73.0 |
) |
|
|
78.9 |
|
|
|
12.4 |
|
|
|
91.3 |
|
|
|
124.3 |
|
|
|
(59.9 |
) |
|
|
64.4 |
|
|
|
10.9 |
|
|
|
75.3 |
|
|
|
21.2 |
% |
EMEA |
|
|
209.3 |
|
|
|
(100.4 |
) |
|
|
108.9 |
|
|
|
21.9 |
|
|
|
130.8 |
|
|
|
199.9 |
|
|
|
(96.8 |
) |
|
|
103.1 |
|
|
|
20.2 |
|
|
|
123.3 |
|
|
|
6.1 |
% |
Asia Pacific |
|
|
227.1 |
|
|
|
(105.4 |
) |
|
|
121.7 |
|
|
|
19.3 |
|
|
|
141.0 |
|
|
|
189.3 |
|
|
|
(89.7 |
) |
|
|
99.6 |
|
|
|
14.4 |
|
|
|
114.0 |
|
|
|
23.7 |
% |
China |
|
|
35.5 |
|
|
|
(3.1 |
) |
|
|
32.4 |
|
|
|
|
|
|
|
32.4 |
|
|
|
29.0 |
|
|
|
(2.2 |
) |
|
|
26.8 |
|
|
|
|
|
|
|
26.8 |
|
|
|
20.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Worldwide |
|
$ |
980.5 |
|
|
$ |
(453.3 |
) |
|
$ |
527.2 |
|
|
$ |
91.4 |
|
|
$ |
618.6 |
|
|
$ |
836.9 |
|
|
$ |
(390.0 |
) |
|
$ |
446.9 |
|
|
$ |
74.8 |
|
|
$ |
521.7 |
|
|
|
18.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in net sales are directly associated with the recruiting and retention of
our distributor force, retailing of our products, the quality and completeness of our product
offerings that the distributor force has to sell and the number of countries in which we operate.
Managements role, both in-country and at the region and corporate level is to provide distributors
with a competitive and broad product line, encourage strong teamwork and leadership among the
Chairmans Club and Presidents Team distributors and offer leading edge business tools to make
doing business with Herbalife simple. Management uses the distributor marketing program coupled
with educational and motivational tools and promotions to incentivize distributors to increase
recruiting, retention and retailing, which in turn affect net sales. Such tools include Company
sponsored sales events such as Extravaganzas, Leadership Development Weekends and World Team
Schools where large groups of distributors gather, thus allowing them to network with other
distributors, learn recruiting, retention and retailing techniques from our leading distributors
and become more familiar with how to market and sell our products and business opportunities.
Accordingly, management believes that these development and motivation programs increase the
productivity of the sales leader network. The expenses for such programs are included in selling,
general and administrative expenses. Sales are driven by several factors, including the number and
productivity of distributors and sales leaders who continually build, educate and motivate their
respective distribution and sales organizations. We also use event and non-event product promotions
to motivate distributors to increase recruiting, retention and retailing activities. These
promotions have prizes ranging from qualifying for events to product prizes and vacations. The
costs of these promotions are included in selling, general and administrative expenses.
The factors described above have helped distributors increase their business, which in turn
helps drive volume points in our business, and thus, net sales. The discussion below of net sales
by geographic region further details some of the specific drivers of growth of our business and
causes of sales increases during the three months ended March 31, 2010, as well as the unique
growth or contraction factors specific to certain geographic regions or major countries. We believe
that the correct business foundation, coupled with ongoing training and promotional initiatives, is
required to increase recruiting and retention of distributors and retailing of our products. This
correct business foundation includes strong country management that works closely with the
distributor leadership, actively engaged and unified distributor leadership, a broad product line
that appeals to local consumer needs, a favorable regulatory environment, a scalable and stable
technology platform and an attractive distributor marketing plan. Initiatives, such as Success
Training Seminars, Leadership Development Weekends, Promotional Events and regional Extravaganzas
are integral components of developing a highly motivated and educated distributor sales
organization that will work toward increasing the recruitment and retention of distributors.
We anticipate that our strategy will continue to include creating and maintaining growth
within existing markets, while expanding into new markets. In addition, new ideas and Daily Method
of Operations, or DMOs, are being generated in many of our regional markets and are globalized
where applicable, through the combined efforts of distributors, country management or regional and
corporate management. Examples of DMOs include the Club concept in Mexico, Premium Herbalife
Opportunity Meetings in Korea, the Healthy Breakfast concept in Russia, and the Internet/Sampling
and Weight Loss Challenge in the U.S. Managements strategy is to review the applicability of
expanding successful country initiatives throughout a region, and where appropriate, financially
support the globalization of these initiatives.
21
North America
The North America region reported net sales of $151.3 million for the three months ended March
31, 2010. Net sales increased $28.2 million, or 22.9%, for the three months ended March 31, 2010 as
compared to the same period in 2009. In local currency, net sales increased 22.4% for the three
months ended March 31, 2010 as compared to the same period in 2009. The overall increase in the
region was a result of net sales growth in the U.S. of $27.6 million, or 23.2%, as compared to the
same period in 2009.
We continue to see the success of our distributors converting their business focus toward a
daily consumption business model, especially the Nutrition Club DMO, and its extension into
Commercial Clubs and Central Clubs, along with the continued development of the Weight Loss
Challenge DMO. In terms of volume, the mix of business in the U.S. was 65% in the U.S. Latin
market and 35% in the General market for the three months ended March 31, 2010.
In January 2010, the region hosted a U.S. Latin market Future Presidents Team Retreat with
almost 500 attendees. The region also hosted January Spectaculars for the General market and Mega
Escuelas for the Latin market. There were more than 8,100 attendees in 15 cities.
Average
active sales leaders in the region increased 13.8% for the three months ended March 31, 2010,
as compared to the same period in 2009. Average
active sales leaders in the U.S. increased 14.5% for the
three months ended March 31, 2010, as compared to the same period in 2009. Total sales leaders in
the region increased 2.2% as of March 31, 2010 compared to March 31, 2009.
In March 2010, Herbalife hosted its annual global Herbalife Leadership Summit event in
Orlando, Florida where President Team members and other qualifying
distributors from around the world met and shared best practices,
conducted leadership training and Herbalife management awarded distributors an aggregate of $36.5
million in Mark Hughes bonus payments related to 2009 performance. The summit was followed by
qualified distributors attending Worldwide Vacations at Atlantis, Bahamas and Don Cesar in Florida.
The combined attendance for the Worldwide Vacations was 3,100 distributors.
We believe the fiscal year 2010 net sales in North America should increase year over year
primarily as a result of the continuing transformation of our distributor business focus to a daily
consumption model.
Mexico
The Mexico region reported net sales of $71.8 million for the three months ended March 31,
2010. Net sales for the three months ended March 31, 2010, increased $12.6 million, or 21.3%, as
compared to the same period in 2009. In local currency, net sales for the three months ended March
31, 2010 increased 7.8% as compared to the same period in 2009. The fluctuation of foreign currency
rates had a favorable impact of $8.0 million on net sales for the three months ended March 31,
2010.
We believe that local currency sales in the first quarter benefited from our distribution
agreement with a large Mexico retailer. This agreement allows distributors to pick up their
product orders at 307 locations in 26 Mexican states. We believe that by leveraging their
distribution system, we are providing distributors with better product accessibility.
Average
active sales leaders in Mexico increased 3.9% for the three months ended March 31, 2010, as
compared to the same period in 2009. Total sales leaders in Mexico decreased 6.6% as of March 31,
2010, compared to March 31, 2009.
In February 2010, Mexico hosted a Future Presidents Team retreat with over 500 attendees.
They also hosted a distributor leadership retreat with approximately 950 attendees.
We believe the fiscal year 2010 net sales in Mexico should increase year over year due to
increase in volume as well as the assumption of a slightly favorable currency exchange rate.
South and Central America
The South and Central America region reported net sales of $91.3 million for the three months
ended March 31, 2010. Net sales increased $16.0 million or 21.2%, for the three months ended March
31, 2010, as compared to the same period in 2009. In local currency, net sales increased 29.6% for
the three months ended March 31, 2010, as compared to the same period in 2009. The fluctuation of
foreign currency rates had a $6.2 million unfavorable impact on net sales for the three months
ended March 31, 2010. The increase in local currency net sales in the region for the three months
ended March 31, 2010 was attributable to sales growth in several
markets including Brazil, Venezuela, Ecuador, Bolivia and Colombia which increased
10.9%, 50.8%, 79.7%, 96.2% and 95.8%, respectively, partially offset by sales decline in Chile of
21.1%.
22
In Brazil, the regions largest market, net sales increased $13.9 million, or 42.1%, for the
three months ended March 31, 2010, as compared to the same period in 2009. In local currency, net
sales increased 10.9% for the three months ended March 31, 2010, as compared to the same period in
2009. The increase in local currency net sales was primarily a result of distributors successfully
transforming this market into a more balanced mix of recruiting, retailing and retention via the
Nutrition Club and other daily consumption based DMOs. The fluctuation of foreign currency rates
had a $10.3 million favorable impact on net sales in Brazil for the three months ended March 31,
2010.
Venezuela, the regions second largest market, experienced a net sales decrease of $8.7
million, or 50.4%, for the three months ended March 31, 2010, as compared to the same period in
2009. The decrease in sales reflects the impact of remeasuring Venezuelas local sales at the
parallel market exchange rate during fiscal year 2010, under highly inflationary accounting rules,
which is 67% less favorable than the official exchange rate that was used to translate Venezuelas
local sales in 2009. In local currency, net sales increased 50.8% for the three months ended March
31, 2010, as compared to the same period in 2009. The sales growth in local currency was partially
driven by a price increase of 10%, 9%, and 12% in June 2009, October 2009, and March 2010,
respectively. We expect to make ongoing changes, as necessary, in pricing in Venezuela to mitigate
the impact of inflation, currency devaluations, and currency restrictions.
Average
active sales leaders in the region increased 2.0% for the three months ended March 31, 2010,
as compared to the same period in 2009. The increase was driven by
increases in average active sales
leaders in several markets including Brazil which increased 3.8% for the three months ended March
31, 2010, as compared to the same period in 2009; and Ecuador, which increased 50.3% for the three
months ended March 31, 2010, as compared to the same period in 2009. Total sales leaders in the
region decreased 25.1% as of March 31, 2010 compared to March 31, 2009. We believe this decrease
reflects current economic conditions coupled with the transition, in several markets, to DMOs which
focus on daily consumption.
In February 2010, the region hosted an Extravaganza in Quito, Ecuador with over 12,500
attendees.
We believe the fiscal year 2010 net sales in South and Central America will show a slight
decrease year over year. This assumes the negative impact of re-measuring Venezuelas local sales
under highly inflationary accounting rules at the parallel market exchange rate during fiscal year
2010 compared to the official exchange rate that was used to translate Venezuelas local sales in
2009. We expect the decrease in Venezuela net sales to be largely offset by slightly higher volume
in other countries, price increases throughout the region, and, other than in Venezuela, a more
favorable currency exchange rate than in 2009.
EMEA
The EMEA region reported net sales of $130.8 million for the three months ended March 31,
2010. Net sales increased $7.5 million, or 6.1%, for the three months ended March 31, 2010, as
compared to the same period in 2009. In local currency, net sales decreased 2.0% for the three
months ended March 31, 2010, as compared to the same period in 2009. The fluctuation of foreign
currency rates had a favorable impact on net sales of $9.9 million for the three months ended March
31, 2010.
Among the largest markets in the region, Italy, Spain and Russia, net sales increased 5.0%,
12.4% and 21.2%, respectively, for the three months ended March 31, 2010, as compared to the same
period in 2009. In local currency, Italy reported a net sales decrease of 0.9% while both Spain and
Russia reported net sales increases of 6.1% for the three months ended March 31, 2010, in each case
as compared to the same period in 2009. In Spain, we are beginning to see an improvement resulting
from the withdrawal of the Spanish Ministry of Health alert regarding Herbalife products. This
alert was withdrawn in April 2009 requiring no action by the Company.
In other markets in the region, net sales in France decreased 16.5% and net sales in the
Netherlands increased 0.9% for the three months ended March 31, 2010, as compared to the same
period in 2009. In local currency, France and Netherlands net sales decreased 21.0% and 4.9%,
respectively, for the three months ended March 31, 2010, as compared to the same period in 2009.
Average
active sales leaders in the region remained relatively flat for the three months ended March
31, 2010, as compared to the same period in 2009. Total sales leaders in the region decreased 11.3%
as of March 31, 2010 compared to March 31, 2009.
There were no major events for the region in the first quarter.
23
We believe fiscal year 2010 net sales in EMEA will show an increase year over year due
primarily to favorable currency exchange rate.
Asia Pacific
The Asia Pacific region, which excludes China, reported net sales of $141.0 million for the
three months ended March 31, 2010. Net sales increased $27.0 million, or 23.7%, for the three
months ended March 31, 2010, as compared to the same period in 2009. In local currency, net sales
increased 10.6% for the three months ended March 31, 2010, as compared to the same period in 2009.
The fluctuation of foreign currency rates had a favorable impact of $15.0 million on net sales for
the three months ended March 31, 2010. The increase in U.S. dollar net sales in Asia Pacific for
the three months ended March 31, 2010, was primarily attributable to net sales increases in South
Korea, India, Indonesia and Malaysia, of 109.5%, 102.0%, 98.8% and
16.7%, respectively, partially
offset by decreases in Taiwan and Japan of 12.0% and 6.6%, respectively.
Net sales in Taiwan, our largest market in the region, decreased $5.2 million, or 12.0%, for
the three months ended March 31, 2010, as compared to the same period in 2009. In local currency,
net sales decreased 17.3% for the three months ended March 31, 2010, as compared to the same period
in 2009. The decrease in first quarter sales compared to the prior year reflects the favorable
impact of a government coupon promotion run in February and March of 2009 which increased net sales
in those months and was not repeated this year. The fluctuation of foreign currency rates had a
favorable impact on net sales of $2.3 million for the three months ended March 31, 2010, as
compared to the same period in 2009.
Net sales in South Korea, our second largest market in the region, increased $18.7 million, or
109.5%, for the three months ended March 31, 2010, as compared to the same period in 2009. In local
currency, net sales increased 69.1% for the three months ended March 31, 2010, as compared to the
same period in 2009. The increase in local currency net sales for the three months ended March 31,
2010 was primarily driven by the successful adoption and operation of the Nutrition Club DMO, in
the form of Commercial Clubs along with the Premium Herbalife Opportunity Meeting. The fluctuation
of foreign currency rates had a favorable impact on net sales of $6.9 million for the three months
ended March 31, 2010, as compared to the same period in 2009.
Net sales in Japan, our third largest market in the region, decreased $1.0 million, or 6.6%,
for the three months ended March 31, 2010, as compared to the same period in 2009. In local
currency, net sales decreased 12.0% for the three months ended March 31, 2010, as compared to the
same period in 2009. The decrease in local currency net sales for the three months ended March 31,
2010, was driven by a continuing decline in distributor recruiting. The fluctuation of foreign
currency rates had a favorable impact on net sales of $0.8 million for the three months ended March
31, 2010, as compared to the same period in 2009.
Net sales in Malaysia, our fourth largest market in the region, increased $1.9 million, or
16.7%, for the three months ended March 31, 2010, as compared to the same period in 2009,
reflecting the continued success of the Road Show DMO, which has generated positive distributor
momentum and increased recruiting. In local currency, net sales increased 8.7% for the three months
ended March 31, 2010, as compared to the same period in 2009. The fluctuation of foreign currency
rates had a favorable impact on net sales of $0.9 million for the three months ended March 31,
2010, as compared to the same period in 2009.
Net sales in India, our fifth largest market in the region, increased $5.1 million, or 102.0%,
for the three months ended March 31, 2010, as compared to the same period in 2009. In local
currency, net sales increased 85.9% for the three months ended March 31, 2010, as compared to the
same period in 2009. The increase in local currency net sales for the three months ended March 31,
2010, was driven by the adoption of the Nutrition Club DMO. The number of clubs at March 31, 2010
was 725 compared to 142 at March 31, 2009. The fluctuation of foreign currency rates had a
favorable impact on net sales of $0.8 million for the three months ended March 31, 2010, as
compared to the same period in 2009.
There were no major events in the region for first quarter 2010.
Average
active sales leaders in the region increased 18.9% for the three months ended March 31, 2010,
as compared to the same period in 2009. Average active sales leaders for South Korea, India and Malaysia
increased 72.2%, 89.3% and 18.9%, respectively, for the three months ended March 31, 2010 compared
to the same period in 2009. These increases were offset by declines in Japan and Australia of 22.2%
and 10.4%, respectively, for the three months ended March 31, 2010 compared to the same period in
2009. Total sales leaders in the region increased 22.5% as of March 31, 2010 compared to March 31,
2009.
We believe the fiscal year 2010 net sales in Asia Pacific should increase year over year due
primarily to higher volume in existing markets as well as the full year impact of Vietnam (which
was opened during the fourth quarter of 2009).
24
China
Net sales in China were $32.4 million for the three months ended March 31, 2010. Net sales
increased $5.6 million, or 20.9%, for the three months ended March 31, 2010, as compared to the
same period in 2009. In local currency, net sales increased 20.4% for the three months ended March
31, 2010, as compared to the same period in 2009. The fluctuation of foreign currency rates did not
have a significant impact on net sales for the three months ended March 31, 2010.
The current focus in China is to expand the Nutrition Club DMO to enhance the retail focus and
thereby increase the emphasis on daily consumption methods of operation. As experienced in other
markets, such as Brazil, which have gone through a similar transition, China has experienced a
slow-down in sales growth as the licensed business providers begin to build their nutrition club
business. We believe that the nutrition club concept is slowly starting to gain traction as
witnessed by the growth in clubs over the past year. While we believe the nutrition club DMO has
tremendous potential to expand throughout China and achieve success similar to Taiwan and South
Korea, we also realize that the process is still in its early development stage and will most
likely build gradually over the next few years.
As of March 31, 2010, we have direct-selling licenses in 11 provinces which represent an
addressable population of approximately 599 million people and we are operating 75 retail stores in
30 provinces in China.
Active sales employees in China increased 5.7% for the three months ended March 31, 2010, as
compared to the same period in 2009. Total sales employees in China decreased 8.0% as of March 31,
2010 compared to March 31, 2009.
We believe the fiscal year 2010 net sales in China should slightly increase year over year,
primarily as a result of higher volume due to continued adoption and expansion of nutrition clubs.
Sales by Product Category
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2010 |
|
|
2009 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handling |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handling |
|
|
|
|
|
|
|
|
|
Retail |
|
|
Distributor |
|
|
Product |
|
|
& Freight |
|
|
Net |
|
|
Retail |
|
|
Distributor |
|
|
Product |
|
|
& Freight |
|
|
Net |
|
|
% Change in |
|
|
|
Sales |
|
|
Allowance |
|
|
Sales |
|
|
Income |
|
|
Sales |
|
|
Sales |
|
|
Allowance |
|
|
Sales |
|
|
Income |
|
|
Sales |
|
|
Net Sales |
|
|
|
(In millions) |
|
Weight Management |
|
|
|
|
|
$ |
630.6 |
|
|
$ |
(302.2 |
) |
|
$ |
328.4 |
|
|
$ |
58.8 |
|
|
$ |
387.2 |
|
|
$ |
542.8 |
|
|
$ |
(262.1 |
) |
|
$ |
280.7 |
|
|
$ |
48.5 |
|
|
$ |
329.2 |
|
|
|
17.6 |
% |
Targeted Nutrition |
|
|
|
|
|
|
225.7 |
|
|
|
(108.2 |
) |
|
|
117.5 |
|
|
|
21.1 |
|
|
|
138.6 |
|
|
|
181.4 |
|
|
|
(87.6 |
) |
|
|
93.8 |
|
|
|
16.2 |
|
|
|
110.0 |
|
|
|
26.0 |
% |
Energy, Sports and Fitness |
|
|
|
|
|
|
42.1 |
|
|
|
(20.2 |
) |
|
|
21.9 |
|
|
|
3.9 |
|
|
|
25.8 |
|
|
|
35.5 |
|
|
|
(17.1 |
) |
|
|
18.4 |
|
|
|
3.2 |
|
|
|
21.6 |
|
|
|
19.4 |
% |
Outer Nutrition |
|
|
|
|
|
|
50.6 |
|
|
|
(24.3 |
) |
|
|
26.3 |
|
|
|
4.7 |
|
|
|
31.0 |
|
|
|
52.0 |
|
|
|
(25.1 |
) |
|
|
26.9 |
|
|
|
4.6 |
|
|
|
31.5 |
|
|
|
(1.6 |
)% |
Literature, Promotional and Other |
|
|
|
|
|
|
31.5 |
|
|
|
1.6 |
|
|
|
33.1 |
|
|
|
2.9 |
|
|
|
36.0 |
|
|
|
25.2 |
|
|
|
1.9 |
|
|
|
27.1 |
|
|
|
2.3 |
|
|
|
29.4 |
|
|
|
22.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
|
|
|
$ |
980.5 |
|
|
$ |
(453.3 |
) |
|
$ |
527.2 |
|
|
$ |
91.4 |
|
|
$ |
618.6 |
|
|
$ |
836.9 |
|
|
$ |
(390.0 |
) |
|
$ |
446.9 |
|
|
$ |
74.8 |
|
|
$ |
521.7 |
|
|
|
18.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales for Weight Management, Targeted Nutrition, Energy, Sports and Fitness and
Literature, Promotional and Other product categories increased for the three months ended March 31,
2010, as compared to the same period in 2009, partially offset by a slight decrease in Outer
Nutrition product category for the three months ended March 31, 2010, as compared to the same
period in 2009, mainly due to the factors described in the above discussions of the individual
geographic regions. In addition, net sales for Outer Nutrition decreased in part due to the
distributor focus on DMOs that are centered towards Weight Management products.
Gross Profit
Gross profit was $478.2 million for the three months ended March 31, 2010, as compared to
$419.3 million for the same period in 2009. As a percentage of net sales, gross profit for the
three months ended March 31, 2010 decreased to 77.3%, as compared to 80.4% for the same period in
2009. The decrease was primarily due to $12.7 million of incremental costs related to imports
during 2009 into Venezuela at the unfavorable parallel market exchange rate, which were recognized
in cost of sales during the first quarter of 2010 as these products were sold, the unfavorable
impact of remeasuring Herbalife Venezuelas Bolivar net sales at the unfavorable parallel market
exchange rate during 2010, as opposed to being translated at the official rate during 2009, the
unfavorable impact of other currency fluctuations, and changes in country mix. See Liquidity and
Capital Resources Working Capital and Operating Activities in this section for further
discussion on currency exchange rate issues in Venezuela. We believe that we have the ability to
partially mitigate certain of these cost pressures through improved optimization of our supply
chain coupled with select increases in the retail prices of our products.
25
Royalty Overrides
Royalty
overrides as a percentage of net sales was 33.5% for the three months ended March 31, 2010, as
compared to 33.7% for the same period in 2009. Generally, this ratio varies
slightly from period to period due to changes in the mix of products and countries because full
royalty overrides are not paid on certain products and in certain
countries. Compensation to our full-time sales employees and
licensed business providers in China is included in selling, general and
administrative expenses as opposed to royalty overrides where it is
included for all other distributors under our worldwide marketing
plan. We anticipate
fluctuations in royalty overrides as a percent of net sales reflecting the growth prospect of our
China business relative to that of our worldwide business.
Selling, General and Administrative Expenses
Selling, general and administrative expenses as a percentage of net sales was 33.4% for the
three months ended March 31, 2010, as compared to 34.8% for the same period in 2009.
For the three months ended March 31, 2010, selling, general and administrative expenses
increased $25.4 million to $206.9 million compared to the same period in 2009. The increase for the
three months ended March 31, 2010, included $11.4 million net foreign exchange loss related to
Venezuela, $6.1 million in higher salaries and benefits, excluding China sales employees; $2.6
million in higher expenses related to China sales employees and licensed business providers, $2.5
million in higher depreciation expense, $2.3 million in higher credit card fees and $1.6 million in
higher advertising and promotion costs. These increases were partially offset by a decrease of
approximately $2.3 million in professional fees.
We expect 2010 selling, general and administrative expenses to increase in absolute dollars
over 2009 levels reflecting higher China sales employee costs and licensed business provider
service fees, increased depreciation, primarily related to our global Oracle implementation, and
various sales growth initiatives, including distributor promotions.
Net Interest Expense
Net interest expense is as follows:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
March 31, |
|
Net Interest Expense |
|
2010 |
|
|
2009 |
|
|
|
(Dollars in millions) |
|
Interest expense |
|
|
2.4 |
|
|
|
3.3 |
|
Interest income |
|
|
(0.5 |
) |
|
|
(1.6 |
) |
|
|
|
|
|
|
|
Net interest expense |
|
$ |
1.9 |
|
|
$ |
1.7 |
|
|
|
|
|
|
|
|
Net interest expense for the three months ended March 31, 2010 was relatively flat compared to
the same period in 2009. The decrease in interest expense and interest income for the three months
ended March 31, 2010 was primarily due to lower interest rates in 2010 as compared to 2009.
Income Taxes
Income taxes were
$10.1 million for the three months ended March 31, 2010, as compared to
$19.0 million for the same period in 2009. As a percentage of pre-tax income, the effective
income tax rate
was 16.3% for the three months ended March 31, 2010, as compared to 31.4% for the same period in
2009. The decrease in the effective tax rate for the three months ended March 31, 2010, as compared
to the same period in 2009, was primarily due to the conversion of Venezuela to a highly
inflationary economy, as well as the change in the operating effective rate reflecting changes in
the country mix and a non-cash benefit of $1.6 million due to the expiration of certain statute of
limitations.
Venezuelas
cumulative inflation rate exceeded 100% during the three-year period ended
December 31, 2009. Therefore, beginning January 1, 2010, Venezuela is considered a highly
inflationary economy for U.S. federal income tax purposes. As a
result, for U.S. federal income tax purposes, Herbalife Venezuela is
required to account for its operations using the Dollar Approximate Separate Transactions Method of
accounting, or DASTM, and use the U.S. dollar as its functional currency. The transitional impact of
DASTM resulted in a one-time deferred income tax benefit of approximately $14.5 million recorded during the
three months ended March 31, 2010.
26
Subsequent Event
On April 29, 2010, we announced that our board of directors has authorized a $0.20 per common
share cash dividend for the first quarter of 2010, payable on
May 24, 2010 to shareholders of record as of May 10, 2010.
On
May 3, 2010, our board of directors approved an increase to the current
share repurchase authorization from $300 million to $1 billion, of which approximately
$100 million
has already been utilized. In addition, our board of directors approved the extension of the
expiration date of the share repurchase program from April 2011 to December 2014.
Liquidity and Capital Resources
We have historically met our working capital and capital expenditure requirements, including
funding for expansion of operations, through net cash flows provided by operating activities. Our
principal source of liquidity is our operating cash flows. Variations in sales of our products
would directly affect the availability of funds. There are no material contractual restrictions on
the ability to transfer and remit funds among our international affiliated companies. We are
closely monitoring various aspects of the current worldwide financial crisis and we do not believe
that there has been or will be a material impact on our liquidity from this crisis. As noted above,
we have historically met our funding needs utilizing cash flow from operating activities and we
believe we will have sufficient resources to meet debt service obligations in a timely manner. Our
existing debt has not resulted from the need to fund our normal operations, but instead has
effectively resulted from our share repurchase and dividend activities over the recent years, which
together, since the inception of these programs in 2007, amounted to approximately $754.0 million.
Our use of the credit facility for these purposes and not for general working capital and capital
expenditure needs has limited the impact that the current worldwide credit crisis has on us. While
a significant net sales decline could potentially affect the availability of funds, many of our
largest expenses are purely variable in nature, which could protect our funding in all but a
dramatic net sales downturn. Further we maintain a revolving credit facility which had $152.0
million of undrawn capacity as of March 31, 2010, and is comprised of banks who are continuing to
support the facility through the recent worldwide financial crisis.
For the three
months ended March 31, 2010, we generated $87.4 million of operating cash flow,
as compared to $86.0 million for the same period in 2009. The
slight increase in cash generated from
operations was primarily due to higher cash-related net income for the three
months ended March 31, 2010, as compared to the same period in 2009.
Capital expenditures, including capital leases, for the three months ended March 31, 2010,
were $11.6 million as compared to $14.4 million for the same period in 2009. The majority of these
expenditures represented investments in management information systems, the development of our
distributor internet initiatives, and the expansion of our domestic and international facilities.
We expect to incur total capital expenditures of approximately $75.0 million for the full year of
2010.
We entered into a $300.0 million senior secured credit facility, comprised of a $200.0 million
term loan and a revolving credit facility of $100.0 million, with a syndicate of financial
institutions as lenders in July 2006. In September 2007, we amended our senior secured credit
facility, increasing the revolving credit facility by $150.0 million to $250.0 million to fund the
increase in our share repurchase program discussed below. The term loan matures on July 21, 2013
and the revolving credit facility is available until July 21, 2012. The term loan bears interest at
LIBOR plus a margin of 1.5%, or the base rate, which represents the prime rate offered by major
U.S. banks, plus a margin of 0.50%. The revolving credit facility bears interest at LIBOR plus a
margin of 1.25%, or the base rate, which represents the prime rate offered by major U.S. banks,
plus a margin of 0.25%. The senior secured credit facility requires us to comply with a leverage
ratio and an interest coverage ratio. In addition, the senior secured credit facility contains
customary covenants, including covenants that limit or restrict our ability to incur liens, incur
indebtedness, make investments, dispose of assets, make certain restricted payments, merge or
consolidate and enter into certain transactions with affiliates.
During 2009, we borrowed an aggregate amount of $212.0 million under the revolving credit
facility and paid $298.7 million of the revolving credit facility. During the first quarter of 2010
we borrowed an aggregate amount of $102.0 million and paid $95.0 million of the revolving credit
facility. These borrowings were primarily related to our share repurchases and dividends program as
discussed further below.
27
The following summarizes our contractual obligations including interest at March 31, 2010, and
the effect such obligations are expected to have on our liquidity and cash flows in future periods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2015 & |
|
|
|
Total |
|
|
2010 |
|
|
2011 |
|
|
2012 |
|
|
2013 |
|
|
2014 |
|
|
Thereafter |
|
|
|
(Dollars in millions) |
|
Borrowings under the senior credit facility |
|
$ |
254.7 |
|
|
$ |
4.2 |
|
|
$ |
5.5 |
|
|
$ |
102.8 |
|
|
$ |
142.2 |
|
|
$ |
|
|
|
$ |
|
|
Capital leases |
|
|
4.6 |
|
|
|
1.4 |
|
|
|
1.7 |
|
|
|
1.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating leases |
|
|
150.7 |
|
|
|
27.4 |
|
|
|
28.3 |
|
|
|
23.1 |
|
|
|
19.0 |
|
|
|
17.2 |
|
|
|
35.7 |
|
Other |
|
|
10.7 |
|
|
|
5.4 |
|
|
|
5.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
420.7 |
|
|
$ |
38.4 |
|
|
$ |
40.8 |
|
|
$ |
127.4 |
|
|
$ |
161.2 |
|
|
$ |
17.2 |
|
|
$ |
35.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Off Balance Sheet Arrangements
At March 31, 2010 and December 31, 2009, we had no material off-balance sheet arrangements as
defined in Item 303(a)(4)(ii) of Regulation S-K.
Share Repurchases
On April 30, 2009, our board of directors authorized a new program for us to repurchase up to
$300 million of our common shares during the next two years, at such times and prices as determined
by management.
During the quarter ended March 31, 2010, we repurchased approximately 0.6 million of our
common shares through open market purchases at an aggregate cost of approximately $25.0 million or
an average cost of $41.42 per share. As of March 31, 2010, the approximate dollar value of
remaining capacity under our share repurchase program was approximately $201.8 million.
Dividends
On February 19, 2010, our board of directors approved a quarterly cash dividend of $0.20 per
common share in an aggregate amount of $12.1 million, for the fourth quarter of 2009 that was paid
to shareholders on March 16, 2010.
Working Capital and Operating Activities
As of March 31, 2010 and December 31, 2009, we had positive working capital of $115.1 million
and $83.5 million, respectively. Cash and cash equivalents were $165.3 million and $150.8 million
at March 31, 2010, and December 31, 2009, respectively.
We expect that cash and funds provided from operations and available borrowings under our
revolving credit facility will provide sufficient working capital to operate our business, to make
expected capital expenditures and to meet foreseeable liquidity requirements, including debt
service on our term loan and amounts outstanding under our revolving credit facility, for the next
twelve months.
The majority of our purchases from suppliers are generally made in U.S. dollars, while sales
to our distributors generally are made in local currencies. Consequently, strengthening of the U.S.
dollar versus a foreign currency can have a negative impact on net sales and operating margins and
can generate transaction losses on intercompany transactions. For discussion of our foreign
exchange contracts and other hedging arrangements, see Part I, Item 3 Quantitative and
Qualitative Disclosures about Market Risk.
Venezuelas Currency Restrictions and Highly Inflationary Economy
Currency
restrictions enacted by the Venezuelan government in 2003 have become more restrictive
and have impacted the ability of our subsidiary in Venezuela, Herbalife Venezuela, to
obtain U.S. dollars in exchange for Venezuelan Bolivars, or Bolivars, at the official
foreign exchange rate from the Venezuelan government and its Foreign Exchange Commission, CADIVI.
The application and approval processes have been intermittently delayed in recent periods.
In certain instances, we have made appropriate applications through CADIVI, for approval to
obtain U.S. dollars to pay for imported products and an annual dividend at the official exchange
rate. In other instances, in order to timely provide products to our distributors, we did not
submit applications but instead have used a legal parallel market mechanism for payment. In this
legal parallel market Bolivars can be exchanged for U.S. dollars, but at a less favorable
exchange rate than the official rate. If CADIVI does not approve further exchanges at the
official exchange rate, Herbalife Venezuela could continue to use a legal parallel exchange
process to exchange U.S. dollars in addition to going through CADIVI to obtain the official rate.
28
Venezuelas
inflation rate as measured using the blended National Consumer Price Index and Consumer Price
Index rate exceeded the three-year cumulative inflation rate of 100%
as of December 31, 2009. Accordingly, effective January 1,
2010, Venezuela is considered a highly inflationary economy.
Pursuant to the highly inflationary basis of accounting, Herbalife Venezuela changed its
functional currency from the Bolivar to the U.S. dollar. Subsequent movements in the Bolivar
to U.S. dollar exchange rate will impact our consolidated earnings. Beginning January 1, 2010,
based on our current facts and circumstances, we use the parallel market exchange rate for
remeasurement purposes and we are no longer required to translate Herbalife Venezuelas financial
statements since their functional currency is now the U.S. dollar. Our ability to access the
official exchange rate and the parallel market exchange rate could impact what exchange rates
we will use for remeasurement purposes in future periods.
On January 1, 2010,
upon Venezuela being designated as a highly inflationary economy, we recorded foreign exchange
losses in our consolidated statement of income relating to the remeasurement of Herbalife
Venezuelas monetary assets and liabilities. We used the parallel market exchange rate for
remeasurement of Herbalife Venezuelas monetary assets and liabilities on its opening balance
sheet and recorded non-tax deductible foreign exchange losses of $15.1 million primarily relating
to Herbalife Venezuelas cash and cash equivalents. This charge included a $9.9 million foreign
exchange loss relating to Herbalife Venezuelas U.S. dollar cash and cash equivalents that were
remeasured at the less favorable parallel market rate and then translated at the official rate at
December 31, 2009, as discussed in the 2009 10-K. Also, Herbalife Venezuelas $34.2 million cash
and cash equivalents reported on our consolidated balance sheet at December 31, 2009, which
included U.S. dollar denominated cash, was reduced to approximately $12.5 million on
January 1, 2010. However, nonmonetary assets, such as inventory, reported on our consolidated
balance sheet at December 31, 2009, remained at historical cost subsequent to Venezuela becoming
a highly inflationary economy. Therefore, the incremental costs related to our 2009 imported
products recorded at the unfavorable parallel market exchange rate negatively impacted our first
quarter 2010 consolidated statement of income by approximately $12.7 million, non-tax deductible,
as these products were sold during the first quarter of 2010.
In early
January 2010, Venezuela announced an official exchange rate devaluation of the Bolivar to an
official rate of 4.30 Bolivars per U.S. dollar for non-essential items and 2.60 Bolivars per
U.S. dollar for essential items. Herbalife Venezuelas imports fall into both classifications.
Since we are using the unfavorable parallel market exchange rate for remeasurement purposes, U.S.
dollars obtained from CADIVI at the official rate could have a positive impact to our consolidated
net earnings. During the three months ended March 31, 2010, $3.7 million foreign exchange gains
were recorded in our consolidated statement of income as result of receiving U.S. dollars approved
by CADIVI at the official exchange rate in the first quarter of 2010 primarily relating to
certain product importations in 2009 which were previously registered with CADIVI. We continue
to assess and monitor the current economic and political environment in Venezuela. As of
March 31, 2010, the parallel market rate was approximately 38% and 62% less favorable than the
official exchange rates for non-essential and essential items, respectively. During 2010, we
plan to continue making applications with CADIVI in order to obtain U.S. dollars at the official
foreign exchange rate from CADIVI.
Herbalife Venezuelas net
sales represented less than 2% of our consolidated worldwide net sales for the three
months ended March 31, 2010. At March 31, 2010, Herbalife Venezuela had reported
cash and cash equivalents of approximately $8.3 million, the majority of which
were denominated in Bolivars and remeasured at the less favorable parallel market rate.
Contingencies
The Company is from time to time engaged in routine litigation. The Company regularly reviews
all pending litigation matters in which it is involved and establishes reserves deemed appropriate
by management for these litigation matters when a probable loss estimate can be made.
As a marketer of dietary and nutritional supplements and other products that are ingested by
consumers or applied to their bodies, the Company has been and is currently subjected to various
product liability claims. The effects of these claims to date have not been material to the
Company, and the reasonably possible range of exposure on currently existing claims is not material
to the Company. The Company believes that it has meritorious defenses to the allegations contained
in the lawsuits. The Company currently maintains product liability insurance with an annual
deductible of $10 million.
On April 16, 2007, Herbalife International of America, Inc. filed a Complaint in the United
States District Court for the Central District of California against certain former Herbalife
distributors who had left the Company to join a competitor. The Complaint alleged breach of
contract, misappropriation of trade secrets, intentional interference with prospective economic
advantage, intentional interference with contract, unfair competition, constructive trust and fraud
and seeks monetary damages, attorneys fees and injunctive relief. (Herbalife International of
America, Inc. v. Robert E. Ford, et al) The court entered a Preliminary Injunction against the
defendants enjoining them from further use and/or misappropriation of the Companys trade secrets
on December 11, 2007. Defendants appealed the courts entry of the Preliminary Injunction to the
U.S. Court of Appeals for the Ninth Circuit. That court
29
affirmed, in relevant part, the Preliminary Injunction. On December 3, 2007, the defendants
filed a counterclaim alleging that the Company had engaged in unfair and deceptive business
practices, intentional and negligent interference with prospective economic advantage, false
advertising and that the Company was an endless chain scheme in violation of California law and
seeking restitution, contract rescission and an injunction. Both sides engaged in discovery and
filed cross motions for Summary Judgment. On August 25, 2009, the court granted partial summary
judgment for Herbalife on all of defendants claims except the claim that the Company is an endless
chain scheme which under applicable law is a question of fact that can only be determined at trial.
The court denied defendants motion for Summary Judgment on Herbalifes claims for misappropriation
of trade secrets and breach of contract. On March 9, 2010 the Court heard oral argument by the
parties on Herbalifes motion for summary judgment to dismiss the defendants sole remaining
counterclaim, and a decision is pending. No date has been set for trial. The Company believes that
there is merit to its remaining claims for relief and that it has meritorious defenses to the
remaining counterclaim if the counterclaim is not dismissed by summary judgment.
Certain of the Companys subsidiaries have been subject to tax audits by governmental
authorities in their respective countries. In certain of these tax audits, governmental authorities
are proposing that significant amounts of additional taxes and related interest and penalties are
due. The Company and its tax advisors believe that there are substantial defenses to their
allegations that additional taxes are owed, and the Company is vigorously contesting the additional
proposed taxes and related charges.
These matters may take several years to resolve. While the Company believes it has meritorious
defenses, it cannot be sure of their ultimate resolution. Although the Company has reserved an
amount that the Company believes represents the most likely outcome of the resolution of these
disputes, if the Company is incorrect in the assessment the Company may have to record additional
expenses.
Critical Accounting Policies
Our Consolidated Financial Statements are prepared in conformity with U.S. GAAP, which require
us to make estimates and assumptions that affect the reported amounts of assets and liabilities and
disclosures of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenue and expenses during the year. We regularly evaluate our estimates and
assumptions related to revenue recognition, allowance for product returns, inventory reserves,
stock-based compensation expense, goodwill and purchased intangible asset valuations, deferred
income tax asset valuation allowances, uncertain tax positions, tax contingencies, and other loss
contingencies. We base our estimates and assumptions on current facts, historical experience and
various other factors that we believe to be reasonable under the circumstances, the results of
which form the basis for making judgments about the carrying values of assets and liabilities and
the recording of revenue, costs and expenses. Actual results could differ from those estimates. We
consider the following policies to be most critical in understanding the judgments that are
involved in preparing the financial statements and the uncertainties that could impact our
operating results, financial condition and cash flows.
We are a network marketing company that sells a wide range of weight management products,
nutritional supplements, energy, sports & fitness products and personal care products within one
industry segment as defined under Financial Accounting Standard Board, or FASB, Accounting
Standards Codification, or ASC, Topic 280, Segment Reporting. Our products are manufactured by
third party providers and manufactured in our Suzhou, China facility, and in our recently acquired
manufacturing facility located in Lake Forest, California, and then are sold to independent
distributors who sell Herbalife products to retail consumers or other distributors. We sell
products in 73 countries throughout the world and we are organized and managed by geographic
region. We have elected to aggregate our operating segments into one reporting segment, except
China, as management believes that our operating segments have similar operating characteristics
and similar long term operating performance. In making this determination, management believes that
the operating segments are similar in the nature of the products sold, the product acquisition
process, the types of customers to whom products are sold, the methods used to distribute the
products, and the nature of the regulatory environment.
Revenue is recognized when products are shipped and title and risk of loss passes to the
independent distributor or importer or as products are sold in our retail stores in China. Sales
are recognized on a net sales basis, which reflects product returns, net of discounts referred to
as distributor allowances, and amounts billed for freight and handling costs. We generally
receive the net sales price in cash or through credit card payments at the point of sale. Related
royalty overrides and allowances for product returns are recorded when the merchandise is shipped.
Allowances for product returns, primarily in connection with our buyback program, are provided
at the time the product is shipped. This accrual is based upon historic return rates for each
country and the relevant return pattern, which reflects anticipated returns to be received over a
period of up to 12 months following the original sale. Historically, product returns and buybacks
have not been significant. Product returns and buybacks were approximately 0.4% and 0.6% of retail
sales for the three months ended March 31, 2010 and 2009, respectively.
30
We record reserves against our inventory to provide for estimated obsolete or unsalable
inventory based on assumptions about future demand for our products and market conditions. If
future demand and market conditions are less favorable than managements assumptions, additional
reserves could be required. Likewise, favorable future demand and market conditions could
positively impact future operating results if previously reserved for inventory is sold. We
reserved for obsolete and slow moving inventory totaling $11.2 million and $9.3 million as of March
31, 2010, and December 31, 2009, respectively.
In accordance with the FASB ASC Topic 360, Property, Plant and Equipment, property, plant, and
equipment, and purchased intangibles subject to amortization, are reviewed for impairment whenever
events or changes in circumstances indicate that the carrying amount of an asset may not be
recoverable. Recoverability of assets to be held and used is measured by a comparison of the
carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by
the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an
impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the
fair value of the asset. Assets to be disposed of would be separately presented in the balance
sheet and reported at the lower of the carrying amount or fair value less costs to sell, and are no
longer depreciated. The assets and liabilities of a disposed group classified as held for sale
would be presented separately in the appropriate asset and liability sections of the balance sheet.
Goodwill and marketing related intangible assets not subject to amortization are tested
annually for impairment, and are tested for impairment more frequently if events and circumstances
indicate that the asset might be impaired. An impairment loss is recognized to the extent that the
carrying amount exceeds the assets fair value. In order to estimate the fair value of goodwill, we
primarily use the discounted cash flow model, known as the income approach. The determination of
impairment is made at the reporting unit level and consists of two steps. First, we determine the
fair value of a reporting unit and compare it to its carrying amount. Second, if the carrying
amount of a reporting unit exceeds its fair value, an impairment loss is recognized for any excess
of the carrying amount of the reporting units goodwill and other intangibles over the implied fair
value. The implied fair value of goodwill is determined in a similar manner as how the amount of
goodwill recognized in a business combination is determined, in accordance with FASB ASC Topic 805,
Business Combinations, or ASC 805. We would assign the fair value of a reporting unit to all of the
assets and liabilities of that reporting unit as if the reporting unit had been acquired in a
business combination and the fair value of the reporting unit was the price paid to acquire the
reporting unit. The excess of the fair value of a reporting unit over the amounts assigned to its
assets and liabilities is the implied fair value of goodwill. As of March 31, 2010 and December 31,
2009, we had goodwill of approximately $102.5 million and marketing franchise of approximately
$310.0 million. No marketing related intangibles or goodwill impairment was recorded during the
quarter ended March 31, 2010.
Contingencies are accounted for in accordance with the FASB ASC Topic 450, Contingencies, or
ASC 450. ASC 450 requires that we record an estimated loss from a loss contingency when information
available prior to issuance of our financial statements indicates that it is probable that an asset
has been impaired or a liability has been incurred at the date of the financial statements and the
amount of the loss can be reasonably estimated. Accounting for contingencies such as legal and
income tax matters requires us to use judgment related to both the likelihood of a loss and the
estimate of the amount or range of loss. Many of these legal and tax contingencies can take years
to be resolved. Generally, as the time period increases over which the uncertainties are resolved,
the likelihood of changes to the estimate of the ultimate outcome increases.
Deferred income tax assets have been established for net operating loss carryforwards of
certain foreign subsidiaries and have been reduced by a valuation allowance to reflect them at
amounts estimated to be ultimately realized. The net operating loss carryforwards expire in varying
amounts over a future period of time. Realization of the income tax carryforwards is dependent on
generating sufficient taxable income prior to expiration of the carryforwards. Although realization
is not assured, we believe it is more likely than not that the net carrying value of the income tax
carryforwards will be realized. The amount of the income tax carryforwards that is considered
realizable, however, could change if estimates of future taxable income during the carryforward
period are adjusted. In the ordinary course of our business, there are many transactions and
calculations where the tax law and ultimate tax determination is uncertain. As part of the process
of preparing our Consolidated Financial Statements, we are required to estimate our income taxes in
each of the jurisdictions in which we operate prior to the completion and filing of tax returns for
such periods. This process requires estimating both our geographic mix of income and our uncertain
tax positions in each jurisdiction where we operate. These estimates involve complex issues and
require us to make judgments about the likely application of the tax law to our situation, as well
as with respect to other matters, such as anticipating the positions that we will take on tax
returns prior to our actually preparing the returns and the outcomes of disputes with tax
authorities. The ultimate resolution of these issues may take extended periods of time due to
examinations by tax authorities and statutes of limitations. In addition, changes in our business,
including acquisitions, changes in our international corporate structure, changes in the geographic
location of business functions or assets, changes in the geographic mix and amount of income, as
well as changes in our agreements with tax authorities, valuation allowances, applicable accounting
rules, applicable tax laws and regulations, rulings and interpretations thereof, developments in tax
audit and other matters, and variations in the estimated and actual level of annual pre-tax income
can affect the overall effective income tax rate.
31
We account for uncertain tax positions in accordance with the FASB ASC Topic 740, Income
Taxes, or ASC 740 which provides guidance on the determination of how tax benefits claimed or
expected to be claimed on a tax return should be recorded in the financial statements. Under ASC
740, we must recognize the tax benefit from an uncertain tax position only if it is more likely
than not that the tax position will be sustained on examination by the taxing authorities, based on
the technical merits of the position. The tax benefits recognized in the financial statements from
such a position are measured based on the largest benefit that has a greater than fifty percent
likelihood of being realized upon ultimate resolution.
We account for share-based compensation in accordance with the FASB ASC Topic 718,
Compensation-Stock Compensation, or ASC 718. Under the fair value recognition provisions of this
statement, share-based compensation cost is measured at the grant date based on the value of the
award and is recognized as an expense over the vesting period. Determining the fair value of
share-based awards at the grant date requires judgment, including estimating our stock price
volatility and employee stock award exercise behaviors. Our expected volatility is primarily based
upon the historical volatility of our common shares and, due to the limited period of public
trading data for our common shares, it is also validated against the volatility of a company peer
group. The expected life of awards is based on the simple average of the average vesting period and
the life of the award, or the simplified method. As share-based compensation expense recognized in
the Statements of Income is based on awards ultimately expected to vest, the amount of expense has
been reduced for estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of
grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those
estimates. If actual forfeitures differ from estimates, additional expense or reversal of previous
expense are recorded. Forfeitures were estimated based on historical experience.
We account for foreign currency transactions in accordance with ASC Topic 830, Foreign
Currency Matters. In substantially all of the countries where we operate, the functional currency
is the local currency. Our foreign subsidiaries asset and liability accounts are translated for
consolidated financial reporting purposes into U.S. dollar amounts at year-end exchange rates.
Revenue and expense accounts are translated at the average rates during the year. Our foreign
exchange translation adjustments are included in accumulated other comprehensive loss on our
accompanying consolidated balance sheets. Foreign currency transaction gains and losses and foreign
currency remeasurements are included in selling, general and administrative expenses in the
accompanying consolidated statements of income.
Recently Adopted Accounting Pronouncements
In January 2010, the FASB, issued Final Accounting Standards Update 2010-06, Improving
Disclosures about Fair Value Measurements, or ASU 2010-06. ASU 2010-06 sets forth additional
requirements and guidance regarding disclosures of fair value measurements. ASU 2010-06 requires
the gross presentation of activity within the Level 3 fair value measurement roll forward and
details of transfers in and out of Level 1 and 2 fair value measurements. It also clarifies two
existing disclosure requirements of ASC, Topic 820, Fair Value Measurements and Disclosures, or ASC
820, relating to the level of disaggregation of fair value measurements and disclosures on inputs
and valuation techniques. ASU 2010-06 is effective for fiscal years and interim periods beginning
after December 15, 2009, except for the Level 3 roll forward, which is effective for fiscal years
and interim periods beginning after December 15, 2010. The adoption of this guidance did not have
a material impact to the Companys consolidated financial statements.
In June 2009, the FASB issued guidance to revise the approach to determine when a variable
interest entity, or VIE, should be consolidated. The new consolidation model for VIEs considers
whether the Company has the power to direct the activities that most significantly impact the VIEs
economic performance and shares in the significant risks and rewards of the entity. The guidance on
VIEs requires companies to continually reassess VIEs to determine if consolidation is appropriate
and provide additional disclosures. The guidance is effective for the Companys 2010 fiscal year.
The adoption of this guidance did not have a material impact to the Companys consolidated
financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to market risks, which arise during the normal course of business from changes
in interest rates and foreign currency exchange rates. On a selected basis, we use derivative
financial instruments to manage or hedge these risks. All hedging transactions are authorized and
executed pursuant to written guidelines and procedures.
32
We have adopted FASB ASC Topic 815, Derivatives and Hedging, or ASC 815, which established
accounting and reporting standards for derivative instruments, including certain derivative
instruments embedded in other contracts, and for hedging activities. All derivatives, whether
designated in hedging relationships or not, are required to be recorded on the balance sheet at
fair value. If the derivative is designated as a fair-value hedge, the changes in the fair value of
the derivative and the underlying hedged item are recognized concurrently in earnings. If the
derivative is designated as a cash-flow hedge, changes in the fair value of the derivative are
recorded in other comprehensive income (loss) and are recognized in the consolidated statements of
income when the hedged item affects earnings. ASC 815 defines the requirements for designation and
documentation of hedging relationships as well as ongoing effectiveness assessments in order to use
hedge accounting. For a derivative that does not qualify as a hedge, changes in fair value are
recognized concurrently in earnings.
A discussion of our primary market risk exposures and derivatives is presented below.
Foreign Exchange Risk
We transact business globally and are subject to risks associated with changes in foreign
exchange rates. Our objective is to minimize the impact to earnings and cash flow fluctuations
associated with foreign exchange rate fluctuations. We enter into foreign exchange derivatives in
the ordinary course of business primarily to reduce exposure to currency fluctuations attributable
to intercompany transactions, translation of local currency revenue, inventory purchases subject to
foreign currency exposure, and to partially mitigate the impact of foreign currency rate
fluctuations. Due to the recent significant volatility in the foreign exchange market, our current
strategy, in general, is to hedge some of the significant exposures on a short-term basis. We will
continue to monitor the foreign exchange market and evaluate our hedging strategy accordingly. With
the exception of our foreign exchange forward contracts relating to forecasted inventory purchases
and intercompany management fees as discussed below in this section, all of our foreign exchange
contracts are designated as free standing derivatives for which hedge accounting does not apply.
The changes in the fair market value of the derivatives not qualifying as cash flow hedges are
included in selling, general and administrative expenses in our consolidated statements of income.
The foreign exchange forward contracts designated as free standing derivatives are used to
hedge advances between subsidiaries and to partially mitigate the impact of foreign currency
fluctuations. Foreign exchange average rate option contracts are also used to mitigate the impact
of foreign currency rate fluctuations. The objective of these contracts is to neutralize the impact
of foreign currency movements on the operating results of our subsidiaries. The fair value of
forward and option contracts is based on third-party bank quotes.
We also purchase foreign currency forward contracts in order to hedge forecasted inventory
purchases and intercompany management fees that are designated as cash-flow hedges and are subject
to foreign currency exposures. We applied the hedge accounting rules as required by ASC Topic 815
for these hedges. These contracts allow us to sell Euros in exchange for U.S. dollars at specified
contract rates. As of March 31, 2010, the aggregate notional amounts of these contracts outstanding
were approximately $91.1million and were expected to mature over the next fifteen months. Our
derivative financial instruments are recorded on the consolidated balance sheet at fair value based
on quoted market rates. For the forecasted inventory purchases, the forward contracts are used to
hedge forecasted inventory purchases over specific months. Changes in the fair value of these
forward contracts, excluding forward points, designated as cash-flow hedges are recorded as a
component of accumulated other comprehensive income (loss) within shareholders equity, and are
recognized in cost of sales in the consolidated statement of income during the period which
approximates the time the hedged inventory is sold. We also hedge forecasted intercompany
management fees over specific months. Changes in the fair value of these forward contracts
designated as cash flow hedges are recorded as a component of accumulated other comprehensive loss
within shareholders equity, and are recognized in selling, general and administrative expenses in
the consolidated statement of income in the period when the hedged item and underlying transaction
affects earnings. As of March 31, 2010 and December 31, 2009, we recorded assets at fair value of
$5.3 million and $2.3 million, respectively, relating to all outstanding foreign currency contracts
designated as cash-flow hedges. We assess hedge effectiveness and measure hedge ineffectiveness at
least quarterly. During the three months ended March 31, 2010, the ineffective portion relating to
these hedges was immaterial and the hedges remained effective as of March 31, 2010.
As of March 31, 2010, all of our foreign exchange forward contracts had a maturity of less
than fifteen months, with substantially all expiring within one year. As of March 31, 2010, there
were no outstanding foreign exchange option contracts.
33
The following table provides information about the details of our foreign exchange forward
contracts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average |
|
|
|
|
|
|
Fair |
|
|
|
Contract |
|
|
Notional |
|
|
Value |
|
Foreign Currency |
|
Rate |
|
|
Amount |
|
|
Gain (Loss) |
|
|
|
|
|
|
(In millions) |
|
|
(In millions) |
|
At March 31, 2010 |
|
|
|
|
|
|
|
|
|
|
|
|
Buy JPY sell USD |
|
|
92.18 |
|
|
$ |
15.3 |
|
|
$ |
(0.2 |
) |
Buy EUR sell USD |
|
|
1.38 |
|
|
$ |
46.1 |
|
|
$ |
(1.0 |
) |
Buy EUR sell GBP |
|
|
0.87 |
|
|
$ |
3.3 |
|
|
$ |
0.1 |
|
Buy EUR sell MXN |
|
|
18.04 |
|
|
$ |
30.1 |
|
|
$ |
(2.3 |
) |
Buy GBP sell EUR |
|
|
0.89 |
|
|
$ |
1.7 |
|
|
$ |
|
|
Buy MXN sell USD |
|
|
12.60 |
|
|
$ |
11.5 |
|
|
$ |
0.2 |
|
Buy PHP sell USD |
|
|
45.37 |
|
|
$ |
3.3 |
|
|
$ |
|
|
Buy TWD sell USD |
|
|
31.93 |
|
|
$ |
4.5 |
|
|
$ |
|
|
Buy USD sell BRL |
|
|
1.90 |
|
|
$ |
6.8 |
|
|
$ |
(0.4 |
) |
Buy USD sell COP |
|
|
2,034.86 |
|
|
$ |
4.9 |
|
|
$ |
(0.3 |
) |
Buy USD sell MXN |
|
|
13.13 |
|
|
$ |
11.0 |
|
|
$ |
(0.7 |
) |
Buy USD sell PHP |
|
|
46.38 |
|
|
$ |
5.8 |
|
|
$ |
(0.1 |
) |
Buy USD sell RUB |
|
|
30.39 |
|
|
$ |
1.3 |
|
|
$ |
|
|
Buy USD sell EUR |
|
|
1.43 |
|
|
$ |
101.9 |
|
|
$ |
5.2 |
|
Buy CLP sell USD |
|
|
504.55 |
|
|
$ |
2.6 |
|
|
$ |
(0.1 |
) |
Buy INR sell USD |
|
|
45.13 |
|
|
$ |
0.4 |
|
|
$ |
|
|
Buy MYR sell USD |
|
|
3.27 |
|
|
$ |
4.5 |
|
|
$ |
|
|
Buy PEN sell USD |
|
|
2.84 |
|
|
$ |
2.4 |
|
|
$ |
|
|
Buy RUB sell USD |
|
|
29.50 |
|
|
$ |
0.3 |
|
|
$ |
|
|
Buy USD sell CLP |
|
|
527.50 |
|
|
$ |
2.5 |
|
|
$ |
|
|
Buy USD sell INR |
|
|
46.79 |
|
|
$ |
4.3 |
|
|
$ |
(0.2 |
) |
Buy USD sell JPY |
|
|
92.83 |
|
|
$ |
6.8 |
|
|
$ |
|
|
Buy USD sell KRW |
|
|
1,136.15 |
|
|
$ |
2.5 |
|
|
$ |
|
|
Buy USD sell TWD |
|
|
31.83 |
|
|
$ |
2.7 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total forward contracts |
|
|
|
|
|
$ |
276.5 |
|
|
$ |
0.2 |
|
|
|
|
|
|
|
|
|
|
|
|
Most of our foreign subsidiaries designate their local currencies as their functional
currencies. At March 31, 2010 and December 31, 2009, the total amount of our foreign subsidiary
cash was $163.4 million and $149.6 million, respectively, of which $11.8 million and $11.9 million,
respectively, was invested in U.S. dollars.
Currency restrictions enacted by the Venezuelan government in 2003 have become more
restrictive and have impacted the ability of Herbalife Venezuela, to obtain U.S. dollars at the
official foreign exchange rate. The application and approval processes have been intermittently
delayed in recent periods, and the timing and ability to obtain U.S. dollars at the official
exchange rate remains uncertain. In certain instances, we have made appropriate applications
through CADIVI, for approval to obtain U.S. dollars to pay for imported products and an annual
dividend at the official exchange rate. In other instances, in order to timely provide products to
our distributors, we did not register certain shipments with CADIVI, or non-CADIVI registered, and
instead used a legal parallel market mechanism for payment. If CADIVI does not approve further
exchanges at the official exchange rate, Herbalife Venezuela could continue to use a legal parallel
exchange process to exchange U.S. dollars in addition to going through CADIVI to obtain the
official rate.
In addition, beginning January 1, 2010, Venezuela is considered a highly inflationary economy.
We use the parallel market exchange rate for remeasurement purposes under highly inflationary
accounting rules based on our specific facts and circumstances including our ability to access the
official exchange rate and the parallel market exchange rate. Also in early January 2010, Venezuela
announced an official rate devaluation of the Bolivar to an official rate of 4.30 Bolivars per U.S.
dollar for non-essential items and 2.60 Bolivars per U.S. dollar for essential items. Therefore,
any future changes to the parallel market exchange rate or the official rate may result in a
significant impact to our consolidated earnings.
As of March 31, 2010, the parallel market rate was approximately 38% and 62% less favorable
than the official exchange rates for non-essential and essential items, respectively, and could
further deteriorate in future periods which would have a negative impact to our earnings if we are
unable to access the official rate. See Part I, Item 2 Managements Discussion and Analysis of
Financial Condition and Results of Operations, for a further discussion on how the currency
restrictions in Venezuela have impacted Herbalife Venezuelas operations.
34
Interest Rate Risk
As of March 31, 2010, the aggregate annual maturities of our senior secured credit facility
were expected to be: 2010-$1.1 million; 2011-$1.5 million; 2012-$99.5 million and 2013-$140.9
million. The fair value of our senior secured credit facility approximates its carrying value of
$243.0 million as of March 31, 2010 and $236.4 million as of December 31, 2009. Our senior secured
credit facility bears a variable interest rate, and on March 31, 2010, and December 31, 2009, the
weighted average interest rate was 1.64% and 1.66%, respectively.
During August 2009, we entered into four interest rate swap agreements with an effective date
of December 31, 2009. The agreements, collectively, provide for us to pay interest for less than a
four-year period at a weighted average fixed rate of 2.78% on notional amounts aggregating to $140
million while receiving interest for the same period at the one month LIBOR rate on the same
notional amounts. These agreements will expire in July 2013. The swaps have been designated as cash
flow hedges against the variability in the LIBOR interest rate on the term loan at LIBOR plus
1.50%, thereby fixing our weighted average effective rate on the notional amounts at 4.28%. We
formally assess, both at inception and at least quarterly thereafter, whether the derivatives used
in hedging transactions are effective in offsetting changes in cash flows of the hedged item. As of
March 31, 2010 the hedge relationships qualified as effective hedges under the ASC 815.
Consequently, all changes in the fair value of the derivatives are deferred and recorded in other
comprehensive income (loss) until the related forecasted transactions are recognized in the
consolidated statements of income. As of March 31, 2010, and December 31, 2009, the fair value of
the interest rate swap agreements are based on third-party bank quotes and we recorded the interest
rate swaps as a liability at fair value of $4.3 million and $2.6 million, respectively.
Item 4. Controls And Procedures
Evaluation of Disclosure Controls and Procedures. Our management, including our Chief
Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure
controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the
Securities Exchange Act of 1934, as amended, or the Exchange Act) as of the end of the period
covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our Chief Executive
Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures
were effective as of March 31, 2010.
Changes in Internal Control over Financial Reporting. There were no changes in our internal
control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange
Act) that occurred during the quarter ended March 31, 2010 that have materially affected, or are
reasonably likely to materially affect, our internal control over financial reporting.
FORWARD-LOOKING STATEMENTS
This document contains forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as
amended. All statements other than statements of historical fact are forward-looking statements
for purposes of federal and state securities laws, including any projections of earnings, revenue
or other financial items; any statements of the plans, strategies and objectives of management for
future operations; any statements concerning proposed new services or developments; any statements
regarding future economic conditions or performance; any statements of belief; and any statements
of assumptions underlying any of the foregoing. Forward-looking statements may include the words
may, will, estimate, intend, continue, believe, expect or anticipate and any other
similar words.
Although we believe that the expectations reflected in any of our forward-looking statements
are reasonable, actual results could differ materially from those projected or assumed in any of
our forward-looking statements. Our future financial condition and results of operations, as well
as any forward-looking statements, are subject to change and to inherent risks and uncertainties,
such as those disclosed or incorporated by reference in our filings with the Securities and
Exchange Commission. Important factors that could cause our actual results, performance and
achievements, or industry results to differ materially from estimates or projections contained in
our forward-looking statements include, among others, the following:
|
|
|
our relationship with, and our ability to influence the actions of, our distributors; |
|
|
|
|
adverse publicity associated with our products or network marketing organization; |
35
|
|
|
uncertainties relating to interpretation and enforcement of recently enacted legislation
in China governing direct selling; |
|
|
|
|
our inability to obtain the necessary licenses to expand our direct selling business in
China; |
|
|
|
|
adverse changes in the Chinese economy, Chinese legal system or Chinese governmental
policies; |
|
|
|
|
improper action by our employees or international distributors in violation of applicable
law; |
|
|
|
|
changing consumer preferences and demands; |
|
|
|
|
loss or departure of any member of our senior management team which could negatively
impact our distributor relations and operating results; |
|
|
|
|
the competitive nature of our business; |
|
|
|
|
regulatory matters governing our products, including potential governmental or regulatory
actions concerning the safety or efficacy of our products, and network marketing program
including the direct selling market in which we operate; |
|
|
|
|
third party legal challenges to our network marketing program; |
|
|
|
|
risks associated with operating internationally and the effect of economic factors,
including foreign exchange, inflation, pricing and currency devaluation risks, especially in
countries such as Venezuela; |
|
|
|
|
our dependence on increased penetration of existing markets; |
|
|
|
|
contractual limitations on our ability to expand our business; |
|
|
|
|
our reliance on our information technology infrastructure and outside manufacturers; |
|
|
|
|
the sufficiency of trademarks and other intellectual property rights; |
|
|
|
|
product concentration; |
|
|
|
|
our reliance on our management team; |
|
|
|
|
uncertainties relating to the application of transfer pricing, duties, value added taxes,
and other tax regulations, and changes thereto; |
|
|
|
|
changes in tax laws, treaties or regulations, or their interpretation; |
|
|
|
|
taxation relating to our distributors; |
|
|
|
|
product liability claims; |
|
|
|
|
any collateral impact resulting from the ongoing worldwide financial crisis, including
the availability of liquidity to us, our customers and our suppliers or the willingness of
our customers to purchase products in a recessionary economic environment; and |
|
|
|
|
whether we will purchase any of our shares in the open markets or otherwise. |
Additional factors that could cause actual results to differ materially from our
forward-looking statements are set forth in this Quarterly Report on Form 10-Q, including under the
heading Risk Factors, Managements Discussion and Analysis of Financial Condition and Results of
Operations and in our Consolidated Financial Statements and the related Notes.
Forward-looking statements in this Quarterly Report on Form 10-Q speak only as of the date
hereof, and forward-looking statements in documents attached that are incorporated by reference
speak only as of the date of those documents. We do not undertake any obligation to update or release any revisions to any forward-looking statement
or to report any events or circumstances after the date hereof or to reflect the occurrence of
unanticipated events, except as required by law.
36
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
See discussion under Note 5, Contingencies, to the Notes to the Consolidated Financial
Statements included in Item 1 of Part I of this Quarterly Report on Form 10-Q, which is
incorporated herein by reference.
Item 1A. Risk Factors
The worldwide financial and economic crisis could negatively impact our access to credit and the
sales of our products and could harm our financial condition and operating results.
We are closely monitoring various aspects of the current worldwide financial and economic
crisis and its potential impact on us, our liquidity, our access to capital, our operations and
our overall financial condition. While we have historically met our funding needs utilizing cash
flow from operating activities and while we believe we will have sufficient resources to meet
current debt service obligations in a timely manner, no assurances can be given that the current
overall downturn in the world economy will not significantly adversely impact us and our business
operations. We note economic and financial markets are fluid and we cannot ensure that there will
not be in the near future a material adverse deterioration in our sales or liquidity.
Our failure to establish and maintain distributor relationships for any reason could negatively
impact sales of our products and harm our financial condition and operating results.
We distribute our products exclusively through approximately 2.1 million independent
distributors, and we depend upon them directly for substantially all of our sales. To increase our
revenue, we must increase the number of, or the productivity of, our distributors. Accordingly, our
success depends in significant part upon our ability to recruit, retain and motivate a large base
of distributors. There is a high rate of turnover among our distributors, which is a characteristic
of the network marketing business. The loss of a significant number of distributors for any reason
could negatively impact sales of our products and could impair our ability to attract new
distributors. In our efforts to attract and retain distributors, we compete with other network
marketing organizations, including those in the weight management, dietary and nutritional
supplement and personal care and cosmetic product industries. Our operating results could be harmed
if our existing and new business opportunities and products do not generate sufficient interest to
retain existing distributors and attract new distributors.
Our distributor organization has a high turnover rate, which is a common characteristic found
in the direct selling industry. In light of this fact, we have our sales leaders re-qualify
annually in order to maintain a more accurate count of their numbers. For the latest twelve month
re-qualification period ending January 2010, 43% of our sales leaders re-qualified. Distributors
who purchase our product for personal consumption or for short-term income goals may stay with us
for several months to one year. Sales leaders who have committed time and effort to build a sales
organization will generally stay for longer periods. Distributors have highly variable levels of
training, skills and capabilities. The turnover rate of our distributors, and our operating
results, can be adversely impacted if we, and our senior distributor leadership, do not provide the
necessary mentoring, training and business support tools for new distributors to become successful
sales people in a short period of time.
We estimate that, of our approximately 2.1 million independent distributors, we had
approximately 327,000 sales leaders as of March 31, 2010. These sales leaders, together with their
downline sales organizations, account for substantially all of our revenues. Our distributors,
including our sales leaders, may voluntarily terminate their distributor agreements with us at any
time. The loss of a group of leading sales leaders, together with their downline sales
organizations, or the loss of a significant number of distributors for any reason, could negatively
impact sales of our products, impair our ability to attract new distributors and harm our financial
condition and operating results.
37
Since we cannot exert the same level of influence or control over our independent distributors as
we could were they our own employees, our distributors could fail to comply with our distributor
policies and procedures, which could result in claims against us that could harm our financial
condition and operating results.
Excluding our China sales employees, our distributors are independent contractors and,
accordingly, we are not in a position to directly provide the same direction, motivation and
oversight as we would if distributors were our own employees. As a result, there can be no
assurance that our distributors will participate in our marketing strategies or plans, accept our
introduction of new products, or comply with our distributor policies and procedures.
Extensive federal, state and local laws regulate our business, products and network marketing
program. Because we have expanded into foreign countries, our policies and procedures for our
independent distributors differ due to the different legal requirements of each country in which we
do business. While we have implemented distributor policies and procedures designed to govern
distributor conduct and to protect the goodwill associated with Herbalife trademarks and
tradenames, it can be difficult to enforce these policies and procedures because of the large
number of distributors and their independent status. Violations by our independent distributors of
applicable law or of our policies and procedures in dealing with customers could reflect negatively
on our products and operations and harm our business reputation. In addition, it is possible that a
court could hold us civilly or criminally accountable based on vicarious liability because of the
actions of our independent distributors.
Adverse publicity associated with our products, ingredients or network marketing program, or those
of similar companies, could harm our financial condition and operating results.
The size of our distribution force and the results of our operations may be significantly
affected by the publics perception of the Company and similar companies. This perception is
dependent upon opinions concerning:
|
|
|
the safety and quality of our products and ingredients; |
|
|
|
|
the safety and quality of similar products and ingredients distributed by other
companies; |
|
|
|
|
our distributors; |
|
|
|
|
our network marketing program; and |
|
|
|
|
the direct selling business generally. |
Adverse publicity concerning any actual or purported failure of our Company or our independent
distributors to comply with applicable laws and regulations regarding product claims and
advertising, good manufacturing practices, the regulation of our network marketing program, the
licensing of our products for sale in our target markets or other aspects of our business, whether
or not resulting in enforcement actions or the imposition of penalties, could have an adverse
effect on the goodwill of our Company and could negatively affect our ability to attract, motivate
and retain distributors, which would negatively impact our ability to generate revenue. We cannot
ensure that all distributors will comply with applicable legal requirements relating to the
advertising, labeling, licensing or distribution of our products.
In addition, our distributors and consumers perception of the safety and quality of our
products and ingredients as well as similar products and ingredients distributed by other companies
can be significantly influenced by media attention, publicized scientific research or findings,
widespread product liability claims and other publicity concerning our products or ingredients or
similar products and ingredients distributed by other companies. For example, in May 2008 public
allegations were made that certain of our products contain excessive amounts of lead thereby
triggering disclosure and labeling requirements under California Proposition 65. While we have
confidence in our products because they fall within the FDA suggested guidelines for the amount of
lead that consumers can safely ingest and do not believe they trigger disclosure or labeling
requirements under California Proposition 65, negative publicity such as this can disrupt our
business. Adverse publicity, whether or not accurate or resulting from consumers use or misuse of
our products, that associates consumption of our products or ingredients or any similar products or
ingredients with illness or other adverse effects, questions the benefits of our or similar
products or claims that any such products are ineffective, inappropriately labeled or have
inaccurate instructions as to their use, could lead to lawsuits or other legal challenges and could
negatively impact our reputation, the market demand for our products, or our general business.
38
From time to time we receive inquiries from government agencies and third parties requesting
information concerning our products. We fully cooperate with these inquiries including, when
requested, by the submission of detailed technical dossiers addressing product composition,
manufacturing, process control, quality assurance, and contaminant testing. We understand that such
materials are undergoing review by regulators in certain markets. In the course of one such inquiry
the Spanish Ministry of Health elected to issue a press release, or communicado, to inform the
public of a then on-going inquiry and dialogue with our Company. Upon completion of its review of
Herbalife products distributed in Spain, the Spanish Ministry of Health withdrew its communicado in
April 2009. We are confident in the safety of our products when used as directed. However, there
can be no assurance that regulators in these or other markets will not take actions that might
delay or prevent the introduction of new products, or require the reformulation or the temporary or
permanent withdrawal of certain of our existing products from their markets.
Adverse publicity relating to us, our products or our operations, including our network
marketing program or the attractiveness or viability of the financial opportunities provided
thereby, has had, and could again have, a negative effect on our ability to attract, motivate and
retain distributors. In the mid-1980s, our products and marketing program became the subject of
regulatory scrutiny in the United States, resulting in large part from claims and representations
made about our products by our independent distributors, including impermissible therapeutic
claims. The resulting adverse publicity caused a rapid, substantial loss of distributors in the
United States and a corresponding reduction in sales beginning in 1985. We expect that negative
publicity will, from time to time, continue to negatively impact our business in particular
markets.
Our failure to appropriately respond to changing consumer preferences and demand for new products
or product enhancements could significantly harm our distributor and customer relationships and
product sales and harm our financial condition and operating results.
Our business is subject to changing consumer trends and preferences, especially with respect
to weight management products. Our continued success depends in part on our ability to anticipate
and respond to these changes, and we may not respond in a timely or commercially appropriate manner
to such changes. Furthermore, the nutritional supplement industry is characterized by rapid and
frequent changes in demand for products and new product introductions and enhancements. Our failure
to accurately predict these trends could negatively impact consumer opinion of our products, which
in turn could harm our customer and distributor relationships and cause the loss of sales. The
success of our new product offerings and enhancements depends upon a number of factors, including
our ability to:
|
|
|
accurately anticipate customer needs; |
|
|
|
|
innovate and develop new products or product enhancements that meet these needs; |
|
|
|
|
successfully commercialize new products or product enhancements in a timely manner; |
|
|
|
|
price our products competitively; |
|
|
|
|
manufacture and deliver our products in sufficient volumes and in a timely manner; and
|
|
|
|
|
differentiate our product offerings from those of our competitors. |
If we do not introduce new products or make enhancements to meet the changing needs of our
customers in a timely manner, some of our products could be rendered obsolete, which could
negatively impact our revenues, financial condition and operating results.
Due to the high level of competition in our industry, we might fail to retain our customers and
distributors, which would harm our financial condition and operating results.
The business of marketing weight management and nutrition products is highly competitive and
sensitive to the introduction of new products or weight management plans, including various
prescription drugs, which may rapidly capture a significant share of the market. These market
segments include numerous manufacturers, distributors, marketers, retailers and physicians that
actively compete for the business of consumers both in the United States and abroad. In addition,
we anticipate that we will be subject to increasing competition in the future from sellers that
utilize electronic commerce. Some of these competitors have longer operating histories,
significantly greater financial, technical, product development, marketing and sales resources,
greater name recognition, larger established customer bases and better-developed distribution
channels than we do. Our present or future competitors may be able to develop products that are
comparable or superior to those we offer, adapt more quickly than we do to new technologies,
evolving industry trends and standards or customer requirements, or devote greater resources to the
development, promotion and sale
of their products than we do. For example, if our competitors develop other diet or weight
loss treatments that prove to be more effective than our products, demand for our products could be
reduced. Accordingly, we may not be able to compete effectively in our markets and competition may
intensify.
39
We are also subject to significant competition for the recruitment of distributors from other
network marketing organizations, including those that market weight management products, dietary
and nutritional supplements and personal care products as well as other types of products. We
compete for global customers and distributors with regard to weight management, nutritional
supplement and personal care products. Our competitors include both direct selling companies such
as NuSkin Enterprises, Natures Sunshine, Alticor/Amway, Melaleuca, Avon Products, Oriflame and
Mary Kay, as well as retail establishments such as Weight Watchers, Jenny Craig, General Nutrition
Centers, Wal-Mart and retail pharmacies.
In addition, because the industry in which we operate is not particularly capital intensive or
otherwise subject to high barriers to entry, it is relatively easy for new competitors to emerge
who will compete with us for our distributors and customers. In addition, the fact that our
distributors may easily enter and exit our network marketing program contributes to the level of
competition that we face. For example, a distributor can enter or exit our network marketing system
with relative ease at any time without facing a significant investment or loss of capital because
(1) we have a low upfront financial cost to become a Herbalife distributor, (2) we do not require
any specific amount of time to work as a distributor, (3) we do not insist on any special training
to be a distributor and (4) we do not prohibit a new distributor from working with another company.
Our ability to remain competitive therefore depends, in significant part, on our success in
recruiting and retaining distributors through an attractive compensation plan, the maintenance of
an attractive product portfolio and other incentives. We cannot ensure that our programs for
recruitment and retention of distributors will be successful and if they are not, our financial
condition and operating results would be harmed.
We are affected by extensive laws, governmental regulations, administrative determinations, court
decisions and similar constraints both domestically and abroad, and our failure or our
distributors failure to comply with these constraints could lead to the imposition of significant
penalties or claims, which could harm our financial condition and operating results.
In both domestic and foreign markets, the formulation, manufacturing, packaging, labeling,
distribution, importation, exportation, licensing, sale and storage of our products are affected by
extensive laws, governmental regulations, administrative determinations, court decisions and
similar constraints. Such laws, regulations and other constraints may exist at the federal, state
or local levels in the United States and at all levels of government in foreign jurisdictions.
There can be no assurance that we or our distributors are in compliance with all of these
regulations. Our failure or our distributors failure to comply with these regulations or new
regulations could lead to the imposition of significant penalties or claims and could negatively
impact our business. In addition, the adoption of new regulations or changes in the interpretations
of existing regulations may result in significant compliance costs or discontinuation of product
sales and may negatively impact the marketing of our products, resulting in significant loss of
sales revenues.
In April 2006, the FTC issued a notice of proposed rulemaking which, if implemented in its
originally proposed form, would have regulated all sellers of business opportunities in the
United States. As originally proposed this rule would have applied to us and, if adopted in its
originally proposed form, could have adversely impacted our U.S. business. On March 18, 2008, the
FTC issued a revised proposed rule and, as indicated in the announcement accompanying the proposed
rule, the revised proposal does not attempt to cover multilevel marketing companies such as
Herbalife. If the revised rule were implemented as it is now proposed, we believe that it would not
significantly impact our U.S. business. Based on information currently available, we anticipate
that the rule may become final within the year.
The FTC has approved revisions to its Guides Concerning the Use of Endorsements and
Testimonials in Advertising, or Guides, which became effective on December 1, 2009. Although the
Guides are not binding, they explain how the FTC interprets Section 5 of the FTC Acts prohibition
on unfair or deceptive acts or practices. Consequently, the FTC could bring a Section 5 enforcement
action based on practices that are inconsistent with the Guides. Under the revised Guides,
advertisements that feature a consumer and convey his or her atypical experience with a product or
service will be required to clearly disclose the results that consumers can generally expect. In
contrast to the 1980 version of the Guides, which allowed advertisers to describe atypical results
in a testimonial as long as they included a disclaimer such as results not typical, the revised
Guides no longer contain such a safe harbor. The revised Guides also add new examples to illustrate
the long-standing principle that material connections between advertisers and endorsers (such as
payments or free products), connections that consumers might not expect, must be disclosed.
Herbalife is reviewing the impact of the revised Guides as well as modifications to its practices
and rules regarding the practices of its independent distributors that might be advisable with
regard to the revised Guides. However, it is possible that our use, and that of our independent
distributors, of testimonials in the advertising and promotion of our products, including but not
limited to our weight management products and of our income opportunity will be significantly
impacted and therefore might negatively impact our sales.
40
Governmental regulations in countries where we plan to commence or expand operations may
prevent or delay entry into those markets. In addition, our ability to sustain satisfactory levels
of sales in our markets is dependent in significant part on our ability to introduce additional
products into such markets. However, governmental regulations in our markets, both domestic and
international, can delay or prevent the introduction, or require the reformulation or withdrawal,
of certain of our products. For example, during the third quarter of 1995, we received inquiries
from certain governmental agencies within Germany and Portugal regarding our product,
Thermojetics® Instant Herbal Beverage, relating to the caffeine content of the product
and the status of the product as an instant tea, which was disfavored by regulators, versus a
beverage. Although we initially suspended the product sale in Germany and Portugal at the request
of the regulators, we successfully reintroduced it once regulatory issues were satisfactorily
resolved. In another example, during the second quarter of 2008 the Spanish Ministry of Health
issued a press release, or communicado, informing the public of a then on-going inquiry into the
safety of our Companys products sold in Spain. Upon completion of its review of Herbalife products
distributed in Spain, the Spanish Ministry of Health withdrew its communicado. Any such regulatory
action, whether or not it results in a final determination adverse to us, could create negative
publicity, with detrimental effects on the motivation and recruitment of distributors and,
consequently, on sales.
On June 25, 2007, the FDA published its final rule for cGMPs affecting the manufacture,
packing, and holding of dietary supplements. The final rule requires identity testing on all
incoming dietary ingredients, but permits the use of certificates of analysis or other
documentation to verify the reliability of the ingredient suppliers. On the same date the FDA also
published an interim final rule that outlined a petition process for manufacturers to request an
exemption to the cGMP requirement for 100 percent identity testing of specific dietary ingredients
used in the processing of dietary supplements. Under the interim final rule the manufacturer may be
exempted from the dietary ingredient testing requirement if it can provide sufficient documentation
that the reduced frequency of testing requested would still ensure the identity of the dietary
ingredient. The final rule includes a phased-in effective date based on the size of the
manufacturer. The final rule and the interim final rule became effective August 24, 2007. To limit
any disruption for dietary supplements produced by small businesses the final rule has a three year
phase in for small businesses. Firms that directly employ more than 500 full-time equivalent
employees must have achieved compliance with the new cGMPs by June 25, 2008, while firms having
between 20-500 full-time equivalent employees must be compliant by 2009 and firms having under 20
full-time equivalent employees must be compliant by 2010. Herbalife initiated enhancements,
modifications and improvements to its manufacturing and corporate quality processes and believes
that it is compliant with the FDAs cGMP final rule with respect to dietary supplements sold by
Herbalife in the United States that the Company produces at its Lake Forest, California facility
and its Suzhou, China facility and that are produced by contract manufacturers. These rules apply
only to manufacturers and holders of finished products and not to ingredient suppliers unless the
ingredient supplier is manufacturing a final dietary supplement. Due to the final cGMP rules, we
have experienced increases in some product costs as a result of the necessary increase in testing
of raw ingredients and finished products and this may cause us to seek alternate suppliers.
Our network marketing program could be found to be not in compliance with current or newly adopted
laws or regulations in one or more markets, which could prevent us from conducting our business in
these markets and harm our financial condition and operating results.
Our network marketing program is subject to a number of federal and state regulations
administered by the FTC and various state agencies in the United States as well as regulations on
direct selling in foreign markets administered by foreign agencies. We are subject to the risk
that, in one or more markets, our network marketing program could be found not to be in compliance
with applicable law or regulations. Regulations applicable to network marketing organizations
generally are directed at preventing fraudulent or deceptive schemes, often referred to as
pyramid or chain sales schemes, by ensuring that product sales ultimately are made to consumers
and that advancement within an organization is based on sales of the organizations products rather
than investments in the organization or other non-retail sales-related criteria. The regulatory
requirements concerning network marketing programs do not include bright line rules and are
inherently fact-based, and thus, even in jurisdictions where we believe that our network marketing
program is in full compliance with applicable laws or regulations governing network marketing
systems, we are subject to the risk that these laws or regulations or the enforcement or
interpretation of these laws and regulations by governmental agencies or courts can change. The
failure of our network marketing program to comply with current or newly adopted regulations could
negatively impact our business in a particular market or in general.
We are also subject to the risk of private party challenges to the legality of our network
marketing program. The multi-level marketing programs of other companies have been successfully
challenged in the past and in a current lawsuit allegations have been made challenging the legality
of our network marketing program in Belgium. Test Ankoop-Test Achat, a Belgian consumer protection
organization, sued Herbalife International Belgium, S.V., or HIB, on August 26, 2004, alleging that
HIB violated Article 84 of the Belgian Fair Trade Practices Act by engaging in pyramid selling,
i.e., establishing a network of professional or non-professional sales people who hope to make a
profit more through the expansion of that network rather than through the sale of products to end-consumers.
41
The plaintiff is seeking a payment of 25,000 (equal to approximately $34,000 as of
March 31, 2010) per purported violation as well as costs of the trial. For the year ended December
31, 2009, our net sales in Belgium were approximately $16.0 million. Currently, the lawsuit is in
the pleading stage. The plaintiffs filed their initial brief on September 27, 2005 and on May 9,
2006 we filed a reply brief. On December 9, 2008 plaintiffs filed a responsive brief and on June
24, 2009 we filed a reply brief. There is no date yet for the oral hearings. An adverse judicial
determination with respect to our network marketing program, or in proceedings not involving us
directly but which challenge the legality of multi-level marketing systems, in Belgium or in any
other market in which we operate, could negatively impact our business. We believe that we have
meritorious defenses to the suit.
On April 16, 2007 Herbalife International of America, Inc. filed a Complaint in the United
States District Court for the Central District of California against certain former Herbalife
distributors who had left the Company to join a competitor. The Complaint alleged breach of
contract, misappropriation of trade secrets, intentional interference with prospective economic
advantage, intentional interference with contract, unfair competition, constructive trust and fraud
and seeks monetary damages, attorneys fees and injunctive relief. (Herbalife International of
America, Inc. v. Robert E. Ford, et al) The court entered a Preliminary Injunction against the
defendants enjoining them from further use and/or misappropriation of the Companys trade secrets
on December 11, 2007. Defendants appealed the courts entry of the Preliminary Injunction to the
U.S. Court of Appeals for the Ninth Circuit. That court affirmed, in relevant part, the Preliminary
Injunction. On December 3, 2007 the defendants filed a counterclaim alleging that the Company had
engaged in unfair and deceptive business practices, intentional and negligent interference with
prospective economic advantage, false advertising and that the Company was an endless chain scheme
in violation of California law and seeking restitution, contract rescission and an injunction. Both
sides engaged in discovery and filed cross motions for Summary Judgment. On August 25, 2009 the
court granted partial summary judgment for Herbalife on all of defendants claims except the claim
that the Company is an endless chain scheme which under applicable law is a question of fact that
can only be determined at trial. The court denied defendants motion for Summary Judgment on
Herbalifes claims for misappropriation of trade secrets and breach of contract. On March 9, 2010
the Court heard oral argument by the parties on Herbalifes motion for summary judgment to dismiss
the defendants sole remaining counterclaim, and a decision is pending. No date has been set for
trial. The Company believes that there is merit to its remaining claims for relief and that it has
meritorious defenses to the remaining counterclaim if the counterclaim is not dismissed by summary
judgment.
A substantial portion of our business is conducted in foreign markets, exposing us to the risks of
trade or foreign exchange restrictions, increased tariffs, foreign currency fluctuations and
similar risks associated with foreign operations.
Approximately 80% of our net sales for the year ended December 31, 2009, were generated
outside the United States, exposing our business to risks associated with foreign operations. For
example, a foreign government may impose trade or foreign exchange restrictions or increased
tariffs, which could negatively impact our operations. We are also exposed to risks associated with
foreign currency fluctuations. For instance, purchases from suppliers are generally made in U.S.
dollars while sales to distributors are generally made in local currencies. Accordingly,
strengthening of the U.S. dollar versus a foreign currency could have a negative impact on us.
Although we engage in transactions to protect against risks associated with foreign currency
fluctuations, we cannot be certain any hedging activity will effectively reduce our exchange rate
exposure. Our operations in some markets also may be adversely affected by political, economic and
social instability in foreign countries. As we continue to focus on expanding our existing
international operations, these and other risks associated with international operations may
increase, which could harm our financial condition and operating results.
Currency restrictions enacted by the Venezuelan government in 2003 have become more
restrictive and have impacted the ability of our subsidiary in Venezuela, or Herbalife Venezuela,
to obtain U.S. dollars at the official foreign exchange rate. The application and approval
processes have been intermittently delayed in recent periods and the timing and ability to obtain
U.S. dollars at the official exchange rate remains uncertain. In certain instances, we have made
appropriate applications through the Venezuelan government and its Foreign Exchange Commission,
CADIVI, for approval to obtain U.S. dollars to pay for imported products and an annual dividend at
the official exchange rate. In other instances, in order to timely provide products to our
distributors, we did not register certain shipments with CADIVI and instead used a legal parallel
market mechanism for payment. Unless our ability to obtain U.S. dollars at the official foreign
exchange rate is made more readily available, the results of Herbalife Venezuelas operations will
be negatively impacted as it may need to obtain more U.S. dollars from alternative sources where
the exchange rate is weaker than the official rate. Additionally, if we are unable to import
products at the official foreign exchange rate in Venezuela, we may implement price increases and
surcharges to the selling price of our products to compensate for the incremental cost of
importation. This could adversely affect sales volume in Venezuela.
Venezuelas inflation rate as measured using the blended National Consumer Price Index and
Consumer Price Index rate exceeded the three-year cumulative inflation rate of 100% as of December
31, 2009. Accordingly, effective January 1, 2010, Venezuela is considered a highly inflationary
economy, which requires Herbalife Venezuela to use the U.S. dollar as their functional currency
with foreign currency gains and losses recorded to the consolidated statement of income. In early
January 2010, Venezuela announced an
official rate devaluation of the Venezuelan Bolivar Fuerte, or Bolivar, to an official rate of
4.30 Bolivars per U.S. dollar for non-essential items and 2.60 Bolivars per U.S. dollar for
essential items. These events will have a negative impact to our earnings as further discussed in
Part I, Item 2 Managements Discussion and Analysis of Financial Condition and Results of
Operations.
42
Our expansion in China is subject to general, as well as industry-specific, economic, political and
legal developments and risks in China and requires that we utilize a different business model from
that which we use elsewhere in the world.
Our expansion of operations into China is subject to risks and uncertainties related to
general economic, political and legal developments in China, among other things. The Chinese
government exercises significant control over the Chinese economy, including but not limited to
controlling capital investments, allocating resources, setting monetary policy, controlling foreign
exchange and monitoring foreign exchange rates, implementing and overseeing tax regulations,
providing preferential treatment to certain industry segments or companies and issuing necessary
licenses to conduct business. Accordingly, any adverse change in the Chinese economy, the Chinese
legal system or Chinese governmental, economic or other policies could have a material adverse
effect on our business in China and our prospects generally.
In August 2005, China published regulations governing direct selling (effective December 1,
2005) and prohibiting pyramid promotional schemes (effective November 1, 2005), and a number of
administrative methods and proclamations were issued in September 2005 and in September 2006. These
regulations require us to use a business model different from that which we offer in other markets.
To allow us to operate under these regulations, we have created and introduced a model specifically
for China. In China, we have Company-operated retail stores that sell through employed sales
personnel to customers and preferred customers. We provide training and certification procedures
for sales personnel in China. We have non-employee sales representatives who sell through our
retail stores. Our sales representatives are also permitted by the terms of our direct selling
licenses to sell away from fixed retail locations in the provinces of Jiangsu, Guangdong, Shandong,
Zhejiang (excluding Ningbo), Guizhou, Beijing, Fuijan, Sichuan, Hubei, Shanxi, and Shanghai. Our
direct selling license for Shanghai will permit us to sell away from fixed retail locations once
our Shanghai outlet is inspected and confirmed by the relevant authority. We have also engaged
independent service providers that meet both the requirements to operate their own business under
Chinese law as well as the conditions set forth by Herbalife to sell products and provide services
to Herbalife customers. These features are not common to the business model we employ elsewhere in
the world, and based on the direct selling licenses we have received and the terms of those which
we hope to receive in the future to conduct a direct selling enterprise in China, our business
model in China will continue in some part to incorporate such features. The direct selling
regulations require us to apply for various approvals to conduct a direct selling enterprise in
China. The process for obtaining the necessary licenses to conduct a direct selling business is
protracted and cumbersome and involves multiple layers of Chinese governmental authorities and
numerous governmental employees at each layer. While direct selling licenses are centrally issued,
such licenses are generally valid only in the jurisdictions within which related approvals have
been obtained. Such approvals are generally awarded on local and provincial bases, and the approval
process requires involvement with multiple ministries at each level. Our participation and conduct
during the approval process is guided not only by distinct Chinese practices and customs, but is
also subject to applicable laws of China and the other jurisdictions in which we operate our
business, including the U.S., and our internal code of ethics. There is always a risk that in
attempting to comply with local customs and practices in China during the application process or
otherwise, we will fail to comply with requirements applicable to us in China itself or in other
jurisdictions, and any such failure to comply with applicable requirements could prevent us from
obtaining the direct selling licenses or related local or provincial approvals. Furthermore, we
rely on certain key personnel in China to assist us during the approval process, and the loss of
any such key personnel could delay or hinder our ability to obtain licenses or related approvals.
For all of the above reasons, there can be no assurance that we will obtain additional
direct-selling licenses, or obtain related approvals to expand into any or all of the localities or
provinces in China that are important to our business. Our inability to obtain, retain, or renew
any or all of the licenses or related approvals that are required for us to operate in China would
negatively impact our business.
Additionally, although certain regulations have been published with respect to obtaining such
approvals, operating under such approvals and otherwise conducting business in China, other
regulations are pending, and there is uncertainty regarding the interpretation and enforcement of
Chinese regulations. The regulatory environment in China is evolving, and officials in the Chinese
government exercise broad discretion in deciding how to interpret and apply regulations. We cannot
be certain that our business model will continue to be deemed by national or local Chinese
regulatory authorities to be compliant with any such regulations. In the past, the Chinese
government has rigorously monitored the direct selling market in China, and has taken serious
action against companies that the government believed were engaging in activities they regarded to
be in violation of applicable law, including shutting down their businesses and imposing
substantial fines. As a result, there can be no guarantee that the Chinese governments current or
future interpretation and application of the existing and new regulations will not negatively
impact our business in China, result in regulatory investigations or lead to fines or penalties
against us or our Chinese distributors.
43
Chinese regulations prevent persons who are not Chinese nationals from engaging in direct
selling in China. We cannot guarantee that any of our distributors living outside of China or any
of our independent sales representatives or employed sales management personnel in China have not
engaged or will not engage in activities that violate our policies in this market, or that violate
Chinese law or other applicable law, and therefore result in regulatory action and adverse
publicity.
China enacted a labor contract law which took effect January 1, 2008 and on September 18, 2008
an implementing regulation took effect. We have reviewed our employment contracts and contractual
relations with employees in China, which include certain of our sales persons, and have made such
changes as we believed to be necessary or appropriate to bring these contracts and contractual
relations into compliance with this new law and its implementing regulation. In addition, we
continue to monitor the situation to determine how this new law and regulation will be implemented
in practice. There is no guarantee that the new law will not adversely impact us, force us to
change our treatment of our distributor employees, or cause us to change our operating plan for
China.
If our operations in China are successful, we may experience rapid growth in China, and there
can be no assurances that we will be able to successfully manage rapid expansion of manufacturing
operations and a rapidly growing and dynamic sales force. There also can be no assurances that we
will not experience difficulties in dealing with or taking employment related actions (such as
hiring, terminations and salary administration, including social benefit payments) with respect to
our employed sales representatives, particularly given the highly regulated nature of the
employment relationship in China. If we are unable to effectively manage such growth and expansion
of our retail stores, manufacturing operations or our employees, our government relations may be
compromised and our operations in China may be harmed.
Our China business model, particularly with regard to sales management responsibilities and
remuneration, differs from our traditional business model. There is a risk that such changes and
transitions may not be understood by our distributors or employees, may be viewed negatively by our
distributors or employees, or may not be correctly utilized by our distributors or employees. If
that is the case, our business could be negatively impacted.
If we fail to further penetrate existing markets or successfully expand our business into new
markets, then the growth in sales of our products, along with our operating results, could be
negatively impacted.
The success of our business is to a large extent contingent on our ability to continue to grow
by entering new markets and further penetrating existing markets. Our ability to further penetrate
existing markets or to successfully expand our business into additional countries in Eastern
Europe, Southeast Asia, South America or elsewhere, to the extent we believe that we have
identified attractive geographic expansion opportunities in the future, is subject to numerous
factors, many of which are out of our control.
In addition, government regulations in both our domestic and international markets can delay
or prevent the introduction, or require the reformulation or withdrawal, of some of our products,
which could negatively impact our business, financial condition and results of operations. Also,
our ability to increase market penetration in certain countries may be limited by the finite number
of persons in a given country inclined to pursue a direct selling business opportunity or consumers
willing to purchase Herbalife products. Moreover, our growth will depend upon improved training and
other activities that enhance distributor retention in our markets. While we have recently
experienced significant growth in certain of our markets, we cannot assure you that such growth
levels will continue in the immediate or long term future. Furthermore, our efforts to support
growth in such international markets could be hampered to the extent that our infrastructure in
such markets is deficient when compared to our more developed markets, such as the U.S. Therefore,
we cannot assure you that our general efforts to increase our market penetration and distributor
retention in existing markets will be successful. If we are unable to continue to expand into new
markets or further penetrate existing markets, our operating results could suffer.
Our contractual obligation to sell our products only through our Herbalife distributor network and
to refrain from changing certain aspects of our marketing plan may limit our growth.
We are a party to an agreement with our distributors that provides assurances that a change in
ownership will not negatively affect certain aspects of their business. Through this agreement, we
committed to our distributors that we will not sell Herbalife products through any distribution
channel other than our network of independent Herbalife distributors. Thus, we are contractually
prohibited from expanding our business by selling Herbalife products through other distribution
channels that may be available to our competitors, such as over the internet, through wholesale
sales, by establishing retail stores or through mail order systems. Since this is an open-ended
commitment, there can be no assurance that we will be able to take advantage of innovative new
distribution channels that are developed in the future.
44
In addition, our agreement with our distributors provides that we will not change certain
aspects of our marketing plan without the consent of a specified percentage of our distributors.
For example, our agreement with our distributors provides that we may increase, but not decrease,
the discount percentages available to our distributors for the purchase of products or the
applicable royalty override percentages, including roll-ups, and production and other bonus
percentages available to our distributors at various qualification levels within our distributor
hierarchy. We may not modify the eligibility or qualification criteria for these discounts, royalty
overrides and production and other bonuses unless we do so in a manner to make eligibility and/or
qualification easier than under the applicable criteria in effect as of the date of the agreement.
Our agreement with our distributors further provides that we may not vary the criteria for
qualification for each distributor tier within our distributor hierarchy, unless we do so in such a
way so as to make qualification easier.
Although we reserved the right to make these changes to our marketing plan without the consent
of our distributors in the event that changes are required by applicable law or are necessary in
our reasonable business judgment to account for specific local market or currency conditions to
achieve a reasonable profit on operations, there can be no assurance that our agreement with our
distributors will not restrict our ability to adapt our marketing plan to the evolving requirements
of the markets in which we operate. As a result, our growth may be limited.
We depend on the integrity and reliability of our information technology infrastructure, and any
related inadequacies may result in substantial interruptions to our business.
Our ability to provide products and services to our distributors depends on the performance
and availability of our core transactional systems. We upgraded our back office systems globally to
the Oracle Enterprise Suite which is supported by a robust hardware and network infrastructure. The
Oracle Enterprise Suite is a scalable and stable solution that provides a solid foundation upon
which we are building our next generation Distributor facing Internet toolset. While we continue to
invest in our information technology infrastructure, there can be no assurance that there will not
be any significant interruptions to such systems or that the systems will be adequate to meet all
of our future business needs.
The most important aspect of our information technology infrastructure is the system through
which we record and track distributor sales, volume points, royalty overrides, bonuses and other
incentives. We have encountered, and may encounter in the future, errors in our software or our
enterprise network, or inadequacies in the software and services supplied by our vendors, although
to date none of these errors or inadequacies has had a meaningful adverse impact on our business.
Any such errors or inadequacies that we may encounter in the future may result in substantial
interruptions to our services and may damage our relationships with, or cause us to lose, our
distributors if the errors or inadequacies impair our ability to track sales and pay royalty
overrides, bonuses and other incentives, which would harm our financial condition and operating
results. Such errors may be expensive or difficult to correct in a timely manner, and we may have
little or no control over whether any inadequacies in software or services supplied to us by third
parties are corrected, if at all.
Since we rely on independent third parties for the manufacture and supply of certain of our
products, if these third parties fail to reliably supply products to us at required levels of
quality, then our financial condition and operating results would be harmed.
The majority of our products are manufactured at third party contract manufacturers, with the
exception of our products sold in China, which are manufactured in our Suzhou China facility, and a
small portion of our top selling products which are manufactured in a recently acquired
manufacturing facility located in Lake Forest, California. It is the Companys intention to expand
the capacity of this recently acquired manufacturing facility to produce additional products for
our North America and international markets. We cannot assure you that our outside manufacturers
will continue to reliably supply products to us at the levels of quality, or the quantities, we
require, especially under the FDAs recently adopted cGMP regulations. While we are not presently
aware of any current liquidity issues with our suppliers, we cannot assure you that they will not
experience financial hardship as a result of the current global financial crisis.
Our supply contracts generally have a two-year term. Except for force majeure events such as
natural disasters and other acts of God, and non-performance by Herbalife, our manufacturers
generally cannot unilaterally terminate these contracts. These contracts can generally be extended
by us at the end of the relevant time period and we have exercised this right in the past. Globally
we have over 40 suppliers of our products. For our major products, we have both primary and
secondary suppliers. Our major suppliers include Natures Bounty for protein powders, Fine Foods
(Italy) for protein powders and nutritional supplements, Valentine Enterprises for protein powders
and PharmaChem Labs for teas and Niteworks®. In the event any of our third-party
manufacturers were to become unable or unwilling to continue to provide us with products in
required volumes and at suitable quality levels, we would be required to identify and obtain
acceptable replacement manufacturing sources. There is no assurance that we would be able to obtain
alternative
manufacturing sources on a timely basis. An extended interruption in the supply of products
would result in the loss of sales. In addition, any actual or perceived degradation of product
quality as a result of reliance on third party manufacturers may have an adverse effect on sales or
result in increased product returns and buybacks. Also, as we experience ingredient and product
price pressure in the areas of soy, dairy products, plastics, and transportation reflecting global
economic trends, we believe that we have the ability to mitigate some of these cost increases
through improved optimization of our supply chain coupled with select increases in the retail
prices of our products.
45
If we fail to protect our trademarks and tradenames, then our ability to compete could be
negatively affected, which would harm our financial condition and operating results.
The market for our products depends to a significant extent upon the goodwill associated with
our trademark and tradenames. We own, or have licenses to use, the material trademark and trade
name rights used in connection with the packaging, marketing and distribution of our products in
the markets where those products are sold. Therefore, trademark and trade name protection is
important to our business. Although most of our trademarks are registered in the United States and
in certain foreign countries in which we operate, we may not be successful in asserting trademark
or trade name protection. In addition, the laws of certain foreign countries may not protect our
intellectual property rights to the same extent as the laws of the United States. The loss or
infringement of our trademarks or tradenames could impair the goodwill associated with our brands
and harm our reputation, which would harm our financial condition and operating results.
Unlike in most of the other markets in which we operate, limited protection of intellectual
property is available under Chinese law. Accordingly, we face an increased risk in China that
unauthorized parties may attempt to copy or otherwise obtain or use our trademarks, copyrights,
product formulations or other intellectual property. Further, since Chinese commercial law is
relatively undeveloped, we may have limited legal recourse in the event we encounter significant
difficulties with intellectual property theft or infringement. As a result, we cannot assure you
that we will be able to adequately protect our product formulations or other intellectual property.
We permit the limited use of our trademarks by our independent distributors to assist them in
the marketing of our products. It is possible that doing so may increase the risk of unauthorized
use or misuse of our trademarks in markets where their registration status differs from that
asserted by our independent distributors, or they may be used in association with claims or
products in a manner not permitted under applicable laws and regulations. Were this to occur it is
possible that this could diminish the value of these marks or otherwise impair our further use of
these marks.
If our distributors fail to comply with labeling laws, then our financial condition and operating
results would be harmed.
Although the physical labeling of our products is not within the control of our independent
distributors, our distributors must nevertheless advertise our products in compliance with the
extensive regulations that exist in certain jurisdictions, such as the United States, which
considers product advertising to be labeling for regulatory purposes.
Our products are sold principally as foods, dietary supplements and cosmetics and are subject
to rigorous FDA and related legal regimens limiting the types of therapeutic claims that can be
made for our products. The treatment or cure of disease, for example, is not a permitted claim for
these products. While we train our distributors and attempt to monitor our distributors marketing
materials, we cannot ensure that all such materials comply with applicable regulations, including
bans on therapeutic claims. If our distributors fail to comply with these restrictions, then we and
our distributors could be subjected to claims, financial penalties, mandatory product recalls or
relabeling requirements, which could harm our financial condition and operating results. Although
we expect that our responsibility for the actions of our independent distributors in such an
instance would be dependent on a determination that we either controlled or condoned a noncompliant
advertising practice, there can be no assurance that we could not be held vicariously liable for
the actions of our independent distributors.
If our intellectual property is not adequate to provide us with a competitive advantage or to
prevent competitors from replicating our products, or if we infringe the intellectual property
rights of others, then our financial condition and operating results would be harmed.
Our future success and ability to compete depend upon our ability to timely produce innovative
products and product enhancements that motivate our distributors and customers, which we attempt to
protect under a combination of copyright, trademark and trade secret laws, confidentiality
procedures and contractual provisions. However, our products are generally not patented
domestically or abroad, and the legal protections afforded by common law and contractual
proprietary rights in our products provide only limited protection and may be time-consuming and
expensive to enforce and/or maintain. Further, despite our efforts,
we may be unable to prevent third parties from infringing upon or misappropriating our proprietary rights or from
independently developing non-infringing products that are competitive with, equivalent to and/or
superior to our products.
46
Monitoring infringement and/or misappropriation of intellectual property can be difficult and
expensive, and we may not be able to detect any infringement or misappropriation of our proprietary
rights. Even if we do detect infringement or misappropriation of our proprietary rights, litigation
to enforce these rights could cause us to divert financial and other resources away from our
business operations. Further, the laws of some foreign countries do not protect our proprietary
rights to the same extent as do the laws of the United States.
Additionally, third parties may claim that products we have independently developed infringe
upon their intellectual property rights. For example, in a pending action in the U.S. federal
courts, the Adidas companies have alleged that certain uses of Herbalifes Tri-Leaf device mark
upon sports apparel items infringe upon their own leaf mark associated with such goods. We are
contesting these claims and do not believe that we are infringing on any third party intellectual
property rights. However, there can be no assurance that one or more of our products will not be
found to infringe upon other third party intellectual property rights in the future.
Since one of our products constitutes a significant portion of our retail sales, significant
decreases in consumer demand for this product or our failure to produce a suitable replacement
should we cease offering it would harm our financial condition and operating results.
Our Formula 1 meal replacement product constitutes a significant portion of our sales,
accounting for approximately 32% of retail sales for the fiscal years ended December 31, 2009 and
2008, and approximately 30% for fiscal year ended December 31, 2007. If consumer demand for this
product decreases significantly or we cease offering this product without a suitable replacement,
then our financial condition and operating results would be harmed.
If we lose the services of members of our senior management team, then our financial condition and
operating results could be harmed.
We depend on the continued services of our Chairman and Chief Executive Officer, Michael O.
Johnson, and our current senior management team as they work closely with the senior distributor
leadership to create an environment of inspiration, motivation and entrepreneurial business
success. Although we have entered into employment agreements with certain members of our senior
management team, and do not believe that any of them are planning to leave or retire in the near
term, we cannot assure you that our senior managers will remain with us. The loss or departure of
any member of our senior management team could adversely impact our distributor relations and
operating results. If any of these executives do not remain with us, our business could suffer.
Also, the loss of key personnel, including our regional and country managers, could negatively
impact our ability to implement our business strategy, and our continued success will also be
dependent on our ability to retain existing, and attract additional, qualified personnel to meet
our needs. We currently do not maintain key person life insurance with respect to our senior
management team.
The covenants in our existing indebtedness limit our discretion with respect to certain business
matters, which could limit our ability to pursue certain strategic objectives and in turn harm our
financial condition and operating results.
Our credit facility contains numerous financial and operating covenants that restrict our and
our subsidiaries ability to, among other things:
|
|
|
pay dividends, redeem share capital or capital stock and make other restricted payments
and investments; |
|
|
|
|
incur additional debt or issue preferred shares; |
|
|
|
|
impose dividend or other distribution restrictions on our subsidiaries; |
|
|
|
|
create liens on our and our subsidiaries assets; |
|
|
|
|
engage in transactions with affiliates; |
|
|
|
|
guarantee other indebtedness; and |
|
|
|
|
merge, consolidate or sell all or substantially all of our assets and the assets of our
subsidiaries. |
47
In addition, our credit facility requires us to meet certain financial ratios and financial
conditions. Our ability to comply with these covenants may be affected by events beyond our
control, including prevailing economic, financial and industry conditions. Failure to comply with
these covenants could result in a default causing all amounts to become due and payable under our
credit facility, which is secured by substantially all of our assets, against which the lenders
thereunder could proceed to foreclose.
If we do not comply with transfer pricing, customs duties, and similar regulations, then we may be
subjected to additional taxes, duties, interest and penalties in material amounts, which could harm
our financial condition and operating results.
As a multinational corporation, in many countries including the United States we are subject
to transfer pricing and other tax regulations designed to ensure that our intercompany transactions
are consummated at prices that have not been manipulated to produce a desired tax result, that
appropriate levels of income are reported as earned by our United States or local entities, and
that we are taxed appropriately on such transactions. In addition, our operations are subject to
regulations designed to ensure that appropriate levels of customs duties are assessed on the
importation of our products. We are currently subject to pending or proposed audits that are at
various levels of review, assessment or appeal in a number of jurisdictions involving transfer
pricing issues, income taxes, customs duties, value added taxes, withholding taxes, sales and use
and other taxes and related interest and penalties in material amounts. For example, we are
currently appealing tax assessments in Spain and Brazil. In another matter, in Mexico, we are
awaiting a formal administrative assessment to start the judicial appeals process. The likelihood
and timing of any such potential assessment is unknown as of the date hereof. The Company believes
that it has meritorious defenses. In some circumstances, additional taxes, interest and penalties
have been assessed and we will be required to pay the assessments or post surety, in order to
challenge the assessments. The imposition of new taxes, even pass-through taxes such as VAT, could
have an impact on our perceived product pricing and therefore a potential negative impact on our
business. We have reserved in the consolidated financial statements an amount that we believe
represents the most likely outcome of the resolution of these disputes, but if we are incorrect in
our assessment we may have to pay the full amount asserted which could potentially be material.
Ultimate resolution of these matters may take several years, and the outcome is uncertain. If the
United States Internal Revenue Service or the taxing authorities of any other jurisdiction were to
successfully challenge our transfer pricing practices or our positions regarding the payment of
income taxes, customs duties, value added taxes, withholding taxes, sales and use, and other taxes,
we could become subject to higher taxes and our earnings would be adversely affected.
Changes in tax laws, treaties or regulations, or their interpretation could adversely affect us.
A change in applicable tax laws, treaties or regulations or their interpretation could result
in a higher effective tax rate on our worldwide earnings and such change could be significant to
our financial results. Tax legislative proposals intending to eliminate some perceived tax
advantages of companies that have legal domiciles outside the U.S. but have certain U.S.
connections have repeatedly been introduced in the U.S. Congress. If these proposals are enacted,
the result would increase our effective tax rate and could have a material adverse effect on the
Companys financial condition and results of operations.
We may be held responsible for certain taxes or assessments relating to the activities of our
distributors, which could harm our financial condition and operating results.
Our distributors are subject to taxation, and in some instances, legislation or governmental
agencies impose an obligation on us to collect taxes, such as value added taxes, and to maintain
appropriate records. In addition, we are subject to the risk in some jurisdictions of being
responsible for social security and similar taxes with respect to our distributors. In the event
that local laws and regulations or the interpretation of local laws and regulations change to
require us to treat our independent distributors as employees, or that our distributors are deemed
by local regulatory authorities in one or more of the jurisdictions in which we operate to be our
employees rather than independent contractors under existing laws and interpretations, we may be
held responsible for social security and related taxes in those jurisdictions, plus any related
assessments and penalties, which could harm our financial condition and operating results.
48
We may incur material product liability claims, which could increase our costs and harm our
financial condition and operating results.
Our products consist of vitamins, minerals and herbs and other ingredients that are classified
as foods or dietary supplements and are not subject to pre-market regulatory approval in the United
States. Our products could contain contaminated substances, and some of our products contain some
ingredients that do not have long histories of human consumption. We conduct limited clinical
studies on some key products but not all products. Previously unknown adverse reactions resulting
from human consumption of these ingredients could occur. As a marketer of dietary and nutritional
supplements and other products that are ingested by consumers or
applied to their bodies, we have been, and may again be, subjected to various product
liability claims, including that the products contain contaminants, the products include inadequate
instructions as to their uses, or the products include inadequate warnings concerning side effects
and interactions with other substances. It is possible that widespread product liability claims
could increase our costs, and adversely affect our revenues and operating income. Moreover,
liability claims arising from a serious adverse event may increase our costs through higher
insurance premiums and deductibles, and may make it more difficult to secure adequate insurance
coverage in the future. In addition, our product liability insurance may fail to cover future
product liability claims, thereby requiring us to pay substantial monetary damages and adversely
affecting our business. Finally, given the higher level of self-insured retentions that we have
accepted under our current product liability insurance policies, which are as high as approximately
$10 million, in certain cases we may be subject to the full amount of liability associated with any
injuries, which could be substantial.
Several years ago, a number of states restricted the sale of dietary supplements containing
botanical sources of ephedrine alkaloids and on February 6, 2004, the FDA banned the use of such
ephedrine alkaloids. Until late 2002, we had sold Thermojetics® original green herbal
tablets, Thermojetics® green herbal tablets and Thermojetics® gold herbal
tablets, all of which contained ephedrine alkaloids. Accordingly, we run the risk of product
liability claims related to the ingestion of ephedrine alkaloids contained in those products.
Currently, we have been named as a defendant in product liability lawsuits seeking to link the
ingestion of certain of the aforementioned products to subsequent alleged medical problems suffered
by plaintiffs. Although we believe that we have meritorious defenses to the allegations contained
in these lawsuits, and are vigorously defending these claims, there can be no assurance that we
will prevail in our defense of any or all of these matters.
We are subject to, among other things, requirements regarding the effectiveness of internal
controls over financial reporting. In connection with these requirements, we conduct regular audits
of our business and operations. Our failure to identify or correct deficiencies and areas of
weakness in the course of these audits could adversely affect our financial condition and operating
results.
We are required to comply with various corporate governance and financial reporting
requirements under the Sarbanes-Oxley Act of 2002, as well as new rules and regulations adopted by
the SEC, the Public Company Accounting Oversight Board and the New York Stock Exchange. In
particular, we are required to include management and auditor reports on the effectiveness of
internal controls over financial reporting as part of our annual reports on Form 10-K, pursuant to
Section 404 of the Sarbanes-Oxley Act. We expect to continue to spend significant amounts of time
and money on compliance with these rules. Our failure to correct any noted weaknesses in internal
controls over financial reporting could result in the disclosure of material weaknesses which could
have a material adverse effect upon the market value of our stock.
On a regular and on-going basis, we conduct audits through our internal audit department of
various aspects of our business and operations. These internal audits are conducted to insure
compliance with our policies and to strengthen our operations and related internal controls. The
Audit Committee of our Board of Directors regularly reviews the results of these internal audits
and, when appropriate, suggests remedial measures and actions to correct noted deficiencies or
strengthen areas of weakness. There can be no assurance that these internal audits will uncover all
material deficiencies or areas of weakness in our operations or internal controls. If left
undetected and uncorrected, such deficiencies and weaknesses could have a material adverse effect
on our financial condition and results of operations.
From time to time, the results of these internal audits may necessitate that we conduct
further investigations into aspects of our business or operations. In addition, our business
practices and operations may periodically be investigated by one or more of the many governmental
authorities with jurisdiction over our worldwide operations. In the event that these investigations
produce unfavorable results, we may be subjected to fines, penalties or loss of licenses or permits
needed to operate in certain jurisdictions, any one of which could have a material adverse effect
on our financial condition or operating results.
Holders of our common shares may face difficulties in protecting their interests because we are
incorporated under Cayman Islands law.
Our corporate affairs are governed by our amended and restated memorandum and articles of
association, by the Companies Law (2009 Revision, as amended), or the Companies Law, and the common
law of the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our
directors under Cayman Islands law are not as clearly established as under statutes or judicial
precedent in existence in jurisdictions in the United States. Therefore, shareholders may have more
difficulty in protecting their interests in the face of actions by our management or board of
directors than would shareholders of a corporation incorporated in a jurisdiction in the United
States, due to the comparatively less developed nature of Cayman Islands law in this area.
49
Shareholders of Cayman Islands exempted companies such as Herbalife have no general rights
under Cayman Islands law to inspect corporate records and accounts or to obtain copies of lists of
our shareholders. Our directors have discretion under our articles
of association to determine whether or not, and under what conditions, our corporate records
may be inspected by our shareholders, but are not obliged to make them available to our
shareholders. This may make it more difficult for you to obtain the information needed to establish
any facts necessary for a shareholder motion or to solicit proxies from other shareholders in
connection with a proxy contest.
A shareholder can bring a suit personally where its individual rights have been, or are about
to be, infringed. Where an action is brought to redress any loss or damage suffered by us, we would
be the proper plaintiff, and a shareholder could not ordinarily maintain an action on our behalf,
except where it was permitted by the courts of the Cayman Islands to proceed with a derivative
action. Our Cayman Islands counsel, Maples and Calder, is not aware of any reported decisions in
relation to a derivative action brought in a Cayman Islands court. However, based on English
authorities, which would in all likelihood be of persuasive authority in the Cayman Islands, a
shareholder may be permitted to bring a claim derivatively on the Companys behalf, where:
|
|
|
a company is acting or proposing to act illegally or outside the scope of its corporate
authority; |
|
|
|
|
the act complained of, although not acting outside the scope of its corporate authority,
could be effected only if authorized by more than a simple majority vote; or |
|
|
|
|
those who control the company are perpetrating a fraud on the minority. |
Provisions of our articles of association and Cayman Islands corporate law may impede a takeover or
make it more difficult for shareholders to change the direction or management of the Company, which
could reduce shareholders opportunity to influence management of the Company.
Our articles of association permit our board of directors to issue preference shares from time
to time, with such rights and preferences as they consider appropriate. Our board of directors
could authorize the issuance of preference shares with terms and conditions and under circumstances
that could have an effect of discouraging a takeover or other transaction.
In addition, our articles of association contain certain other provisions which could have an
effect of discouraging a takeover or other transaction or preventing or making it more difficult
for shareholders to change the direction or management of our Company, including a classified
board, the inability of shareholders to act by written consent, a limitation on the ability of
shareholders to call special meetings of shareholders and advance notice provisions. As a result,
our shareholders may have less input into the management of our Company than they might otherwise
have if these provisions were not included in our articles of association.
The Cayman Islands have recently introduced provisions to the Companies Law to facilitate
mergers and consolidations between Cayman Islands companies and non-Cayman Islands companies. These
provisions, contained within Part XVA of the Companies Law, are broadly similar to the merger
provisions as provided for under Delaware Law.
There are however a number of important differences that could impede a takeover. First, the
thresholds for approval of the merger plan by shareholders are higher. The thresholds are (a) a
shareholder resolution by majority in number representing 75% in value of the shareholders voting
together as one class or (b) if the shares to be issued to each shareholder in the consolidated or
surviving company are to have the same rights and economic value as the shares held in the
constituent company, a special resolution of the shareholders (being 66 2/3% of those present in
person or by proxy and voting) voting together as one class.
As it is not expected that the shares would have the same rights and economic value following
a takeover by way of merger, it is expected that the first test is the one which would commonly
apply. This threshold essentially has three requirements: a majority in number of the
shareholders of the Company must approve the transaction, such approving majority must hold at
least 75% in value of all the outstanding shares and the shareholders must vote together as one
class.
Additionally, the consent of each holder of a fixed or floating security interest (in essence
a documented security interest as opposed to one arising by operation of law) is required to be
obtained unless the Grand Court of the Cayman Islands waives such requirement.
The merger provisions contained within Part XVA of the Companies Law do contain shareholder
appraisal rights similar to those provided for under Delaware law. Such rights are limited to a
merger under Part XVA and do apply to schemes of arrangement as discussed below.
50
The Companies Law also contains separate statutory provisions that provide for the merger,
reconstruction and amalgamation of companies. Those are commonly referred to in the Cayman Islands
as schemes of arrangement.
The procedural and legal requirements necessary to consummate these transactions are more
rigorous and take longer to complete than the procedures typically required to consummate a merger
in the United States. Under Cayman Islands law and practice, a scheme of arrangement in relation to
a solvent Cayman Islands company must be approved at a shareholders meeting by a majority of each
class of the companys shareholders who are present and voting (either in person or by proxy) at
such meeting. The shares voted in favor of the scheme of arrangement must also represent at least
75% of the value of each relevant class of the companys shareholders present and voting at the
meeting. The convening of these meetings and the terms of the amalgamation must also be sanctioned
by the Grand Court of the Cayman Islands. Although there is no requirement to seek the consent of
the creditors of the parties involved in the scheme of arrangement, the Grand Court typically seeks
to ensure that the creditors have consented to the transfer of their liabilities to the surviving
entity or that the scheme of arrangement does not otherwise materially adversely affect creditors
interests. Furthermore, the court will only approve a scheme of arrangement if it is satisfied
that:
|
|
|
the statutory provisions as to majority vote have been complied with; |
|
|
|
|
the shareholders who voted at the meeting in question fairly represent the relevant class
of shareholders to which they belong. |
|
|
|
|
the scheme of arrangement is such as a businessman would reasonably approve; and |
|
|
|
|
the scheme of arrangement is not one that would more properly be sanctioned under some
other provision of the Companies Law. |
If the scheme of arrangement is approved, the dissenting shareholder would have no rights
comparable to appraisal rights, which would otherwise ordinarily be available to dissenting
shareholders of U.S. corporations, providing rights to receive payment in cash for the judicially
determined value of the shares.
In addition, if an offer by a third party to purchase shares in us has been approved by the
holders of at least 90% of our outstanding shares (not including such a third party) pursuant to an
offer within a four-month period of making such an offer, the purchaser may, during the two months
following expiration of the four-month period, require the holders of the remaining shares to
transfer their shares on the same terms on which the purchaser acquired the first 90% of our
outstanding shares. An objection can be made to the Grand Court of the Cayman Islands, but this is
unlikely to succeed unless there is evidence of fraud, bad faith, collusion or inequitable
treatment of the shareholders.
There is uncertainty as to shareholders ability to enforce certain foreign civil liabilities in
the Cayman Islands.
We are incorporated as an exempted company with limited liability under the laws of the Cayman
Islands. A material portion of our assets are located outside of the United States. As a result, it
may be difficult for our shareholders to enforce judgments against us or judgments obtained in U.S.
courts predicated upon the civil liability provisions of the federal securities laws of the United
States or any state of the United States.
We have been advised by our Cayman Islands counsel, Maples and Calder, that although there is
no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the
courts of the Cayman Islands will based on the principle that a judgment by a competent foreign
court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been
given recognize and enforce a foreign judgment of a court of competent jurisdiction if such
judgment is final, for a liquidated sum, not in respect of taxes or a fine or penalty, is not
inconsistent with a Cayman Islands judgment in respect of the same matters, and was not obtained in
a manner, and is not of a kind, the enforcement of which is contrary to the public policy of the
Cayman Islands. There is doubt, however, as to whether the Grand Court of the Cayman Islands will
(1) recognize or enforce judgments of U.S. courts predicated upon the civil liability provisions of
the federal securities laws of the United States or any state of the United States, or (2) in
original actions brought in the Cayman Islands, impose liabilities predicated upon the civil
liability provisions of the federal securities laws of the United States or any state of the United
States, on the grounds that such provisions are penal in nature.
The Grand Court of the Cayman Islands may stay proceedings if concurrent proceedings are being
brought elsewhere.
51
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(a) None.
(b) None.
(c) Our original share repurchase program announced on April 18, 2007, expired on April 17,
2009 pursuant to its terms. On April 30, 2009, our board of directors authorized a new program to
repurchase up to $300 million of our common shares during the next two years, at such times and
prices as determined by management.
The following is a summary of our repurchases of common shares during the three months ended
March 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Number |
|
|
Approximate |
|
|
|
|
|
|
|
|
|
|
|
of Shares |
|
|
Dollar |
|
|
|
|
|
|
|
|
|
|
|
Purchased as |
|
|
Value of Shares |
|
|
|
Total |
|
|
Average |
|
|
Part of Publicly |
|
|
that May Yet Be |
|
|
|
Number |
|
|
Price |
|
|
Announced |
|
|
Purchased Under |
|
|
|
of Shares |
|
|
Paid per |
|
|
Plans or |
|
|
the Plans or |
|
Period |
|
Purchased |
|
|
Share |
|
|
Programs |
|
|
Programs |
|
January 1 January 31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
226,801,761 |
|
February 1 February 28 |
|
|
114,800 |
|
|
$ |
39.52 |
|
|
|
114,800 |
|
|
$ |
222,264,670 |
|
March 1 March 31 |
|
|
489,120 |
|
|
|
41.86 |
|
|
|
489,120 |
|
|
$ |
201,789,510 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
603,920 |
|
|
$ |
41.42 |
|
|
|
603,920 |
|
|
$ |
201,789,510 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 3. Defaults Upon Senior Securities
None.
Item 4. (Removed and Reserved)
None.
Item 5. Other Information
(a) None.
(b) None.
Item 6. Exhibits
(a) Exhibit Index:
EXHIBIT INDEX
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
Description |
|
Reference |
|
|
|
|
|
3.1
|
|
Form of Amended and Restated Memorandum and Articles of Association of Herbalife Ltd.
|
|
(d) |
|
|
|
|
|
4.1
|
|
Form of Share Certificate
|
|
(d) |
|
|
|
|
|
10.1
|
|
Form of Indemnity Agreement between Herbalife International Inc. and certain officers and
directors of Herbalife International Inc.
|
|
(a) |
|
|
|
|
|
10.2#
|
|
Herbalife International of America, Inc.s Senior Executive Deferred Compensation Plan, effective
January 1, 1996, as amended
|
|
(a) |
52
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
Description |
|
Reference |
|
|
|
|
|
10.3#
|
|
Herbalife International of America, Inc.s Management Deferred Compensation Plan, effective
January 1, 1996, as amended
|
|
(a) |
|
|
|
|
|
10.4
|
|
Master Trust Agreement between Herbalife International of America, Inc. and Imperial Trust
Company, Inc., effective January 1, 1996
|
|
(a) |
|
|
|
|
|
10.5#
|
|
Herbalife International Inc. 401K Profit Sharing Plan and Trust, as amended
|
|
(a) |
|
|
|
|
|
10.6
|
|
Trust Agreement for Herbalife 2001 Executive Retention Plan, effective March 15, 2001
|
|
(a) |
|
|
|
|
|
10.7#
|
|
Herbalife 2001 Executive Retention Plan, effective March 15, 2001
|
|
(a) |
|
|
|
|
|
10.8
|
|
Notice to Distributors regarding Amendment to Agreements of Distributorship, dated as of July 18,
2002 between Herbalife International, Inc. and each Herbalife Distributor
|
|
(a) |
|
|
|
|
|
10.9
|
|
Indemnity agreement dated as of July 31, 2002, by and among WH Holdings (Cayman Islands) Ltd., WH
Acquisition Corp., Whitney & Co., LLC, Whitney V, L.P., Whitney Strategic Partners V, L.P., GGC
Administration, L.L.C., Golden Gate Private Equity, Inc., CCG Investments (BVI), L.P., CCG
Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV, LLC-Series C, CCG AV, LLC-Series C, CCG
AV, LLC-Series E, CCG Associates-QP, LLC and WH Investments Ltd.
|
|
(a) |
|
|
|
|
|
10.10#
|
|
Independent Directors Stock Option Plan of WH Holdings (Cayman Islands) Ltd.
|
|
(a) |
|
|
|
|
|
10.11#
|
|
WH Holdings (Cayman Islands) Ltd. Stock Incentive Plan, as restated, dated as of November 5, 2003
|
|
(a) |
|
|
|
|
|
10.12#
|
|
Non-Statutory Stock Option Agreement, dated as of April 3, 2003 between WH Holdings (Cayman
Islands) Ltd. and Michael O. Johnson
|
|
(a) |
|
|
|
|
|
10.13#
|
|
Side Letter Agreement dated as of April 3, 2003 by and among WH Holdings (Cayman Islands) Ltd.,
Michael O. Johnson and the Shareholders listed therein
|
|
(a) |
|
|
|
|
|
10.14#
|
|
Form of Non-Statutory Stock Option Agreement (Non-Executive Agreement)
|
|
(a) |
|
|
|
|
|
10.15#
|
|
Form of Non-Statutory Stock Option Agreement (Executive Agreement)
|
|
(a) |
|
|
|
|
|
10.16
|
|
Indemnity Agreement, dated as of February 9, 2004, among WH Capital Corporation and Gregory Probert
|
|
(a) |
|
|
|
|
|
10.17
|
|
Indemnity Agreement, dated as of February 9, 2004, among WH Capital Corporation and Brett R.
Chapman
|
|
(a) |
|
|
|
|
|
10.18
|
|
First Amendment to Amended and Restated WH Holdings (Cayman Islands) Ltd. Stock Incentive Plan,
dated November 5, 2003
|
|
(a) |
|
|
|
|
|
10.19
|
|
Registration Rights Agreement, dated as of July 31, 2002, by and among WH Holdings (Cayman
Islands) Ltd., Whitney V, L.P., Whitney Strategic Partners V, L.P., WH Investments Ltd., CCG
Investments (BVI), L.P., CCG Associates-QP, LLC, CCG Associates-AI, LLC, CCG Investment Fund-AI,
L.P., CCG AV, LLC-Series C and CCG AV, LLC-Series E.
|
|
(b) |
|
|
|
|
|
10.20
|
|
Share Purchase Agreement, dated as of July 31, 2002, by and among WH Holdings (Cayman Islands)
Ltd., Whitney Strategic Partners V, L.P., WH Investments Ltd., Whitney V, L.P., CCG Investments
(BVI), L.P., CCG Associates-QP, LLC, CCG Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV,
LLC-Series C and CCG AV, LLC-Series E.
|
|
(b) |
|
|
|
|
|
10.21
|
|
Form of Indemnification Agreement between Herbalife Ltd. and the directors and certain officers of
Herbalife Ltd.
|
|
(c) |
|
|
|
|
|
10.22#
|
|
Herbalife Ltd. 2004 Stock Incentive Plan, effective December 1, 2004
|
|
(c) |
|
|
|
|
|
10.23
|
|
Indemnification Agreement, dated as of December 13, 2004, by and among Herbalife Ltd., Herbalife
International, Inc., Whitney V, L.P., Whitney Strategic Partners V, L.P., CCG Investments (BVI),
L.P., CCG Associates-QP, LLC, CCG Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV,
LLC-Series C, CCG AV, LLC-Series E, CCG CI, LLC and GGC Administration, LLC.
|
|
(d) |
|
|
|
|
|
10.24#
|
|
Amendment No. 1 to Herbalife Ltd. 2004 Stock Incentive Plan
|
|
(e) |
|
|
|
|
|
10.25#
|
|
Form of Stock Bonus Award Agreement
|
|
(e) |
|
|
|
|
|
10.26#
|
|
Form of 2004 Herbalife Ltd. 2004 Stock Incentive Plan Stock Option Agreement
|
|
(f) |
|
|
|
|
|
10.27#
|
|
Form of 2004 Herbalife Ltd. 2004 Stock Incentive Plan Non-Employee Director Stock Option Agreement
|
|
(f) |
53
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
Description |
|
Reference |
|
|
|
|
|
10.28#
|
|
Independent Directors Deferred Compensation and Stock Unit Plan
|
|
(g) |
|
|
|
|
|
10.29#
|
|
Independent Directors Stock Unit Award Agreement
|
|
(g) |
|
|
|
|
|
10.30#
|
|
Amended and Restated Herbalife Ltd. 2005 Stock Incentive Plan
|
|
(h) |
|
|
|
|
|
10.31#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit Award Agreement
|
|
(i) |
|
|
|
|
|
10.32#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Appreciation Right Award Agreement
|
|
(i) |
|
|
|
|
|
10.33#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit Award Agreement applicable to Mr.
Michael O. Johnson
|
|
(j) |
|
|
|
|
|
10.34#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Appreciation Right Award Agreement
applicable to Mr. Michael O. Johnson
|
|
(j) |
|
|
|
|
|
10.35#
|
|
Amendment to Herbalife Ltd. Independent Directors Deferred Compensation and Stock Unit Plan
|
|
(k) |
|
|
|
|
|
10.36#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit Award Agreement applicable to Messrs.
Brett R. Chapman and Richard Goudis
|
|
(l) |
|
|
|
|
|
10.37#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Appreciation Right Award Agreement
applicable to Messrs. Brett R. Chapman and Richard Goudis
|
|
(l) |
|
|
|
|
|
10.38
|
|
Form of Credit Agreement, dated as of July 21, 2006, by and among Herbalife International Inc.,
Herbalife Ltd., WH Intermediate Holdings Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L.,
Herbalife International Luxembourg S.á.R.L., HLF Luxembourg Holdings, S.á.R.L., WH Capital
Corporation, WH Luxembourg Intermediate Holdings S.á.R.L., HV Holdings Ltd., Herbalife
Distribution Ltd., Herbalife Luxembourg Distribution S.á.R.L., and the Subsidiary Guarantors party
thereto in favor of Merrill Lynch Capital Corporation, as Collateral Agent
|
|
(m) |
|
|
|
|
|
10.39
|
|
Form of Security Agreement, dated as of July 21, 2006, by and among Herbalife International, Inc.,
Herbalife Ltd., WH Intermediate Holdings Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L.,
Herbalife International Luxembourg S.á.R.L., HLF Luxembourg Holdings, S.á.R.L., WH Capital
Corporation, WH Luxembourg Intermediate Holdings S.á.R.L., HV Holdings Ltd., Herbalife
Distribution Ltd., Herbalife Luxembourg Distribution S.á.R.L., and the Subsidiary Guarantors party
thereto in favor of Merrill Lynch Capital Corporation, as Collateral Agent
|
|
(m) |
|
|
|
|
|
10.40#
|
|
Amended and Restated Independent Directors Deferred Compensation and Stock Unit Plan
|
|
(m) |
|
|
|
|
|
10.41#
|
|
Employment Agreement by and between Herbalife Ltd. and Brett R. Chapman dated October 10, 2006
|
|
(n) |
|
|
|
|
|
10.42#
|
|
Stock Unit Agreement by and between Herbalife Ltd. and Brett R. Chapman dated October 10, 2006
|
|
(n) |
|
|
|
|
|
10.43#
|
|
Amendment dated October 10, 2006, to Stock Option Agreement by and between Herbalife Ltd. and
Brett R. Chapman dated September 1, 2004
|
|
(n) |
|
|
|
|
|
10.44#
|
|
Amendment dated October 10, 2006, to Stock Option Agreement by and between Herbalife Ltd. and
Brett R. Chapman dated December 1, 2004
|
|
(n) |
|
|
|
|
|
10.45#
|
|
Amendment dated October 10, 2006, to Stock Option Agreement by and between Herbalife Ltd. and
Brett R. Chapman dated April 27, 2005
|
|
(n) |
|
|
|
|
|
10.46#
|
|
Employment Agreement by and between Herbalife Ltd. and Richard P. Goudis dated October 24, 2006
|
|
(o) |
|
|
|
|
|
10.47#
|
|
Stock Unit Agreement by and between Herbalife Ltd. and Richard P. Goudis dated October 24, 2006
|
|
(o) |
|
|
|
|
|
10.48#
|
|
Amendment dated October 24, 2006, to Stock Option Agreement by and between Herbalife Ltd. and
Richard P. Goudis dated June 14, 2004
|
|
(o) |
|
|
|
|
|
10.49#
|
|
Amendment dated October 24, 2006, to Stock Option Agreement by and between Herbalife Ltd. and
Richard P. Goudis dated September 1, 2004
|
|
(o) |
|
|
|
|
|
10.50#
|
|
Amendment dated October 24, 2006, to Stock Option Agreement by and between Herbalife Ltd. and
Richard P. Goudis dated December 1, 2004
|
|
(o) |
|
|
|
|
|
10.51#
|
|
Amendment dated October 24, 2006, to Stock Option Agreement by and between Herbalife Ltd. and
Richard P. Goudis dated April 27, 2005
|
|
(o) |
|
|
|
|
|
10.52#
|
|
Form of Herbalife Ltd. 2005 Stock
Incentive Plan Stock Unit Award Agreement applicable to Michael O Johnson
|
|
(p) |
54
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
Description |
|
Reference |
|
|
|
|
|
10.53#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Appreciation Right Award Agreement
applicable to Michael O. Johnson
|
|
(p) |
|
|
|
|
|
10.54#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit Award Agreement applicable to Messrs.
Richard P. Goudis and Brett R. Chapman
|
|
(p) |
|
|
|
|
|
10.55#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Appreciation Right Award Agreement
applicable to Messrs. Richard P. Goudis and Brett R. Chapman
|
|
(p) |
|
|
|
|
|
10.56#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Unit Award Agreement
|
|
(p) |
|
|
|
|
|
10.57#
|
|
Form of Herbalife Ltd. 2005 Stock Incentive Plan Stock Appreciation Right Award Agreement
|
|
(p) |
|
|
|
|
|
10.58
|
|
First Amendment dated June 21, 2007, to Form of Credit Agreement, dated as of July 21, 2006, by
and among Herbalife International Inc., Herbalife Ltd., WH Intermediate Holdings Ltd., HBL Ltd.,
WH Luxembourg Holdings S.á.R.L., Herbalife International Luxembourg S.á.R.L., HLF Luxembourg
Holdings, S.á.R.L., WH Capital Corporation, WH Luxembourg Intermediate Holdings S.á.R.L., HV
Holdings Ltd., Herbalife Distribution Ltd., Herbalife Luxembourg Distribution S.á.R.L., and the
Subsidiary Guarantors party thereto in favor of Merrill Lynch Capital Corporation, as Collateral
Agent
|
|
(q) |
|
|
|
|
|
10.59
|
|
Second Amendment dated September 17, 2007, to Form of Credit Agreement, dated as of July 21, 2006,
by and among Herbalife International Inc., Herbalife Ltd., WH Intermediate Holdings Ltd., HBL
Ltd., WH Luxembourg Holdings S.á.R.L., Herbalife International Luxembourg S.á.R.L., HLF Luxembourg
Holdings, S.á.R.L., WH Capital Corporation, WH Luxembourg Intermediate Holdings S.á.R.L., HV
Holdings Ltd., Herbalife Distribution Ltd., Herbalife Luxembourg Distribution S.á.R.L., and the
Subsidiary Guarantors party thereto in favor of Merrill Lynch Capital Corporation, as Collateral
Agent
|
|
(q) |
|
|
|
|
|
10.60
|
|
Third Amendment dated November 30, 2007, to Form of Credit Agreement, dated as of July 21, 2006,
by and among Herbalife International Inc., Herbalife Ltd., WH Intermediate Holdings Ltd., HBL
Ltd., WH Luxembourg Holdings S.á.R.L., Herbalife International Luxembourg S.á.R.L., HLF Luxembourg
Holdings, S.á.R.L., WH Capital Corporation, WH Luxembourg Intermediate Holdings S.á.R.L., HV
Holdings Ltd., Herbalife Distribution Ltd., Herbalife Luxembourg Distribution S.á.R.L., and the
Subsidiary Guarantors party thereto in favor of Merrill Lynch Capital Corporation, as Collateral
Agent
|
|
(r) |
|
|
|
|
|
10.61#
|
|
Herbalife Ltd. Employee Stock Purchase Plan
|
|
(r) |
|
|
|
|
|
10.62
|
|
Fourth Amendment dated February 21, 2008, to Form of Credit Agreement, dated as of July 21, 2006,
by and among Herbalife International Inc., Herbalife Ltd., WH Intermediate Holdings Ltd., HBL
Ltd., WH Luxembourg Holdings S.á.R.L., Herbalife International Luxembourg S.á.R.L., HLF Luxembourg
Holdings, S.á.R.L., WH Capital Corporation, WH Luxembourg Intermediate Holdings S.á.R.L., HV
Holdings Ltd., Herbalife Distribution Ltd., Herbalife Luxembourg Distribution S.á.R.L., and the
Subsidiary Guarantors party thereto in favor of Merrill Lynch Capital Corporation, as Collateral
Agent
|
|
(r) |
|
|
|
|
|
10.63#
|
|
Employment Agreement dated as of March 27, 2008 between Michael O. Johnson and Herbalife
International of America, Inc.
|
|
(s) |
|
|
|
|
|
10.64#
|
|
Stock Unit Award Agreement by and between Herbalife Ltd. and Michael O. Johnson, dated March 27,
2008.
|
|
(s) |
|
|
|
|
|
10.65#
|
|
Stock Appreciation Right Award Agreement by and between Herbalife Ltd. and Michael O. Johnson,
dated March 27, 2008.
|
|
(s) |
|
|
|
|
|
10.66#
|
|
Stock Appreciation Right Award Agreement by and between Herbalife Ltd. and Michael O. Johnson,
dated March 27, 2008.
|
|
(s) |
|
|
|
|
|
10.67#
|
|
Amendment No. 1 to Employment Agreement dated as of April 4, 2008 between Gregory L. Probert and
Herbalife International of America, Inc.
|
|
(t) |
|
|
|
|
|
10.68
|
|
Fifth Amendment dated September 25, 2008, to Form of Credit Agreement, dated as of July 21, 2006,
by and among Herbalife International Inc., Herbalife Ltd., WH Intermediate Holdings Ltd., HBL
Ltd., WH Luxembourg Holdings S.á.R.L., Herbalife International Luxembourg S.á.R.L., HLF Luxembourg
Holdings, S.á.R.L., WH Capital Corporation, WH Luxembourg Intermediate Holdings S.á.R.L., HV
Holdings Ltd., Herbalife Distribution Ltd., Herbalife Luxembourg Distribution S.á.R.L., and the
Subsidiary Guarantors party thereto in favor of Merrill Lynch Capital Corporation, as Collateral
Agent
|
|
(u) |
|
|
|
|
|
10.69#
|
|
Amendment to Herbalife International Inc. 401K Profit Sharing Plan and Trust
|
|
(v) |
55
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
Description |
|
Reference |
|
|
|
|
|
10.70#
|
|
Amendment to Amended and Restated Independent Directors Deferred Compensation and Stock Unit Plan
|
|
(v) |
|
|
|
|
|
10.71#
|
|
Form of Independent Directors Stock Appreciation Right Award Agreement
|
|
(v) |
|
|
|
|
|
10.72#
|
|
Second Amendment to Amended and Restated Independent Directors Deferred Compensation and Stock
Unit Plan
|
|
* |
|
|
|
|
|
10.73#
|
|
Amendment to Form of Independent Directors Stock Appreciation Right Award Agreement
|
|
* |
|
|
|
|
|
31.1
|
|
Rule 13a-14(a) Certification of Chief Executive Officer
|
|
* |
|
|
|
|
|
31.2
|
|
Rule 13a-14(a) Certification of Chief Financial Officer
|
|
* |
|
|
|
|
|
32.1
|
|
Section 1350 Certification of Chief Executive Officer and Chief Financial Officer
|
|
* |
|
|
|
* |
|
Filed herewith. |
|
# |
|
Management contract or compensatory plan or arrangement. |
|
(a) |
|
Previously filed on October 1, 2004 as an Exhibit to the Companys
registration statement on Form S-1 (File No. 333-119485) and is
incorporated herein by reference. |
|
(b) |
|
Previously filed on November 9, 2004 as an Exhibit to Amendment No. 2
to the Companys registration statement on Form S-1 (File No.
333-119485) and is incorporated herein by reference. |
|
(c) |
|
Previously filed on December 2, 2004 as an Exhibit to Amendment No. 4
to the Companys registration statement on Form S-1 (File No.
333-119485) and is incorporated herein by reference. |
|
(d) |
|
Previously filed on December 14, 2004 as an Exhibit to Amendment No. 5
to the Companys registration statement on Form S-1 (File No.
333-119485) and is incorporated herein by reference. |
|
(e) |
|
Previously filed on February 17, 2005 as an Exhibit to the Companys
registration statement on Form S-8 (File No. 333-122871) and is
incorporated herein by reference. |
|
(f) |
|
Previously filed on June 14, 2005 as an Exhibit to the Companys
Current Report on Form 8-K and is incorporated herein by reference. |
|
(g) |
|
Previously filed on February 28, 2006 as an Exhibit to the Companys
Annual Report on Form 10-K for the year ended December 31, 2005 and is
incorporated herein by reference. |
|
(h) |
|
Previously filed on
April 30, 2010 as an Exhibit to the Companys
Current Report on Form 8-K and is incorporated herein by reference. |
|
(i) |
|
Previously filed on March 29, 2006 as an Exhibit to the Companys
Current Report on Form 8-K and is incorporated herein by reference. |
|
(j) |
|
Previously filed on March 29, 2006 as an Exhibit to the Companys
Current Report on Form 8-K and is incorporated herein by reference. |
|
(k) |
|
Previously filed on March 30, 2006 as an Exhibit to the Companys
Current Report on Form 8-K and is incorporated herein by reference. |
|
(l) |
|
Previously filed on March 31, 2006 as an Exhibit to the Companys
Current Report on Form 8-K and is incorporated herein by reference. |
|
(m) |
|
Previously filed on November 13, 2006 as an Exhibit to the Companys
Quarterly Report on Form 10-Q for the quarter ended September 30, 2006
and is incorporated by reference. |
|
(n) |
|
Previously filed on October 12, 2006 as an Exhibit to the Companys
Current Report on Form 8-K and is incorporated herein by reference. |
|
(o) |
|
Previously filed on October 26, 2006 as an Exhibit to the Companys
Current Report on Form 8-K and is incorporated herein by reference. |
|
(p) |
|
Previously filed on May 29, 2007 as an Exhibit to the Companys
Current Report on Form 8-K and is incorporated herein by reference. |
|
(q) |
|
Previously filed on November 6, 2007 as an Exhibit to the Companys
Quarterly Report on Form 10-Q for the quarter ended September 30, 2007
and is incorporated by reference. |
|
(r) |
|
Previously filed on February 26, 2008 as an Exhibit to the Companys
Annual Report on Form 10-K for the year ended
December 31, 2007 and is
incorporated herein by reference. |
56
|
|
|
|
(s) |
|
Previously filed on April 7, 2008 as an Exhibit to the Companys
Current Report on Form 8-K and is incorporated herein by reference. |
|
(t) |
|
Previously filed on April 9, 2008 as an Exhibit to the Companys
Current Report on Form 8-K and is incorporated herein by reference. |
|
(u) |
|
Previously filed on November 3, 2008 as an Exhibit to the Companys
Quarterly Report on Form 10-Q for the quarter ended September 30, 2008
and is incorporated by reference. |
|
(v) |
|
Previously filed on May 4, 2009 as an Exhibit to the Companys
Quarterly Report on Form 10-Q for the quarter ended March 31, 2009 and
is incorporated by reference. |
57
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
HERBALIFE LTD.
|
|
|
By: |
/s/ JOHN DESIMONE
|
|
|
|
John DeSimone |
|
|
|
Chief Financial Officer |
|
|
Dated: May 3, 2010
58